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ABSTRACT 
Ion channels are proteins that traverse the cell membrane and form gated pores that open 
and close in response to various stimuli.  In order to experimentally probe aspects of ion 
channel functionality, we performed subtle structure-function studies using the in vivo 
nonsense-suppression method, which allows for the incorporation of synthetically 
accessible unnatural amino acids and hydroxy acids into an ion channel at a site of 
interest. 
Fluorinated aromatic amino acids are good probes for a cation-π interaction because 
fluorine substituents reduce the binding affinity of the aromatic for a cation in a linear, 
step-wise fashion.  In collaboration with Professor Richard Horn at the Thomas Jefferson 
University, we substituted a series of fluorinated-phenylalanines for important tyrosines 
in the Shaker B K+ channel and experimentally determined that TEA was binding to the 
residues through a cation-π interaction.  We also determined that Ca2+ binds to and blocks 
the NaV1.4 channel through a cation-π interaction with a tyrosine at the top of the pore of 
this channel.  We found that tetrodotoxin, another channel blocker, also binds to this 
same residue through a cation-π interaction.  Finally, we proved that lidocaine and other 
local anesthetics bind to a phenylalanine at the bottom of the pore of this channel through 
a cation-π interaction. 
An important aspect of our work is the development of unnatural amino acids that can be 
used in the study of ion channels through the in vivo nonsense-suppression methodology.  
We determined that D-amino acids could not be incorporated into ion channels using this 
method. We synthesized several novel fluorescent-MTS reagents to be used in FRET 
 
ix 
studies.  We probed the sterics around phenylalanines using the unnatural amino acid 3,5-
dimethylphenylalanine. We also attempted to incorporate 4-amino-phenylalanine, but, 
unfortunately, we never saw the enhanced binding of a cationic ligand that was our 
expected phenotype. 
Finally, we also designed and synthesized two α-hydroxy acids capable of site-specific 
proteolysis upon UV irradiation.  We used a tripeptide model system to isolate and 
characterize the cleavage fragments, proving that these two residues are indeed capable 
of site-specific proteolysis through the predicted mechanism. 
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C h a p t e r  I 
 
SUMMARY 
 
I like nonsense, it wakes up the brain cells. 
~ Dr. Seuss 
 
While Theodore Seuss Geisel, more commonly known as Dr. Seuss, was referring to his 
affection for fantasy, this quote has a slightly different meaning for this thesis:  it 
humorously merges the crucial methodology described herein, nonsense suppression, 
with this thesis’s overarching interest in understanding the intricacies of the brain.  
Applying the in vivo nonsense-suppression methodology to neurobiology “wakes up” 
studies on proteins important to learning, memory, addiction, and disease by moving 
beyond the twenty natural amino acids and into a realm of amino acids that is limited 
only by imagination and, of course, the ribosome.   
 
Introduction 
The human brain is made up of approximately 100 billion neurons, and each neuron 
makes approximately 10,000 synaptic connections to other neurons.  This complex 
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neuronal network uses both electrical and chemical signals to rapidly pass information 
from one neuron to the next.  A signal in one neuron is propagated through that neuron in 
the form of an electrical current, which culminates in the release of small molecules, 
called neurotransmitters, upon reaching the end of the axon.  These neurotransmitters 
diffuse across the synapse until they connect with the postsynaptic neuron (figure 1.1).  
To encode the thoughts, sounds, smells, and more that occur to a human brain, the 
specificity of the wiring of the neurons and the precise patterns of signals are thought to 
be crucial.  To begin to explore this complexity, our studies focus on one type of protein, 
the ion channel, which is found across the surface of the neuron and is immensely 
important to neuronal communication.  Voltage-gated ion channels propagate the 
electrical impulse that flows through a neuron, and ligand-gated ion channels located 
across the synapse translate the chemical message of the neurotransmitters sent by the 
presynaptic neuron into an electrical signal in the postsynaptic neuron.  
Ion channels are dynamic proteins found in the membranes of not only neurons but also 
all other types of cells.  These proteins allow their namesake, ions, to pass into and out of 
cellular compartments, essentially creating an electrical current (figure 1.2).1  They 
function by remaining closed until triggered by an external stimulus, such as the binding 
of a small molecule, a change in membrane voltage, or the tensing of the membrane, 
which alters the protein structure in such a way as to open the channel.  The resulting 
pore in the membrane is not a featureless hole.  Instead, it is rich in structure and can 
select for the passage of certain ions over others down their chemical gradient.  There 
exist K+-selective channels, Na+-selective channels, channels that select for a wider range 
of cations, and Cl--selective channels, all of which will be discussed in this thesis. 
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Figure 1.1.  An illustration of signals traveling through nerve cells in the brain. 
 
4 
 
 
Figure 1.2.  An illustration of the current produced by an ion channel upon the binding of 
neurotransmitters. 
 
A Brief Introduction to Four Ion Channels 
Shaker B K+ Channel 
The first ion channel studied in this thesis is the voltage-gated K+ channel Shaker B 
(ShB).  This channel appears in chapters 2, 6, 7, and 8.  ShB is a homotetramer that has a 
long intracellular N-terminus, six transmembrane domains with a pore loop between the 
fifth and sixth transmembrane domains, and a short intracellular C-terminus (figure 1.3).  
The fourth transmembrane helix of this channel contains several positively charged 
arginines that allow it to sense changes in the voltage across the membrane of the cell.  
The movement of this helix is thought to pull the channel open when the cell becomes 
depolarized.  By responding to changes in voltage, K+ channels can control the action 
potential, the electrical impulse that travels down an axon.  
Neurotransmitter 
Ion Flow = Current 
Ligand-Gated Ion Channel 
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As revealed upon the publication of the crystal structure of the bacterial K+ channel 
KcsA,2 this channel and others in its family select for K+ because of the ordered 
framework of amino acids located in the pore loop; specifically, the conserved GYG 
residues position their backbone carbonyls into the pore, and when aligned together with 
the other subunits, the carbonyls mimic the hydration shell that typically surrounds a K+ 
ion. Another characteristic feature more specific to ShB is rapid N-type inactivation, 
which is the blocking of the channel by the N-terminus of one of its subunits almost 
immediately upon channel activation (figure 1.3).  The first twenty amino acids of the N-
terminus make up a “ball” that is connected through a “chain” of amino acids to the 
channel.  N-type channel inactivation occurs when one of the four balls of the 
homotetrameric channel swings up and plugs the channel.3-6  Removal of the N-terminus 
region of the protein eliminates this N-type inactivation.   
 
Figure 1.3.  Views of the K+ channel.  A)  Schematic of one subunit of ShB.  The S4 domain is voltage-
sensing component of the channel.  C)  Representation of the K+ channel Kv1.2, which is similar in 
structure to ShB, adapted from Long et al.7  TM = Transmembrane domain, T1 = N-terminal intracellular 
domain, β = β subunit. 
A) B)  Open                               Inactivated 
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NaV1.4 Na+ Channel 
The voltage-gated Na+ channel NaV1.4 is the second channel that is explored in this 
thesis; it is found in chapters 3, 4, and 5 and makes a brief appearance in chapter 7. While 
this specific channel is closely associated with skeletal muscle, Na+ channels are also 
involved in the rise of the action potential in a neuron.  The structure of this channel is 
similar to that of a K+ channel except that this channel is composed of only one subunit 
with 24 transmembrane domains (figure 1.4).  The protein is divided into four domains 
(D1-D4), and each resembles a K+ channel subunit with six transmembrane helices and a 
reentrant pore loop.  A crystal structure of the Na+ channel has not yet been published, 
but Lipkind and Fozzard have made a model of the transmembrane helices nearest the 
pore (S5-P-S6 for all four domains) using the crystal structure of the K+ channel KcsA 
(figure 1.4B, C).8  Highlighted in figure 1.4C are the four residues thought to make the 
most important contributions to the selectivity of this channel for Na+: aspartate, 
glutamate, lysine, and alanine, from D1, D2, D3, and D4, respectively.  
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Figure 1.4. Views of the Na+ channel.  A)  Topology of a voltage-gated Na+ channel. Na+ channels are 
composed of four domains (D1-D4), each with six transmembrane segments.  The + labels the primary 
component of the voltage-sensor, and the P labels the reentrant pore loop.  B)  Space-filling model of the 
NaV1.4 as published by Lipkind and Fozzard.8  C)  A close-up view of the DEKA selectivity filter as 
published by Lipkind and Fozzard.8 
 
Nicotinic Acetylcholine Receptor 
The nicotinic acetylcholine receptor (nAChR) is the prototypical ligand-gated ion channel 
and is explored in chapters 6, 7, and 8.  Unlike the two channels introduced above, it 
A) 
B) C) 
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allows for a range of cations to pass through its pore, it has a large extracellular domain 
that has evolved to bind acetylcholine, and it is made up of a pentagonal array of 
subunits.  In humans there are 17 nAChR subunits, α1-10, β1-4, δ, γ, and ε.  The nAChR 
used in this study is found in muscle fibers and made up of two α1 subunits, a β1 subunit, 
a δ subunit, and a γ subunit.9  The muscle nAChR serves as a model for neuronal 
nAChRs, which is important for gaining insight into synaptic ACh signaling between 
neurons, nicotine addition (nicotine mimics ACh in the extracellular binding site of this 
protein), and mental disorders such as schizophrenia, attention deficit hyperactivity 
disorder, Alzheimer’s disease, Parkinson’s disease, and more. 
Each subunit has a large N-terminal domain and four transmembrane domains.  The α 
subunits are characterized by a loop formed by a disulfide bond between two cysteines in 
the N-terminal domain of the protein, appropriately named the Cys loop.  Each α subunit 
(yellow in figure 1.5) can also provide four of the five aromatic amino acids that make up 
the binding site for acetylcholine (circled in figure 1.5C).  The fifth aromatic amino acid 
in the binding site is provided by the neighboring subunit (blue in figure 1.5), which can 
be either an α or a non-α subunit.  The second transmembrane domain (TM2) of each 
nAChR subunit predominantly lines the pore of the channel.  A ring of leucines, one from 
each TM2, forms part of the hydrophobic band that occludes the pore of the channel 
when closed (highlighted with a red arrow in figure 1.5).  This leucine is called Leu9’.  
The association of acetylcholine in the binding site created by the five aromatic amino 
acids in the extracellular domain results in a conformational change in the protein that 
ultimately widens this band of leucines enough to allow cations to flow through the 
channel.  
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Figure 1.5.  Views of the nAChR.  A)  An illustration of the pentameric channel.  B)  Each subunit has a 
large extracellular domain and four transmembrane domains.  The α subunit is characterized by the Cys 
loop.  C)  Representation of a nAChR from PDB 2BG9.10  The binding box (top circle) and a pore lining 
leucine (Leu9’, bottom arrow) are highlighted. 
 
GABAC Receptor 
Ionotropic GABA receptors are the dominant inhibitory channels in the brain, though the 
specific type of GABA receptor studied in chapter 7, the GABAC receptor, is primarily 
A) 
B) 
C) 
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associated with the retina.  These channels are so named because they bind and open in 
response to the neurotransmitter γ-aminobutyric acid (GABA).  Since GABA receptors 
are in the Cys-loop superfamily with nAChRs,11 they are very similar in structure to the 
channels described immediately above, but they specifically select for Cl- ions instead of 
cations.  Like nAChRs, these channels are made up of a pentagonal array of subunits, and 
the specific channel studied in this thesis is a homopentamer of ρ1 subunits.  Also like 
nAChRs, the large extracellular domain of this channel has a ligand-binding site that 
consists of aromatic amino acids. 
 
The Power of Unnatural Amino Acids 
Ion channels are dynamic proteins.  Therefore, while the structures shown above provide 
an extensive amount of information about the structure of these proteins, they are static 
pictures capturing only a moment in the life of the active protein and can only provide 
predictions on how the protein functions in vivo.  To truly understand how structure 
relates to function in a channel, the channel needs to be studied while opening, closing, 
and going through all of the other states in its natural gating pathway.  
The traditional method for exploring structure-function relationships in ion channels is 
through conventional mutagenesis, where the DNA for the protein of interest is altered so 
that it encodes a sequence that contains amino acid changes at known sites.  For instance, 
if the importance of a phenylalanine was being explored, then the side chain could be 
ablated by mutating the residue to alanine, or the global importance of having a generic 
aromatic amid acid at this site could be explored by mutating the residue to one of the 
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other natural aromatic amino acids, tyrosine or tryptophan (figure 1.6).  Each of these 
mutations alters many of the features of the phenylalanine though, so only global 
information can be gained.  If the limits imposed by the 20 natural amino acids are lifted, 
then chemical-scale explorations into the importance of the aromaticity of the ring could 
begin with the replacement of the aromatic ring with a cyclohexyl ring, creating 
cyclohexylalanine.  As shown in figure 1.6, cyclohexylalanine is similar in size and shape 
to phenylalanine.  Because of the more subtle change with a phenylalanine to 
cyclohexylalanine mutation, any difference in the function of an ion channel could be 
interpreted as due to the direct loss of the aromatic nature of that specific residue. To 
gradually reduce the aromatic character of the phenylalanine instead of simply removing 
it, fluorine atoms could be substituted for the hydrogen atoms on the aromatic ring.  Since 
fluorine atoms are electronegative, they will pull a small amount of electron density away 
from the ring.  The electrostatic potential surfaces of benzene and the various fluorinated 
benzenes in figure 1.6 show that as the number of fluorine substituents on the ring is 
increased, the negative potential (red) on the surface of the ring is reduced.  These 
examples are just the beginning of the chemical-scale structure-function questions that 
can be addressed using unnatural amino acids.    
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Figure 1.6.  Unnatural mutagenesis allows for more subtle alteration in the structure of an amino acid such 
as phenylalanine than conventional mutagenesis. 
 
The In Vivo Nonsense-Suppression Method 
The in vivo nonsense-suppression method was developed as an extension of conventional 
mutagenesis for the purpose that was described above:  probing specific structure-
function relationships in ion channels.12  It offers a highly sensitive assay that allows for 
site-specific control over the structure of ion channels while they function in a membrane.  
The technology is similar to conventional mutagenesis, but instead of mutating the amino 
acid of interest to one of the twenty coded amino acids, almost any unnatural amino acid 
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UAG 
or α-hydroxy acid can be selected.  This versatility is due to the hijacking of the 
translational system.  In the nonsense-suppression method the codon for the amino acid 
of interest has been converted to a blank codon, either a stop codon (typically UAG) or a 
four-base codon (typically GGGU), which is not recognized by a natural tRNA (figure 
1.7).  A combination of chemical synthesis and molecular biology allow the blank codon 
to instead be recognized by an orthogonal suppressor tRNA acylated with the desired 
unnatural amino acid.13,14  The development of this method followed the work of Schultz 
and co-workers, who first reported a general procedure for the incorporation of unnatural 
amino acids in vitro using the E. coli translational system.15,16  Nonsense suppression was 
adapted for use in vivo with the heterologous expression system Xenopus laevis oocytes 
by former members of the Dougherty laboratory in order to functionally study ion 
channels.12,17  The specific advantages of the Xenopus oocyte include the ease of 
injection; the few endogenous channels; and the stores of enzymes, organelles, and 
proteins that efficiently produce foreign protein.18,19   
 
Figure 1.7.  The hijacking of the translation machinery that occurs in nonsense suppression. 
mRNA with UAG or 
four-base codon at 
site of interest 
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The specifics of the in vivo nonsense-suppression method as used in this thesis are 
outlined below (figure 1.8).  First, either the nonsense codon TAG or the four-base codon 
GGGT are inserted at the site of interest in the DNA that encodes the ion channel being 
studied.  The DNA is then converted to mRNA using in vitro methodology, giving 
mRNA with a UAG or a GGGU codon at the site of interest (, figure 1.8).  Second, the 
desired unnatural amino acid is protected on its amine, activated as an ester, and then 
coupled to a dinucleotide that mimicks the 3’ end of tRNA, dCA (the 2’ hydroxyl of 
cytosine is removed since it is not necessary for translation and since its deletion 
increases the specificity of aminoacylation).  The acylated dinucleotide is then ligated to 
a suppressor tRNA (either THG73 with its CUA anticodon or YFaFs with its ACCC 
anticodon) using T4 RNA ligase (, figure 1.8).  Third, the mRNA and the tRNA are 
coinjected into a Xenopus oocyte (, figure 1.8) where protein synthesis, processing, 
assembly, and transportation to the surface are carried out by the Xenopus translation 
system (, figure 1.8).20  Finally, the functional consequences of the mutagenesis can be 
studied using established two-electrode voltage clamp techniques (, figure 1.8).  It 
should be noted that the amount of protein synthesized by the Xenopus oocyte is limited 
by the amount of tRNA added to the system since the tRNA cannot be reaminoacylated 
by the cell.  This drawback restricts the widespread use of this technique, since not all 
protein function assays are as sensitive as electrophysiology. 
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Figure 1.8.  An outline of the experimental steps for in vivo nonsense suppression. 
 
Exploiting the Scope of Nonsense Suppression 
The work in this thesis takes advantage of many different unnatural amino acids to 
explore many different proteins.  In the first half of this thesis, the fluorinated 
phenylalanine derivatives and cyclohexylalanine introduced above in figure 1.6 were 
used to explore four different hypothesized cation-π interactions between the voltage-
gated channels ShB and NaV1.4 and several cationic small molecules known to 
selectively block these channels.  Only when a small aromatic is perched at the top of the 
pore in ShB can TEA can block this channel.21-23  Early work suggested that a cation-π 
interaction was important,22 but more recently published crystal structures rejected this 
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proposal.  The experimental work discussed in chapter 2 proves that a cation-π 
interaction is important for the association of this blocker to the channel.24  Chapters 3 
through 5 represent the first examples of in vivo nonsense suppression on NaV1.4.  The 
first studies in this channel targeted an important tyrosine in NaV1.4 that is located in the 
pore just above the aspartate in the DEKA selectivity filter.  This tyrosine, Tyr401, was 
found to bind two of its known channel blockers, Ca2+ and tetrodotoxin, through a cation-
π interaction, as discussed in chapter 3 and 4.25,26  Several aromatic residues at the bottom 
of the pore of NaV1.4 have been linked to anesthetic block of this channel.27,28  The work 
in chapter 5 shows that only one, Phe1579, binds lidocaine and other cationic anesthetics 
through a cation-π interaction.29 
The second half of this thesis serves to enhance and explore the variety of unnatural 
amino acids that can be incorporated by nonsense suppression.  This technique has been 
used to incorporate over 100 amino acids and α-hydroxy acids (figure 1.9), and this 
number will expand as novel unnatural amino acids are designed to probe new and 
specific structure-function relationships in ion channels.30  This thesis describes several 
such novel unnatural amino acids and α-hydroxy acids, their syntheses, and their 
incorporation (or attempts at incorporation) in the four ion channels introduced above.  
D-amino acids were targeted for their ability to achieve backbone peptide bond angles 
that are rare for natural L-amino acids.  Unfortunately, as seen in chapter 6, D-amino 
acids were not compatible with nonsense suppression.  In chapter 7 a variety of aromatic 
unnatural amino acids were studied, each for its unique properties.  First, a set of 
fluorophore tags was synthesized for the purpose of making fluorescent amino acids in 
situ.  Next, 3,5-dimethylphenylalanine was designed to probe the sterics around the meta 
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position of important phenylalanines.  Finally, 4-amino-phenylalanine was incorporated 
into several known cation-π interaction sites in the anticipation that it would enhance the 
binding of the small molecule to the channel.  Unfortunately, the expected functional 
enhancement was not seen in ShB, GABAC, or nAChR.  In chapter 8, the last chapter of 
this thesis, the synthesis is described of two novel unnatural α-hydroxy acids that were 
designed to site-specifically cleave the backbone of a protein upon irradiation with UV 
light.31  Much of the chapter is devoted to the work that went into the design and 
optimization of the model system that was used to prove that both α-hydroxy acids were 
capable of proteolysis.  Though successful in the model system, their success in vivo has 
yet to be seen. 
 
Figure 1.9.  Examples of unnatural amino acids and α-hydroxy acids that have been incorporated into 
proteins using in vivo nonsense suppression. 
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Conclusion 
The work included in this thesis focuses on understanding chemical-scale features of 
important proteins relevant to the nervous system through the use of the in vivo nonsense-
suppression technique.  Proving that TEA binds to the aromatic at the top of the pore of 
ShB through a cation-π interaction dispels the controversy created upon the introduction 
of the K+ channel crystal structure.  Understanding how tetrodotoxin and lidocaine bind 
to NaV1.4 not only provides structural information as to how these blockers function but 
also aids in the mapping of the still mysterious Na+ channel pore. 
This thesis also serves to expand the limits of the nonsense-suppression methodology by 
testing its boundaries and adding more unnatural amino acids to its library.  The 
development of novel unnatural amino acids is important to expand the scope structure-
function relationships investigated.  The design and synthesis of 3,5-
dimethylphenylalanine added another dimension to the study of the sterics around 
phenylalanines.  Because of it, interesting functional maps can be created that would have 
otherwise been missed.  The two novel α-hydroxy acids capable of cleaving the peptide 
backbone upon photolysis provide another means for exploring the importance of 
covalent connections in these and other dynamic proteins.  Together, the many different 
avenues of exploration taken in this thesis all were directed toward enhancing the 
understanding of the brain, the proteins that encourage neuronal communication, and an 
important technique used to study those types of proteins. 
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C h a p t e r  I I 
 
A CATION-π INTERACTION BETWEEN EXTRACELLULAR TEA AND AN 
AROMATIC RESIDUE IN POTASSIUM CHANNELS 
 
Open-channel blockers such as tetraethylammonium (TEA) have a long history as probes 
of the permeation pathway of ion channels.  High-affinity blockade by extracellular TEA 
requires the presence of an aromatic amino acid at a position that sits at the external 
entrance of the permeation pathway (residue 449 in the eukaryotic voltage-gated K+ 
channel Shaker B (ShB)).  The importance of a cation-π interaction between TEA and 
such an aromatic residue to TEA block was investigated using the in vivo nonsense-
suppression method to incorporate a series of increasingly fluorinated-phenylalanine side 
chains at position 449.  Fluorination, which is known to decrease the cation-π binding 
ability of an aromatic ring, progressively increased the inhibitory constant Ki for TEA 
block of ShB.  A larger increase in Ki was observed when the benzene ring of Phe449 
was substituted by nonaromatic cyclohexane.  These results support a strong cation-π 
component to the TEA block.  The data provide an empirical basis for choosing between 
ShB models that are based on two classes of reported crystal structures for the bacterial 
channel KcsA, showing residue Tyr82 in orientations either compatible or incompatible 
with a cation-π mechanism.  We propose that the aromatic residue at this position in ShB 
is favorably oriented for a cation-π interaction with the permeation pathway.  This choice 
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is supported by high-level ab initio calculations of the predicted effects of phenylalanine 
modifications on TEA binding energy. 
 
Introduction 
It is exactly a decade since the ion channel field was electrified by the first atomic-
resolution images of a K+-selective ion channel, the KcsA channel from the bacterium 
Streptomyces lividans.1  Since then, a number of important K+ channel structures have 
appeared, all but one imaging a channel of bacterial origin. The KcsA structure (and 
subsequent structures of other K+ channels) was consistent with and rationalized a wide 
range of biochemical and biophysical studies of K+ channels, clearly establishing its 
relevance to mammalian K+ channels—including the location of a residue associated with 
blockade of K+ channels by the external application of the cation TEA.  For many years 
open-channel blockers such as TEA have been exploited to gain insights into the 
processes of gating and permeation.2-13  Tyr82 of KcsA is positioned at the mouth of the 
channel in a location that appears well suited to binding extracellular TEA.  This KcsA 
residue aligns with Thr449 in the eukaryotic ShB, and early work established its critical 
role for external TEA blockade.  In particular, high-affinity blockade by TEA requires an 
aromatic amino acid (tyrosine or phenylalanine) at this site;4,6,14 the ShB mutants 
Thr449Tyr and Thr449Phe have high TEA affinity, as do other K+ channels that naturally 
have a tyrosine or phenylalanine at the aligned site.4,15,16   Aromaticity is critical, as 
nonaromatic amino acids either more hydrophobic, such as leucine, isoleucine, and 
valine, or more hydrophilic, such as serine, threonine, glutamate or lysine, lead to low-
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affinity block by extracellular TEA.6,17  The unique requirement of an aromatic amino 
acid at position 449 led Heginbotham and MacKinnon to propose that a cation-π 
interaction was critical to the high-affinity binding of TEA.6  An optimal cation-π 
interaction is supported only if the cation, in this case TEA, interacts with the face, not 
the edge, of the aromatic ring, an arrangement that will be referred to as en face.   
Reported crystal structures of KcsA actually show two orientations for residue Tyr82.  In 
support of the cation-π hypothesis, a recent crystal structure of a noninactivating mutant 
of KcsA shows an en face orientation of Tyr82 (orange side chain, figure 2.1B),18 
suggesting that this orientation might be obtained in eukaryotic K+ channels. However, 
other reported KcsA structures pose a possible problem.  Specifically, the side chain of 
Tyr82 in many published structures of KcsA (e.g., 1BL8,1 1K4C,19 1R3J,20 2A9H,21 and 
1ZWI18 in the Protein Data Bank, www.rcsb.org/pdb/) is aligned such that a TEA 
positioned to block the channel would not interact with the face of the aromatic ring (blue 
side chains in figure 2.1).  Furthermore, several molecular dynamics studies of KcsA 
complexed with TEA support this nonoptimal geometry at Tyr82, such that the edges of 
the tyrosine rings point toward the blocker.22-25  Indeed, a subsequent crystal structure of 
KcsA complexed with the TEA analogue tetraethylarsonium (TEAs) also has this edge-
on conformation.26   It was thus concluded that a cation-π interaction was not involved in 
binding TEA to KcsA, but rather the crucial tyrosine influenced the local hydration 
structure of the binding site.  
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Figure 2.1. Two orientations of Tyr82 residues of KcsA. The atomic coordinates (2BOC and 2ATK) were 
obtained from the Protein Data Bank. 2BOC (blue) is wild-type KcsA cocrystallized with TEAs.26  2ATK 
(orange) is one of two crystal forms of the E71A mutant.18  The first is a side view of two opposing 
subunits of 2BOC with TEAs, and the second is the top view of 2BOC aligned with 2ATK, showing the 
approximate en face orientation of Tyr82 in 2ATK. 
 
There is, therefore, support both for and against a cation-π interaction at the aromatic 
residue at the entrance to K+ channels.  Simulation studies of the edge-on KcsA channel 
argue against a cation-π interaction, but the binding studies of TEA to eukaryotic K+ 
channels, and the recent en face KcsA structure, allow for such an interaction.  Here a 
cation-π mechanism in ShB will be directly assessed using a definitive probe developed 
for functional ion channels and receptors.  Modifying the side chain of an aromatic amino 
acid with fluorine substantially diminishes the cation-π binding ability of the aromatic 
ring, and multiple substitutions produce additive effects.27-30  Such substitutions in ShB 
are achieved using the nonsense-suppression methodology for unnatural amino acid 
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incorporation.31  This methodology has numerous advantages, making it ideal for probing 
potential cation-π interactions.  In comparison to conventional mutagenesis, the steric 
perturbation introduced by fluorine substitution is universally considered to be minimal.  
Also, fluorine substitution does not substantially alter the hydrophobicity of the ring.  For 
example, benzene and hexafluorobenzene have nearly identical logP (water/octanol 
partition) values.32  Therefore, induced affinity shifts in cation binding cannot be 
attributed solely to effects of hydrophobicity.  This fluorination strategy has been 
successfully used to probe cation binding sites in the nicotinic acetylcholine receptor 
(nAChR),33 the 5-HT3 receptor,34,35 the GABAC receptor,36 the GABAA receptor,37 the 
NMDA receptor,38 and more. 
In this study a choice between the edge-on and en face orientations is provided by 
applying the side chain fluorination approach to position 449 of ShB.  A compelling 
correlation is found between degree of fluorination of the phenylalanine suppressed at 
Thr449 and loss of TEA affinity. The correlation is supported by ab initio quantum 
mechanical calculations of the two disparate models of the TEA binding site.  Therefore, 
there is, indeed, a significant cation-π interaction involved in the binding of TEA to ShB, 
suggesting that an aromatic residue at this position adopts an en face orientation.  
 
 
27 
 
Results 
Synthesis of Fluorinated Phenylalanine-tRNA 
To fully explore the importance of the potential cation-π interaction between TEA and 
the aromatic residues at position 449 in ShB using in vivo nonsense-suppression 
technology, tRNAs aminoacylated with threonine, which is identical to the wild-type 
residue; with successively fluorinated phenylalanines, which increasingly reduce the 
negative electrostatic potential on the face of the aromatic ring; and with 
cyclohexylalanine, which completely abolishes the aromatic nature while mimicking the 
sterics of phenylalanine, were necessary.  The synthesis of phenylalanine-tRNA is shown 
in scheme 2.1.31,39,40  The amine was first protected with the nitroveratryloxycarbonyl 
(NVOC) photolabile protecting group.41  Next, the acid was activated as a cyanomethyl 
ester.  This compound was then coupled to the tetrabutylammonium salt of dCA.  At this 
point, the amino acid can be attached to either the 2’ or the 3’ hydroxyl of dCA since it is 
thought to rapidly sample both sites.  Finally, the aminoacylated dCA was ligated to 
THG-73 using T4 RNA ligase. 
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Scheme 2.1. Synthesis of phenylalanine-tRNA. 
 
The synthesis of 3,5-F2-phenylalanine-dCA was attempted, but while the protection of 
the amine and the activation of the acid were successful, the coupling of the compound to 
dCA was never productive (scheme 2.2).  Therefore, 3,5-F2-phenylalanine-dCA was 
obtained from Dr. Niki Zacharias, a former graduate student in the Dougherty laboratory.  
4-F-Phenylalanine-dCA, 3,4,5-F3-phenylalanine-dCA, cyclohexylalanine-dCA, and 
threonine-dCA were also acquired thanks to the synthetic efforts of Dr. Tingwei Mu, Dr. 
Wenge Zhong, and other former members of the Dougherty laboratory.  
 
Scheme 2.2.  Attempt to synthesize 3,5-F2-phenylalanine-tRNA. 
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Evaluating the Role of the Cation-π Interaction 
To test for the role of a cation-π interaction between extracellular TEA and an aromatic 
residue at position 449 of ShB, the phenylalanine analogs described above, were 
incorporated at this site.  Figure 2.2 shows examples of inactivation-removed ShB 
currents obtained with this method.  In all cases the cRNA encoding for ShB was 
identical, containing a UAG codon at position 449. This cRNA was coinjected into 
oocytes with one of six different constructs of suppressor tRNAs, each containing the 
anticodon CUA and all but one synthetically acylated with an amino acid.  Figure 2.2A-D 
show families of K+ currents in which the tRNAs were acylated with phenylalanine and 
three of its fluorinated derivatives.  Inserts show color-coded electrostatic potential 
surfaces, determined by ab initio calculations, of benzene and these fluorinated 
derivatives.  On this color scale, red indicates negative electrostatic and blue positive 
electrostatic potential.  As shown, successive substitution of fluorine atoms for hydrogen 
atoms on a benzene ring produces a successive decrease in the negative electrostatic 
potential on the face of the aromatic ring, leading to a monotonic decrease in intrinsic 
cation binding ability.27,28  Figure 2.2E shows currents from the mutant cyclohexylalanine 
(Cha) in which the benzene ring of phenylalanine was replaced by cyclohexane.  In 
general the currents in all of the mutants examined had similar kinetics and voltage 
dependence.  Figure 2.2F shows the absence of current from an oocyte coinjected with 
ShB Thr449UAG and a suppressor tRNA that had not been charged with an amino acid 
(dCA-tRNA).  This control ensures that the suppressor tRNA is not reaminoacylated by 
the cell with a natural amino acid, which could then get incorporated into the channel 
protein.  To control for read through, namely the possibility that another tRNA species 
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can incorrectly recognize the UAG codon and attach its amino acid at position 449, 
cRNA for ShB Thr449UAG alone was injected. This control was performed routinely for 
every experiment and also produced no detectable K+ currents, ruling out read through. 
 
Figure 2.2.  Functional expression of unnatural amino acids in ShB at position 449.  A-E) Representative 
families of K+ currents elicited by test depolarizations for 10 mV increments between −60 mV and +50 
mV, from a holding potential of −80 mV.  Leak and capacitance currents were subtracted online with a  
–P/8 protocol.   The label beneath each panel indicates the introduced amino acid.  In each case, the inset 
shows the 6-31G** electrostatic potential surface of benzene derivatives, with red and blue corresponding 
to −20 and +20 kcal/mol, respectively.27,28  The numbered positions of the fluorine atoms are shown with 
respect to the δ-carbon of phenylalanine.  F) Lack of K+ currents originating from cellular tRNA acylation 
when ShB Thr449UAG mRNA was coinjected with an uncharged tRNA. 
 
 
31 
 
The block of extracellular TEA in channels containing six different residues at position 
449 were measured.  These residues included phenylalanine, threonine (wild type), the 
three fluorinated derivatives of phenylalanine, and cyclohexylalanine. In all cases the 
block was rapid, as typically observed for extracellular TEA.42  That is, the blocker 
reduced the macroscopic current amplitude with no effect on gating kinetics (e.g., figure 
2.3A, B).  Figure 2.3C plots the fraction of unblocked channels at +50 mV versus the 
extracellular TEA concentration, and table 2.1 lists the concentrations producing half 
block (Ki) based on fits of dose-response curves in figure 2.3C.  The pivotal role of the 
residue at position 449 is evident in this figure and in table 2.1.  The absolute magnitudes 
and relative Ki values for phenylalanine and the native threonine residue at this position 
in ShB agree with a previous study.6  The affinities differ by nearly two orders of 
magnitude between these two natural amino acid residues, supporting the hypothesis that 
an aromatic residue plays a critical role in TEA binding.  
Table 2.1  Inhibitory constants for TEA block.* 
T449X, where X= Ki (mM) ΔΔG (kcal/mol) 
Phe (n = 10) 0.39 ± 0.04  0 
Thr (n = 7) 33.5 ± 8.9 2.58 
4-F-Phe (n = 5) 3.3 ± 0.6  1.23 
3,5-F2-Phe (n = 7) 47.6 ± 5.9  2.78 
3,4,5-F3-Phe (n = 7) 175.2 ± 36.2  3.54 
Cha (n = 3) 249.2 ± 20.1  3.75 
 
                                                
* Ki values given as mean ± sem.  Free energy (ΔΔG) is calculated as i,X
i,Phe
ln( )KG RT KΔΔ = , where 
RT is 0.58 kcal/mol at room temperature. 
 
32 
 
The potency of TEAs as a blocker for ShB was measured for a comparison to the study of 
TEAs cocrystallized with KcsA.26  A crude sample of TEAs was obtained from Dr. 
Adrian Gross,26 and its concentration was determined by NMR, using glycine as a 
standard.  TEAs was found to make up 70% of the crude mixture.  Taking this offset into 
account, TEAs was found to be a weaker blocker than TEA by a factor of 25 in ShB 
Thr449Phe.  
One of the distinctions between aromatic and nonaromatic residues at position 449 is the 
voltage dependence of TEA block. TEA apparently senses 19% of the transmembrane 
electric field for Thr449 and only 4% for Tyr449.6  This difference suggests that TEA 
blocks at a more superficial site when an aromatic residue at 449 creates a high-affinity 
binding site. Because fluorination of phenylalanine reduces TEA affinity, it might also 
allow TEA to bind at a deeper location in the electric field. However, the voltage 
dependence of block was found to be shallow (2%-8%) for all fluorinated derivatives of 
Phe449 (figure 2.4), supporting the idea that the blocking site for TEA is the same for all 
of these derivatives. Note that the measured voltage dependence from the plots in figure 
2.4 could be due to the distribution of K+ ions within the selectivity filter rather than to 
the position of TEA within the electric field.43 
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Figure 2.3.  Evidence for a cation-π interaction in TEA block.  A-B) Reversible TEA inhibition for 
phenylalanine and cyclohexylalanine currents at +50 mV.  C) TEA inhibition plots for ShB channels 
containing the indicated residue at position 449.  Curves are standard binding isotherms fitted to the data. 
Increased fluorination monotonically increases the dissociation constant Ki (table 2.1).  Cyclohexylalanine, 
which is devoid of aromatic character, renders the channel nearly insensitive to TEA. 
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Figure 2.4.  Voltage dependence of block is similar for all fluorinated derivatives.  A-D) Natural logarithm 
of the relative fraction of unblocked channels (Fun) versus blocked channels is plotted against membrane 
potential. [TEA] = 1 mM, 1 mM, 10 mM, and 10 mM for Phe (n = 10), 4-F-Phe (n = 4), 3,5-F2-Phe (n = 7), 
and 3,4,5-F3-Phe (n = 8), respectively. 
 
If an electrostatic component of TEA binding were due to a cation-π interaction involving 
the aromatic side chain at residue 449, then one would expect increasing substitution of 
fluorine atoms to decrease the binding affinity monotonically.27,28 This trend is exactly 
what was observed (figure 2.3C and table 2.1).  In other systems such a trend has been 
interpreted as compelling evidence for a sizable cation-π interaction involving the site 
undergoing substitution.33-36 The first such conclusion, the cation-π interaction between 
acetylcholine and the tryptophan residue at position 149 in the α1 subunit of the muscle 
nAChR,33 was subsequently confirmed by X-ray crystallography.44  
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The largest effect on TEA affinity, 640-fold, occurs with the nonaromatic residue 
cyclohexylalanine.  As discussed below, this observation provides further support for a 
cation-π interaction in TEA binding and contributes valuable information on proposed 
alternative models underlying TEA affinity.  
 
Discussion 
Our data argue that high-affinity TEA blockade results in part from a significant cation-π 
interaction between TEA and an aromatic amino acid at position 449 in ShB.  As in other 
studies of this type, it is not a single mutation that leads to this conclusion, but rather a 
consistent trend across a systematic series of subtle mutations. Figure 2.5A plots the 
change in free energy of TEA binding (open squares) for the phenylalanine derivatives 
against the effect on the energy of Na+ ion binding to comparable derivatives of benzene.  
Na+ binding energy in the gas phase was determined by ab initio calculations. The 
monotonic, nearly linear relationship for ShB establishes a cation-π contribution to TEA 
block. Moreover, previous studies show that fluorination has little effect on 
“nonelectrostatic” energetic components of cation binding to a benzene ring (e.g., donor-
acceptor, charge-transfer, and induced dipoles in the aromatic30).  
To estimate the energetic contribution of the cation-π interaction, a comparison of 
phenylalanine and 3,4,5-F3-phenylalanine is useful. Examination of the electrostatic 
potential surfaces of figure 2.2 shows that three fluorine atoms effectively erase the 
electrostatic attractiveness of the aromatic ring to the cation, and earlier studies showed 
that trifluorobenzene is a good model for an aromatic that has little or no electrostatic 
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binding ability.27,28,45  From this perspective, the ∆∆G values of table 2.1 suggest that the 
cation-π interaction is the dominant factor in distinguishing strong from weak TEA 
binders, in that the energetic consequence of the phenylalanine to 3,4,5-F3-phenylalanine 
mutation (3.5 kcal/mol) is comparable with that of the phenylalanine to threonine 
mutation (2.6 kcal/mol).  
The biggest decrease in TEA affinity is seen for the phenylalanine to cyclohexylalanine 
mutation (3.8 kcal/mol).  This decrease is consistent with both theoretical and 
experimental studies showing that cyclohexane binds cations more poorly than any of the 
aromatics considered here.27,28,46  Note that the side chains of phenylalanine and 
cyclohexylalanine, modeled here as benzene and cyclohexane, respectively, are similar in 
size, shape, and hydrophobicity (figure 2.2).  The most noticeable difference, in the 
context of noncovalent binding interactions, is that the negative electrostatic potential that 
leads to cation binding in benzene disappears in cyclohexane. The phenylalanine to 
cyclohexylalanine mutation thus further confirms that the π character and its associated 
negative electrostatic potential dominate strong TEA binding when phenylalanine is 
present at position 449.  Note also that cyclohexane is considerably more polarizable than 
benzene,47 ruling out any special role for an induced dipole in the binding of TEA by 
phenylalanine and its derivatives.   
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Figure 2.5. Thermodynamic and ab initio calculations support an en face model of TEA binding to ShB.  
A) Relative binding energy of TEA to phenylalanine derivatives plotted against that calculated for Na+ 
binding to benzene derivatives.  Data obtained experimentally for ShB, black squares, display a linear 
change (black line, slope = 0.19 ± 0.01, R2 = 0.88) in binding energy as π electrons are withdrawn by 
fluorine substitutions.  Ab initio calculations for the binding energetics of a reduced system comprised of 
four aromatics and a single TEA molecule are shown on the same plot for comparison.  B) The reduced 
system (minus hydrogen atoms) based on the coordinates of KcsA and TEAs.26  These coordinates predict 
enhanced binding (red diamonds in A)) as π electrons are removed from the aromatic face, a trend 
inconsistent with experimental data.  Conversely, a 60° rotation displayed in C) qualitatively reproduces 
(blue triangles in A)) the trend of TEA binding energetics obtained experimentally from ShB. 
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Previous computational studies of the KcsA channel are based on structures with Tyr82 
in the edge-on orientation and have led others to conclude that the cation-π interaction 
does not contribute substantially to external TEA blockade. These studies instead 
emphasize local hydration structure as a crucial component of the energetics of TEA 
binding,22-25 although electrostatic stabilization by the backbone carbonyls of Tyr78 and 
Gly79 (in KcsA) may also play a role.24 The distribution of K+ ions within the selectivity 
filter also appears to affect TEA binding energy,22-24 another possible source of 
electrostatic energy.  Energetic contributions of local hydration include both electrostatic 
and hydrophobic forces.  However, an essential role of attractive hydrophobic forces 
between TEA and its binding site is contradicted by earlier data from ShB, where 
relatively hydrophobic residues at site 449 are not in general better at binding TEA.6  
Comparison of the essentially isosteric residues valine and threonine, for example, shows 
that polar threonine is associated with a higher TEA affinity.6  Also, leucine, isoleucine, 
and valine are all substantially more hydrophobic than phenylalanine,48 yet produce weak 
TEA binding sites. The phenylalanine/cyclohexylalanine pair described here presents 
another isosteric comparison, and again hydrophobics do not explain the results.  Also, 
the size, but not hydrophobicity, of the alkylammonium blocker appears to be a critical 
factor in binding affinity.6,49  Furthermore, examination of the temperature dependence of 
TEA block shows that enthalpy rather than entropy largely accounts for the free energy of 
binding,6 again arguing against a fundamental role of hydrophobic forces in TEA 
binding. 
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Computational Examination of the TEA-Channel Interaction 
To investigate the evidence for a cation-π mechanism further, the TEA-side chain 
interaction was modeled computationally.  One constraint was the necessity to use KcsA 
structures for the computational modeling, because KcsA is the only crystallized K+ 
channel with an aromatic residue (Tyr82) at this position.  The structure 2BOC, a 
cocrystal of KcsA and TEAs (blue side chain in figure 2.1),26 was the initial starting 
point.  KcsA is highly homologous to voltage-gated K+ channels in this region of the 
protein.  In the vicinity of the selectivity filter, KcsA has the sequence TTVGYGDLY, 
whereas in KV1.2 it is TTVGYGDMV.  In addition, the crystallographic distances across 
the tetramer between the α-carbons of these residues agree within 1 Å when comparing 
KcsA structures to the mammalian KV1.2 (2A79).  With respect to a cation-π mechanism, 
the majority of published structures of KcsA display an unfavorable orientation of the 
Tyr82 aromatic rings.  Moreover, the closest carbon-carbon distance between the blocker 
and the aromatic side chains (4.1 Å) is larger than typically observed for simple cation-π 
interactions (e.g., 2.4 Å between Na+ and the center of a benzene ring29,30).  To examine 
the energetic consequences of withdrawing π electrons by fluorinating the aromatic ring 
of this residue, a reduced molecular model of TEA and its four coordinating 
phenylalanine residues was constructed, based on the 2BOC structure.26  In this reduced 
system (117 atoms; figure 2.5B) high-level ab initio quantum mechanical calculations of 
the binding energy of TEA were performed.  Instead of decreasing the binding, as was 
observed experimentally (black squares in figure 2.5A), successively fluorinating these 
phenylalanine residues in silico had a nonmonotonic effect on TEA binding energy (red 
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diamonds in figure 2.5A), the main effect being a substantial increase of TEA affinity in 
the difluorinated and trifluorinated derivatives.  
Our ab initio calculations can be rationalized as follows.  The cationic blocker is directed 
more towards the edge than the face of the aromatic ring (figure 2.5B).  The electrostatic 
potential along the edge of a simple aromatic ring is positive (e.g., insert in figure 2.2A), 
and would therefore electrostatically repel TEA. Fluorination, however, introduces 
negative electrostatic potential to the edge of the ring via the fluorines (figure 2.2), and 
this would tend to attract TEA, especially in the 3 or 5 position of the aromatic ring 
(figures 2.1, 2.5B). In fact, the 3,5-F2- and 3,4,5-F3-derivatives of phenylalanine show the 
most dramatic increases in TEA affinity in the ab initio calculations.  
Because these self-consistent theoretical results disagree with our experimental data, the 
possibility that the aromatic rings were rotated to face the central axis of the pore was 
considered (figure 2.5C), as proposed before the crystal structures of KcsA were 
available.6,50  In this en face orientation TEA would be attracted to the negative 
electrostatic potential on the face of the aromatic rings.  Fluorination would then decrease 
the negative electrostatic potential presented to TEA and destabilize its binding, a 
prediction consistent with our experimental data.  To quantify this idea, the energetic 
consequences of fluorinating the aromatic rings of Phe82 on TEA binding in this 
conformation were calculated.  The only modification of the structure of figure 2.5B was 
a 60° rotation of the aromatic rings, maintaining all other coordinates of the four Phe 
residues.  With this single change, the results of the ab initio calculations now resemble 
our experimental results, showing a monotonic destabilization of TEA binding as the 
aromatic rings are increasingly fluorinated (blue triangles in figure 2.5A).  Moreover, the 
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rotation itself enhanced TEA affinity by 3 kcal/mol. Although the optimal dihedral angle 
was not examined in detail, rotations of 40° or 80° were less effective at replicating our 
experimental data.  Given the crudeness of this model, and the fact that it is based on a 
crystal structure of KcsA rather than a eukaryotic voltage-gated K+ channel, the 
agreement is quite acceptable.  Even the larger perturbation associated with the 
nonaromatic cyclohexylalanine residue is reproduced by the calculations. 
Although the 144° χ2 dihedral angle in our en face model is unusual for both tyrosine and 
phenylalanine residues in known protein structures,51 an en face orientation of Tyr82 was 
reported for one of the crystal structures of the functional Glu71Ala mutant of KcsA.18  
Figure 2.1B shows this structure (2ATK, orange Tyr82 side chains) aligned with that of 
KcsA cocrystallized with TEAs (blue Tyr82 side chains). The similarity to our en face 
model (figure 2.5C) is apparent.  There are other subtle structural changes in this region 
of the 2ATK structure that enable en face geometry. Of note, the selectivity filter has 
conformational variants in wild-type KcsA, depending on the concentration of permeant 
ions,19 supporting the possibility that the functional conformation of ShB is compatible 
with an en face orientation of Phe449 residues. It also raises the possibility that the open 
states of K+ channels in general have conformational flexibility including the orientation 
of an aromatic residue at this position.   
The slope of the experimental fluorination plot as shown in figure 2.5A is considered a 
crude indication of the energetic magnitude of the cation-π interaction.  The slope of this 
plot (0.19) is comparable to those seen in studies of agonists such as GABA and 5-HT3 
binding to neuroreceptors.34,36  However, the receptor studies measure the binding of an 
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3R-NH
+  ion to a single aromatic residue.  Here, four aromatic residues are simultaneously 
being modified.  Thus, the slope in the present case suggests that any single TEA-
aromatic interaction is not very strong, which is consistent with the low affinity of TEA 
and the fact that TEA is a very diffuse cation, and so it is expected to experience a 
weaker cation-π interaction than more focused cations such as 3R-NH
+ .  The energetic 
magnitude of the cation-π interaction taken from the slope may also reflect the fact that 
TEA cannot make van der Waals contact with all four rings at once, in either of the en 
face conformations that were considered (figures 2.1B, 2.5C), which should weaken the 
cation-π interaction. Nevertheless, the magnitude of the cation-π interaction does not fall 
off steeply with distance,29 and therefore four nonoptimal interactions can combine to 
create a moderate effect. It is worth noting that a closer approach of the aromatic side 
chains to the blocker may be impossible if the open channel structure is maintained, 
because this residue is only two amino acids downstream from the TVGYGD signature 
sequence of the selectivity filter. Functional data argue against a large-scale collapse of 
the aromatics onto the blocker, because TEA has no effect on open dwell times of single 
channels.42 
Not considering all possible energetic factors in the described calculations was 
intentional.  Our calculations primarily evaluate one component of the binding 
interaction—the electrostatic attraction between a cation and the side–chain.  The fact 
that binding energies correlate so nicely with this term establishes an important role for 
electrostatic attractions in the binding.  Additional effects such as hydrophobics are 
neither ruled out nor ruled in; the data simply show that electrostatics must be important.  
The functional data on eukaryotic K+ channels shows that while there may well be a 
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hydrophobic contribution to binding, it is not the factor that discriminates among 
residues. Another factor that might contribute to TEA binding in these experiments is the 
possibility that the electronegative fluorine atoms could influence the local structure of 
water molecules in the vicinity of the blocker.  However, it is not clear how this effect 
would produce the systematic destabilization of TEA binding that was observed (figures 
2.3C, 2.5A). To explore this possibility the Gibbs free energy of TEA binding in our 
reduced edge-on model was estimated, accounting both for the gas-phase ab initio 
energies, as well as the energies of hydration, using a self-consistent reaction field 
method with the Poisson-Boltzmann solver in the program Jaguar 
(http://www.schrodinger.com/).  As in the gas-phase calculations of figure 2.5A, 
difluorinating the phenylalanine residue in this conformation enhanced TEA binding (by 
2.3 kcal/mol), again inconsistent with our experimental results. 
How are our conclusions resolved with earlier works disputing a role for a cation-π 
mechanism?  As noted, previous simulations were based on analysis of two edge-on 
crystallographic structures (1BL8 and 2BOC) of the bacterial channel KcsA, rather than 
on a eukaryotic, voltage-gated K+ channel or on the en face structure of a KcsA mutant 
(2ATK).  Note that even though KcsA contains an aromatic residue at the aligned 
position (Tyr82), it does not bind TEA strongly.  Its Ki for TEA block is 3.2 mM,52 
almost tenfold higher than for ShB Thr449Phe.  Also, KcsA Tyr82Thr shows a TEA 
blocking constant of 143 mM, significantly higher than obtained in ShB with its wild-
type Thr449.  Finally, the TEA analogue TEAs used for the 2BOC crystal structure 
shown in figure 2.1 has a 25-fold larger inhibitory constant than TEA in ShB Thr449Phe, 
allowing for the possibility that the structure may not be representative of TEA in its 
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binding site.  Thus, inherent but unknown aspects of the KcsA channel, perhaps including 
a nonoptimal arrangement of Tyr82 residues, underlie a relatively weak TEA binding 
site.  
 
Conclusion 
In conclusion, this chapter shows that a cation-π interaction makes a substantial 
contribution to high-affinity blockade by extracellular TEA in voltage-gated K+ channels.  
Evidently, the orientation of an aromatic residue at this position is favorable for a cation-
π mechanism. This hypothesis is supported by our experimental and theoretical results, 
and it provides a simple explanation of the longstanding observation that aromatics at 
position 449 are necessary and sufficient for high-affinity, external TEA blockade in 
voltage-gated K+ channels.  The (presumably subtle) conditions that govern 
crystallization of KcsA in one state or the other are not yet understood, but the functional 
form relevant to ShB in this region is apparently the en face orientation. 
 
Methods 
The work in this chapter was a collaborative effort that included important contributions 
from Dr. Chris Ahern and Dr. Richard Horn of the Jefferson Medical College in 
Philadelphia, PA.  Detailed methods for the experiments discussed in this chapter that 
were not performed by the author can be found in Ahern et al.53 
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Synthesis 
All reactions were performed at ambient temperature and pressure unless otherwise 
noted.  All reactions involving potentially air-sensitive compounds were conducted under 
an inert atmosphere using Schlenk techniques.  Solvents were purified by passage 
through alumina.54  Unless otherwise noted, all chemicals and reagents were used as 
received without further purification.  Flash chromatography was performed using EMD 
(Gibbstown, NJ) silica gel 60 (particle size 0.040-0.063 mm).  Thin-layer 
chromatography (TLC) was performed using EMD (Gibbstown, NJ) silica gel 60 F254 
precoated plates (0.25 mm) and visualized by UV and potassium permanganate.  Nuclear 
magnetic resonance spectroscopy (NMR) was preformed on a Varian (Palo Alto, CA) 
Mercury 300 instrument, and NMR resonances are reported relative to Me4Si (δ 0.0), 
CD3OD (δ 3.31), or D2O (δ 4.79).  Data for 1H NMR spectra are reported as follows: 
chemical shift (δ ppm), integration, multiplicity, and coupling constant (Hz).  Mass 
spectroscopy (MS) spectra were obtained from the Caltech Mass Spectrometry Lab.  
Electrospray ionization mass spectrometry (ESI-MS) was preformed on an LCQ Classic 
ion trap (ThermoFinnigan, Waltham, MA) in direct infusion mode.  HPLC was 
preformed using Waters (Milford, MA) equipment and software (510 HPLC pumps and 
996 Photodiode Array Detector) and reverse-phase Nova-Pak® 18C columns (3.9 × 150 
mm analytical column, 7.8 × 300 mm preparatory column). 
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NVOC-L-phenylalanine 2.1:  L-Phenylalanine (0.297 g, 1.8 mmol, 1 eq) was added to a 
round-bottom flask and dissolved in 10% (w/v) sodium carbonate in water (7 mL).  To 
this solution was added dioxane (7 mL).  The mixture was stirred in an ice bath and 
nitroveratryloxycarbonyl chloride (0.50 g, 1.9 mmol, 1.1 eq) was added slowly.  The 
mixture was allowed to warm to room temperature while stirring for 4 hours.  The 
mixture was then poured into distilled water and washed with ether (3x).  Under vigorous 
stirring, the aqueous solution was adjusted to pH 2 by slowly adding 5 M HCl.  The 
yellow precipitate that formed was filtered to afford NVOC-L-phenylalanine 2.1 as a 
yellow solid.  1H NMR (300 MHz, CD3OD, 298 K) δ 7.63 (1H, s), 7.15 (5H, s), 6.98 (1H, 
s), 5.31 (2H, d, J = 10.5 Hz), 4.31 (1H, m), 3.79 (3H, s), 3.76 (3H, s), 3.11 (1H, m), 2.83 
(1H, m). 
O
O NO2
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H
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O
O
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2.2  
NVOC-L-phenylalanine cyanomethyl ester 2.2:  NVOC-L-phenylalanine 2.1 (0.254 g, 
0.63 mmol) was added to a round-bottom flask under Ar (g) and dissolved in DMF (2 
mL).  Chloroacetonitrile (2 mL) and then triethylamine (0.25 mL) were added to the 
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solution.  The mixture was stirred at room temperature for 75 minutes and then the 
solvent was removed under vacuum.  The crude product was purified by flash column 
chromatography (CH2Cl2, then 5% EtOAc in CH2Cl2 once the yellow product started 
eluting) to afford NVOC-L-phenylalanine cyanomethyl ester 2.2 as pale yellow crystals.  
1H NMR (300 MHz, CDCl3, 298 K) δ 7.72 (1H, s), 7.33 (3H, m), 7.16 (2H, d, J = 6.3 
Hz), 6.93 (1H, s), 5.53 (2H, q, J = 15 Hz), 5.26 (1H, d, J = 8.4 Hz), 4.77 (2H, m), 3.96 
(3H, s), 3.95 (3H, s), 3.18 (2H, t, J = 5.1 Hz). 
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NVOC-L-phenylalanine-dCA 2.3:  NVOC-L-phenylalanine cyanomethyl ester 2.2 (0.011 
g, 0.025 mmol, 3.4 eq) was added to a round-bottom flask under Ar (g) and dissolved in 
DMF (0.5 mL).  This solution was transferred to another round-bottom flask under Ar 
(g), which contained dCA (0.020 g, 0.017 mmol, 1 eq) as a tetrabutylammonium salt (2.4 
eq).  The reaction was stirred at room temperature for 18 hours while being monitored by 
reverse-phase analytical HPLC with a linear solvent gradient from 5% acetonitrile in 25 
mM NH4OAc buffer pH 4.5 to 100% acetonitrile.  The crude product was purified using 
reverse-phase semipreparative HPLC with the same linear solvent gradient.  The fractions 
 
48 
 
containing the NVOC-L-phenylalanine-dCA 2.3 were combined, and the solvent was 
removed by lyophilization.  The solid was redissolved in 10 mM acetic acid and 
reconcentrated via lyophilization (3x) to afford NVOC-L-phenylalanine-dCA 2.3 as a 
white powder (0.0016 g, 0.0015 mmol, 19% yield).   ESI-MS m/z calc’d for 
C38H44N10O20P2 [M-H]:  1021.2; found:  1021.4. 
O
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NVOC-L-3,5-F2-phenylalanine 2.4:  The procedure described above for 2.1 was repeated 
using L-3,5-F2-phenylalanine (0.72 g, 3.6 mmol, 1 eq) to afford NVOC-L-3,5-F2-
phenylalanine 2.4 (1.3 g, 2.9 mmol, 80% yield).  Rf = 0.62 (100% EtOAc); 1H NMR (300 
MHz, CD3OD, 298 K) δ 7.64 (1H, s), 7.02 (1H, s), 6.78 (2H, dd, J = 8.6, 2.1 Hz), 6.69 
(1H, tt, J = 9.3, 2.4 Hz), 5.33 (2H, q, J = 15 Hz), 4.33 (1H, m), 3.81 (3H, s), 3.80 (3H, s), 
3.16 (1H, m), 2.86 (1H, m). 
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NVOC-L-3,5-F2-phenylalanine cyanomethyl ester 2.5:  The procedure described above 
for 2.2 was repeated using NVOC-L-3,5-F2-phenylalanine 2.4 (0.264 g, 0.60 mmol).  The 
crude product was purified by trituration with CH2Cl2 to afford NVOC-L-3,5-F2-
phenylalanine cyanomethyl ester 2.5.  Rf = 0.54 (17% EtOAc in CH2Cl2); 1H NMR (300 
MHz, d6DMSO, 298 K) δ 8.2 (1H, d), 7.7 (1H, s), 7.1 (1H, s), 7.0 (3H, m), 5.3 (2H, d), 
5.0 (2H, s), 4.5 (1H, m), 3.8 (3H, s), 3.8 (3H, s), 3.0 (2H, m). 
 
Molecular Biology  
The aminoacylated dinucleotides for the amino acids used in this chapter were ligated to 
a modified tRNA from Tetrahymena thermophila, THG73, using T4 RNA ligase (New 
England Biolabs, Ipswich, MA).31,39  
 
Determining the Concentration of TEAs 
Glycine (0.0035 g,  0.047 mmol, 1 eq) was placed in an NMR tube and dissolved in D2O 
(0.5 mL).  1H NMR (300 MHz, D2O, 298 K) δ 3.53 (2H, s).  To this solution was added a 
crude mixture containing an unknown amount of tetraethylarsonium (0.0041 g, ~0.018 
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mmol, ~0.38 g).  1H NMR (300 MHz, D2O, 298 K) δ 3.53 (2H, s), 2.36 (2.1H, q, J = 7.8 
Hz), 1.29 (2.8H, b).  Analysis of the NMR resonance integrations, tetraethylarsonium was 
found to constitute 70% of the mass of the crude tetraethylarsonium mixture (0.0041 g, 
0.013 mmol, 0.29 eq). 
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C h a p t e r  I I I 
 
CALCIUM BLOCK OF SINGLE SODIUM CHANNELS:  ROLE OF A PORE-LINING 
AROMATIC RESIDUE 
 
Extracellular Ca2+ ions cause a rapid block of voltage-gated Na+ channels, manifest as an 
apparent reduction of the amplitude of single-channel currents.  Here the influence on 
both single-channel conductance and Ca2+ block of Tyr401 in the Na+ channel isoform 
NaV1.4 from rat was examined.  One possible explanation for the link between Ca2+ 
block and this tyrosine is that the cationic blocker and the aromatic residue interface 
through a cation-π interaction.  To test this hypothesis the attraction between small metal 
cations (Na+ and Ca2+) and this residue was explored using a series of fluorinated 
derivatives of phenylalanine incorporated at this position.  As described in chapter 2, 
increasing fluorination decreases the strength of the possible cation-π interaction, which 
would be evidenced by reduced single-channel conductance or pore block.  The results 
show a monotonic decrease in Ca2+ block as the aromatic ring is increasingly fluorinated, 
a result in accord with a cation-π interaction between Ca2+ and the aromatic ring.  This 
decrease occurred without a change of single-channel conductance, consistent with a 
greater electrostatic effect of the π system on divalent than on monovalent cations.  High-
level quantum mechanical calculations show that Ca2+ ions likely do not bind directly to 
the aromatic ring because of the substantial energetic penalty of dehydrating a Ca2+ ion.  
However, the complex of a Ca2+ ion with its inner hydration shell, Ca2+(H2O)6, interacts 
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electrostatically with the aromatic ring in a way that affects the local concentration of 
Ca2+ ions in the extracellular vestibule. 
 
Introduction 
Voltage-gated Na+ channels are transmembrane proteins involved critically in a variety of 
physiological functions, including muscle contraction, generation of action potentials in 
neurons, and secretion of neurotransmitters and hormones.  These channels control the 
diffusion of Na+ ions across the cell membrane in response to changes of transmembrane 
potential.   When open, ion channels allow high-ionic fluxes while discriminating among 
ions based on charge and size.   Understanding the basis of Na+ permeation requires the 
identification of amino acids that form the selectivity filter, a narrow region of the pore 
where ions are partially dehydrated.  As in structurally similar K+ and Ca2+ channels, Na+ 
channels have a pore or “P” region, a reentrant loop between the fifth and sixth 
transmembrane spanning segments in each of four homologous domains (figure 3.1).  
This P region houses the selectivity filter.  In Na+ channels there are four key residues 
responsible for determining the selectivity of Na+ over other cations (boxed in figure 3.1).  
These resides, one from each domain (D), are aspartate in D1, glutamate in D2, lysine in 
D3, and alanine in D4.  This sequence is referred to as DEKA 1.  Mutation of any of these 
residues alters the channel’s selectivity.  
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Figure 3.1.  Topology of a voltage-gated Na+ channel. Na+ channels are composed of four domains (D1-
D4), each with six transmembrane segments (S1-S6).  S4 is the primary component of the voltage sensor 
(+), and the loop between S5-S6 is the pore (P) region.  The amino acid sequence of the highlighted portion 
of the pore is shown below each domain.  The DEKA ring is outlined in blocks, the outer negative ring 
underlined.  Tyr401 (bold) in D1 is one residue above the DEKA ring. 
 
The side chain of lysine (D3) is perhaps the most important player of DEKA.  Changing 
from DEKA to DEAA eliminates selectivity among monovalent cations (Li+, Na+, K+, 
Rb+, Cs+) and enhances permeability to divalent cations (Mg2+, Ca2+, Ba2+) 1-5.  Enhanced 
Ca2+ permeation is obtained for all charge-altering substitutions of lysine (D3), but not by 
substitution with a charge-preserving arginine 2. By contrast, wild-type Na+ channels are 
typically blocked by extracellular Ca2+ ions.  The apparent blocking affinity is strongly 
correlated with the overall negative charge of residues at the DEKA positions, 
establishing an important role of electrostatics 3.  The close relationship between 
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selectivity and block in these studies suggests that external Ca2+ block occurs at or near 
the DEKA ring 5. 
Single-channel measurements have shown that block by extracellular Ca2+ is voltage-
dependent and fast, manifest as an apparent reduction of single-channel current 
amplitude.  Estimates of the inhibition constant range between 10 and 35 mM, with the 
blocking site apparently located 20% to 30% of the way into the transmembrane electric 
field 3,6-11.  A separate effect of changing external Ca2+ concentration ([Ca2+]) is a shift in 
the activation gating range for Na+ channels.  This phenomenon has been ascribed to Ca2+ 
ions screening and/or binding to negative surface charges that influence the voltage-
sensing mechanism 12.   
Charge-altering mutations involving either DEKA or a more extracellular ring of 
negatively charged residues (underlined residues EEDD in figure 3.1) strongly reduce 
block by the guanidinium toxins tetrodotoxin (TTX) and saxitoxin (STX).  Mutations of 
residues adjacent to these two charged rings typically have smaller effects, if any, on 
toxin block.  These experiments suggest that the charged rings create part of the 
extracellular mouth or pore wall of the Na+ channel 13.  In addition, neutralizing any 
negative residue causes a decrease in single-channel conductance, consistent with the 
idea that the negative charges act to concentrate cations in the extracellular vestibule of 
the pore 13.  Nevertheless, the influence of charged vestibule residues on Na+ permeation 
cannot be explained entirely by the charges of these residues 2,14,15.  
Charged residues are not the only determinants of permeation and pore block. An 
aromatic residue in D1, either tyrosine or phenylalanine, is found exclusively in Na+ 
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channels that have nanomolar affinity for TTX block 16-20.  This residue, Tyr401 in 
NaV1.4, is located between the charged rings in the primary sequence (figure 3.1). 
Mutating this residue to cysteine, its homolog in the TTX-resistant cardiac channel 
NaV1.5, results in a decrease in TTX sensitivity as well as in single-channel conductance 
16,17.  The lowered conductance is similar in magnitude to that found in human NaV1.5 
16,17.  Interestingly, the converse mutation in human NaV1.5 (Cys374Tyr) produces no 
change in single-channel conductance 17.  This residue also affects Ca2+ block.  Single-
channel recording shows that NaV1.4 is more sensitive to Ca2+ block than NaV1.5 21,22; 
however see Ravindran, Schild, and Moczydlowski and Sheets and Hanck for an 
alternative interpretation 8,9.  This observation leads naturally to the question of how a 
hydrophobic aromatic residue could enhance the pore block of a small metal cation. One 
possibility is an electrostatic attraction between the π electrons of the aromatic ring and 
the cationic blocker.  
The intention of the work presented in this chapter is not to explore the isoform 
differences that might affect permeation or Ca2+ block.  Rather the focus is on residue 
401 of rat NaV1.4 and asking (i) whether a cation-π interaction is a contributing factor, 
based on experimental data, and (ii) whether such an interaction between a metal cation 
and an aromatic ring can be rationalized theoretically in an aqueous environment.  
 
Results 
Outside-out patches from oocytes were used to measure single-channel Na+ currents.   
Figure 3.2A shows representative single-channel currents of the mutant Tyr401Phe in 
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response to a depolarization to −50 mV (arrow), using an extracellular solution 
containing 2 mM Ca2+.  This mutant was created by standard mutagenesis and serves as 
our control for unnatural amino acid substitutions.  The data in figure 3.2A were 
converted into an amplitude histogram that was fit by a sum of two Gaussian functions 
(figure 3.2B).  Notice the slight excess of points between the two prominent peaks, 
largely a consequence of a single opening at a subconductance level.  The mean current 
level was estimated as the difference between the means of each Gaussian function, −1.9 
pA at this membrane potential.  The prolonged open durations in our experiments are a 
consequence of internal modification by fenvalerate, which does not affect the single-
channel conductance 23.  In agreement with this, figure 3.2C shows indistinguishable 
amplitudes of single-channel currents of wild-type NaV1.4 recorded without (open 
squares) and with (triangles) 20 µM fenvalerate added to the pipette, in this case in the 
absence of added Ca2+.  
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Figure 3.2.  Representative single-channel recording, histogram analysis, and current-voltage relationship. 
A) Single-channel currents of Tyr401Phe, with 2 mM Ca2+ in response to a 30 ms depolarization (arrow) to 
−50 mV. Prolonged open durations are due to the effects of 10 µM intracellular fenvalerate.  B)  Data from 
figure 3.2A converted to an amplitude histogram and fit by a sum of two Gaussian functions.  The single-
channel current amplitude is −1.9 pA at this membrane potential.  C) Single-channel amplitude versus 
voltage of wild-type rat NaV1.4 recorded without (open squares) and with (triangles) 10 µM internal 
fenvalerate; 0 mM Ca2+.  Data from 2-5 patches at each membrane potential. Fenvalerate shifts the 
activation range in the hyperpolarizing direction but does not change the single-channel current amplitude. 
The regression line was from the fit to the data for fenvalerate. 
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Figure 3.3 shows representative single-channel openings at −60 mV, in either 0.1 (below) 
or 10 mM external Ca2+ (above).  Raising the external [Ca2+] reduces the amplitude of 
single-channel currents with phenylalanine incorporated at position 401 (figure 3.3A) due 
to Ca2+ block 3,6-8,11,21,22.  Figure 3.3B shows that Ca2+ also blocks when the trifluorinated 
mutant 3,4,5-F3-phenylalanine is incorporated at this site, although less effectively 
(arrow/dashed line shows current amplitude for the Tyr401Phe mutant in panel 3.3A).  
Trifluorination approximately abolishes the negative electrostatic potential of an aromatic 
ring 24,25 without significantly affecting hydrophobicity, polarizability, or shape, 
suggesting that the change in electrostatics is responsible for the relief of Ca2+ block in 
this experiment.  Insets show color-coded electrostatic potential surfaces of benzene and 
the trifluorinated derivative.  On this color scale red, blue, and green indicate negative, 
positive, and zero electrostatic potential, respectively.  By contrast to the effect on Ca2+ 
block, the single-channel conductance in 0.1 mM extracellular Ca2+ was not significantly 
different among the fluorinated variants of phenylalanine at position 401, ranging 
between 23.2 ± 2.2 pS for 4-F1-phenylalanine and 25.9 ± 1.6 pS for 3,5-F2-phenylalanine 
(legend for figure 3.4). This result is consistent with a greater effect of the negative 
electrostatic potential on the local concentration of Ca2+ ions than on that of Na+ ions at 
the entrance of the selectivity filter.  
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Figure 3.3.  Fluorination of phenylalanine at position 401 reduces sensitivity of the channel to Ca2+ block. 
Single-channel currents in response to a depolarization to −60 mV in either 10 or 0.1 external Ca2+. 
Openings are downward.  A) Single-channel recordings of the mutant Tyr401Phe.  Raising the external 
[Ca2+] from 0.1 to 10 mM Ca2+ reduces the amplitude of the single-channel current.  B) Currents of the 
mutant 3,4,5-F3-phenylalanine. The two channel constructs have similar current amplitudes in 0.1 mM 
Ca2+. However, fluorination of phenylalanine at position 401 relieves Ca2+ block. Arrow shows the current 
amplitude of Tyr401Phe in 10 mM Ca2+ (mean of 4 patches).  Insets show color-coded electrostatic 
surfaces of benzene and 3,4,5-F3-benzene (blue is +20 kcal/mol, red is −20 kcal/mol). 
 
Single-channel current-voltage relationships for phenylalanine at position 401 and three 
fluorinated mutants are shown in figure 3.4 at three different Ca2+ concentrations, 0.1 
mM (open circles), 2 mM (filled squares) and 10 mM (open triangles). Because the 
patches tended to be unstable in the absence of added Ca2+ and because the amplitudes of 
single-channel currents were indistinguishable between 0 and 0.1 mM Ca2+, 0.1 mM Ca2+ 
was used as the unblocked control.  The single-channel current-voltage relationships in 
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0.1 mM extracellular Ca2+ were fit by straight lines, and the fractional block at higher 
[Ca2+] is represented as 
2
2 2
([ ], ) ( )
([ ] 0.1mM, ) ( ) [ ]
I Ca V K V
I Ca V K V Ca
+
+ +
=
= +
. 
The voltage-dependent inhibition constant K(V), based on a simple Woodhull-type 
model,26 is defined as 
( ) (0)exp( ),j
zFVK V K
RT
δ
=  
where V is the membrane potential, (0)jK  is the inhibition constant at 0 mV for a mutant 
containing j fluorine atoms (j = 0, 1, 2, 3) on the phenylalanine incorporated at position 
401, δ  is the effective fraction through the electric field for a blocker with valence z, and 
RT/F = 25 mV at room temperature.  For the least squares fit, the value of δ  was 
constrained to be identical for all mutants in this study. The monotonic effect of 
fluorination on Ca2+ block is evident from the block observed at 2 mM Ca2+ and from the 
estimated values of (0)jK  (legend of figure 3.4 and figure 3.5). The curvature of the 
current-voltage relationship, most obvious at 10 mM Ca2+, is indicative of the voltage 
dependence of the block.  The estimated value of δ  was 0.18 ± 0.03, comparable to 
previous estimates for Ca2+ block of single Na+ channels.8,9,11 The curvature of the 
current-voltage relationship is noticeably muted in the trifluorinated mutant (figure 3.4D).  
Although only speculation can be drawn on this observation, it suggests either that the 
blocking site is more superficial in this mutant or that trifluorination reduces the local 
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concentration of cations (see discussion) whose distribution might be affected by 
membrane potential.  
 
Figure 3.4.  Single-channel current-voltage relationships of the phenylalanine mutants at position 401. Ca2+ 
concentrations are 0.1 mM (open circles), 2 mM (filled squares), and 10 mM Ca2+ (open triangles).  Each 
symbol represents data from 2-8 patches.  Data for 0.1 mM Ca2+ were fit by straight lines (slopes: 25.3 ± 
0.8, 23.2 ± 2.2, 25.9 ± 1.6, 23.4 ± 1.6 pS, for Tyr401Phe, 4-F-Phe, 3,5-F2-Phe, and 3,4,5-F3-Phe, 
respectively) while fractional block at higher [Ca2+] was fit by a Woodhull model (see results). The 
curvature of the current-voltage relationship illustrates the voltage-dependent block. The effective fraction 
through the electric field (δ ) for Ca2+ block, constrained to be the same for each Phe variant, was 0.18 ± 
0.03.  Note the decrease in Ca2+ block with increased fluorination.  The estimates of inhibition constants 
were K0(0) = 20.9 ± 2.8 mM, K1(0) = 25.0 ± 3.2 mM, K2(0) = 36.7 ± 5.1 mM, and K3(0) = 58.9 ± 9.2 mM. 
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Figure 3.5. Exponential effect of fluorination on the inhibition constant for Ca2+ block. The data points are 
the estimates (± standard error) of the inhibition constants at 0 mV, i.e., Kj(0), from figure 3.4 (j is the 
number of fluorines). The best-fit theoretical curve is (0) 19.2exp(0.344 )jK j=  mM. 
 
Discussion 
The side chains of amino acids that line the extracellular aqueous vestibule of a Na+ 
channel pore could affect permeation in a variety of ways, primarily by consequences on 
the local concentration or hydration of permeant ions and blockers. Amino acid side 
chains may, for example, interact directly (i.e., within the range of van der Waals forces) 
with ions in the vestibule. For permeant ions, such contacts would generally have to be 
brief to be consistent with the high transport rate through open channels. Vestibule-lining 
side chains could also contribute to the electrostatic potential experienced by ions.  
Finally, the protein lining of the vestibule effectively decreases the local dielectric 
constant compared to water by presenting a dielectric boundary.27,28  Deeper residues that 
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line the selectivity filter presumably have the most intimate contact with permeant ions, 
and also perhaps with small pore blockers.  Large effects on permeation or block in Na+ 
channels are caused by mutations of either the DEKA selectivity ring or of the outer 
EEDD ring of negative charges.1-5,13,14,18,29-32  The main exception to these generalities 
involves the aromatic residue Tyr401 in rat NaV1.4 and aligned residues in other 
isoforms. A neutral, nonaromatic substitution of this residue decreases TTX affinity by as 
much as three orders of magnitude.16,17,19  A substantial component of cationic TTX’s 
binding energy is due to an electrostatic interaction with the π system of Tyr401,33 
discussed in detail in chapter 4, suggesting that the aromatic ring is oriented to face the 
permeation pathway. This raises the possibility that other extracellular cations, especially 
Na+ and Ca2+, are also attracted to the negative electrostatic potential on the aromatic face 
of this residue. 
The electrostatic potential projecting out from the center of a benzene ring in aqueous 
solution, and the effects on it of fluorination, are shown in figure 3.6A.  These estimates 
agree with experimental and theoretical analyses showing that trifluorination effectively 
neutralizes the quadrupole moment.24,25  In fact the quadrupole moment is slightly 
reversed in sign by trifluorination (figure 3.6A), in agreement with experimental 
observations.34  The results of the present study show that systematic fluorination of the 
aromatic ring progressively reduces Ca2+ block without affecting the single-channel 
conductance for Na+ ions.  Here it is explored whether these results are consistent with an 
electrostatic mechanism.  
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Figure 3.6.  Electrostatic potentials and Ca2+ binding energies.  A) Electrostatic potential for benzene and 
its fluorinated derivatives. Electrostatic potential was determined along the C6 axis projecting from the 
center of the benzene ring using a polarizable continuum model of water.  B) Interaction energy of a Ca2+ 
ion with benzene and fluorinated derivatives along the C6 axis. Gas-phase energies are plotted as solid 
lines, and aqueous energies as dashed lines. Values were calculated in 0.5 Å increments from 2 to 4 Å and 
in 1 Å increments for greater distances. The vertical dotted line is set at the minimum-energy distance 
between the Ca2+ ion and benzene. This line shows that progressive fluorination monotonically destabilizes 
the attraction of Ca2+ for the aromatic ring.  C) Optimized geometry of the complex between Ca2+(H2O)6 
and a benzene ring.  D) Interaction energy between Ca2+(H2O)6 and benzene, calculated in gas or in water 
at the optimized geometry. The energies increase linearly with the number of added fluorines. 
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A negative electrostatic potential on the aromatic face of residue at position 401 could 
enhance Ca2+ block in two ways.  First, a Ca2+ ion might bind directly (essentially at van 
der Waals contact) to the face of the aromatic ring where it would prevent the flux of Na+ 
ions.  Second, the negative potential might increase the probability that a Ca2+ ion would 
be found in the vicinity of the blocking site without direct contact between the metal ion 
and the aromatic ring.  The second scenario is favored because direct binding of Ca2+ to a 
simple aromatic ring would require partial dehydration of the Ca2+ ion, an energetically 
costly task for the diffuse quadrupole moment of an aromatic ring.35  To show this 
explicitly, the binding energy of a Ca2+ ion to benzene was determined using high-level 
(HF/6-31++G**) ab initio calculations.  The optimized position for Ca2+ in the gas phase 
was on the C6 symmetry axis of the benzene ring 2.54 Å from its center (figure 3.6B).  
Although the interaction energy is highly favorable at this position in the gas phase, −64 
kcal/mol, the Gibbs free energy for Ca2+ binding in an aqueous environment is highly 
unfavorable, +31 kcal/mol, a consequence of the substantial mismatch between the 
hydration energies of a Ca2+ ion ( Ca(hyd)GΔ  = −390 kcal/mol) and benzene ( Benz(hyd)GΔ  = 
−1.5 kcal/mol).  This result is presented graphically in figure 3.6B by plotting the 
calculated free energy of the interaction of a Ca2+ ion with benzene as a function of 
distance from the center of the benzene ring.  The solid and dotted lines represent the 
interaction energy in the gas phase and in aqueous solution, respectively.  Benzene 
(black) attracts a Ca2+ ion in the gas phase and repels it in water; this conclusion holds at 
any distance greater than 2 Å from the center of the aromatic ring. 
Figure 3.6B also shows the effect of fluorination on these interaction energies.  The 
vertical dotted line highlights these energies at the optimized position of Ca2+ in the gas 
 
70 
 
phase. Both in gas and in aqueous solution, fluorination diminishes the energy of 
interaction between Ca2+ and benzene at distances closer than 4.5 Å.  Note that at larger 
distances water molecules would be able to penetrate the space between the cation and 
the aromatic ring.  Therefore, although a benzene ring has a net repulsive effect on a Ca2+ 
ion in water, the repulsion is exacerbated by fluorinating the ring.  From the point of view 
of a cation, it could be that the negative electrostatic potential ameliorates the 
hydrophobic (unattractive) properties of the aromatic side chain.  These calculations 
strongly suggest that in aqueous solution Ca2+ ions do not make direct contact with the 
aromatic ring of Tyr401 (or phenylalanine at this site), but that fluorination nevertheless 
has an electrostatic effect on Ca2+ ions in the vicinity of the ring.  To rationalize the 
unfavorable interaction energies in water, an alternative viewpoint was explored, namely 
that an appropriate treatment of the interaction between an aromatic ring and Ca2+ must 
include explicit water, namely the inner hydration shell of the cation. 
The substantial desolvation penalty for a Ca2+ ion, approximately 30 kcal/mol to remove 
one water molecule from the inner hydration shell, indicates that when interacting with an 
aromatic ring, Ca2+ will maintain this hydration shell of 6 waters.36,37  Nevertheless, the 
charge of the cation will orient and polarize the hydration waters so that the hydrated 
complex, Ca2+(H2O)6, can interact favorably with the face of an aromatic ring.38,39  In 
essence, Ca2+(H2O)6 is a larger, more polarizable cation than an isolated Ca2+ ion. The 
increased size and delocalized charge are expected to decrease the interaction energy with 
a benzene ring.39-41  Figure 3.6C shows the octahedral arrangement of waters in 
Ca2+(H2O)6  and the optimized geometry of this metal-water complex with benzene.  The 
Ca2+ ion lies 5.70 Å from the centroid of benzene at an angle of 8.9° from the normal of 
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the aromatic ring plane.  The interaction energies of Ca2+(H2O)6 with benzene in this 
optimized geometry are −10.6 and +3.7 kcal/mol in gas and water, respectively, 
significantly smaller in magnitude than the energies observed for an isolated Ca2+ ion, in 
part because of the greater distance between Ca2+(H2O)6 and the benzene ring.  The effect 
of fluorinating the benzene ring on the binding energy of Ca2+(H2O)6 was calculated at 
the fixed, optimized geometry shown in figure 3.6C.  These interaction energies are 
plotted in figure 3.6D as a function of the number of fluorine atoms appended to the 
benzene ring.  As in the case of a nonhydrated Ca2+ ion (vertical dotted line in figure 
3.6B), the interaction energy increases monotonically as the benzene ring is progressively 
fluorinated (figure 3.6D).  The relationship is steeper when calculated in the gas phase. 
The energetic effect of altering the benzene ring, a linear increase in interaction energy 
with fluorination (figure 3.6D), leads to a prediction of the consequences of fluorination 
on Ca2+ block.  Figure 3.7 shows a molecular model of the outer vestibule of the pore of 
the Na+ channel,42 with Ca2+(H2O)6 aligned in its optimized geometry with the aromatic 
ring of Tyr401. The side chains of the DEKA ring are shown below Tyr401. The 
transparent, solvent-accessible surface of the hydrated Ca2+ ion is also shown.  Previous 
modeling and experimental evidence suggest that the aromatic ring of Tyr401 faces the 
central axis of the pore,33,42 and that a stable blocking site for Ca2+ is likely to be at the 
DEKA ring where it can interact with the two acidic side chains.3  The structural model 
in figure 3.7, with Ca2+(H2O)6 at a more superficial location near Tyr401, is also likely to 
be nonconductive for Na+ ions because of both the substantial volume occupied by the 
hydrated metal ion and its charge.  Therefore, this conformation is also a blocked state, 
albeit weaker presumably than the site at the DEKA ring.  We propose that the aromatic 
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ring does not interact with this hydrated ion when it is in its deeper blocking site at the 
DEKA ring.  Rather, the aromatic side chain affects the local concentration of Ca2+ 
( 2+ local[Ca ] ) in the immediate vicinity of this deeper site.  Within the limits of reliability 
of the structural model in figure 3.7, a hydrated Ca2+ ion must pass near the aromatic face 
of Tyr401 on its way to its deeper site at the DEKA ring.  The probability of finding 
Ca2+(H2O)6 at the location shown in the figure can be expressed as 
1
1 exp( )
j
j
p G
RT
=
Δ
+
, 
where j is the number of fluorine atoms, Phe jj k
k
G G GΔ = Δ + Δ∑  is the free energy of 
Ca2+(H2O)6 at that location, R is the universal gas constant, and T is the absolute 
temperature. Phe jGΔ  is the contribution to the free energy of the aromatic ring, and 
k
k
GΔ∑  represents all other contributions due to the environment in the vicinity of the 
aromatic side chain.  If it is assumed that in this aqueous environment jp  is very low, 
due both to the low dielectric walls of the vestibule and to the positive energy contributed 
by the aromatic ring (figure 3.6D), then  
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jGΔΔ  increases linearly with fluorination (figure 3.6D), this exponential relationship 
conforms exactly to our experimental results (figure 3.5).  
It remains to be considered why the electrostatic effect of fluorinating the aromatic has 
little consequence on single-channel conductance.  The primary reason, we propose, is 
that changes in electrostatic potential will have a larger effect on divalent Ca2+ ions than 
on the monovalent Na+ ions that carry the inward current.  Using the above quantum-
mechanical approach for calculating the interaction energy of a Na+ ion with benzene in 
water, it was found, for example, that trifluorinating benzene has a sixfold greater effect 
on 2+ local[Ca ]  than on 
+
local[Na ]  at a distance of 4 Å from the center of the ring.  Therefore 
the threefold increase in Kj(0) for Ca2+ block between phenylalanine and 3,4,5-F3-
phenylalanine (figure 3.5) would correspond roughly to a 50% decrease in + local[Na ] . 
This reduction would have only a moderate effect on single-channel current amplitude, 
because [Na+] has a nonlinear, saturating relationship with single-channel 
conductance.11,14,43 
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Figure 3.7.  Model of the extracellular vestibule of the channel showing Ca2+(H2O)6 in optimal apposition 
to Tyr401 (figure 3.6C). The molecular model42 depicts part of the pore helix and pore loop from each 
domain of the Na+ channel. The side chains of Tyr401 and the DEKA ring are rendered. Ca2+(H2O)6 is 
shown enveloped by a transparent solvent-accessible surface. 
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The above analysis sidestepped the explicit role of the conserved negatively charged ring 
(EEDD, figure 3.1) that will tend to concentrate cations within the extracellular vestibule. 
Functional studies suggest that the negative electrostatic potential in the vestibule is in 
excess of −100 mV.14,44  As was seen here, however, a more challenging task for the 
channel is to overcome the energetic burden for metal cations to leave the relative 
comfort of the extracellular solution and enter a cavity lined by low-dielectric protein. 
These calculations show that even in the presence of an electrostatic potential of −140 
mV at a distance of 5.7 Å from a benzene ring (figure 3.6A), the aqueous environment 
remains unfavorable for Ca2+ (+15.3 kcal/mol) and only slightly favorable for Na+ (−0.24 
kcal/mol).  Nevertheless, neutralizing any of the EEDD charges has substantial effects on 
both cation block and single-channel conductance,13,14,18,29,31 confirming a strong role for 
electrostatics. 
The cation-π interaction has been examined extensively in the past two decades and is 
now known to play a significant energetic role in the interaction between organic cations 
and proteins, as well as between basic and aromatic side chains in proteins.41,45,46  A 
previous study, however, found no evidence for a postulated cation-π interaction between 
the divalent cation Mg2+ and the aromatic side chain of a tryptophan residue in the 
NMDA receptor.47  As was discussed here, this result may not be surprising when the 
cation is very small and highly charged.  One feature of a strong cation-π interaction is 
the match of hydration energies between a large cation with its delocalized charge and an 
aromatic ring.  In the absence of other energetic constraints the hydration mismatch 
between a Ca2+ ion and an aromatic ring precludes direct binding, in spite of a powerful 
electrostatic attraction.  Nevertheless, a systematic reduction of blocking affinity for Ca2+ 
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was seen as the phenylalanine incorporated at position 401 is progressively fluorinated, a 
distinguishing characteristic of a cation-π mechanism.  Although induction (polarization) 
energy makes an attractive energetic contribution for both monovalent and divalent 
cations with benzene,48,49 the predominant consequences of fluorination arise from 
changes of the electrostatic interaction between the metal cation and the quadrupole 
moment of the aromatic ring.24,50  In comparison to the threefold destabilization of Ca2+ 
block, incorporating 3,4,5-F3-phenylalanine at position 401 destabilizes the organic pore-
blocker TTX by 50-fold,33 suggesting a more intimate interaction between an aromatic 
residue at this site and the larger toxin in its binding site (chapter 4). 
Although this study reveals a modest role for a cation-π mechanism in the interaction 
between a Ca2+ ion and an aromatic residue at position 401, it does not address isoform 
differences between TTX-sensitive channels that have an aromatic residue at this position 
and TTX-resistant channels that have either a cysteine or a serine at position 401. 
Differences in Ca2+ block between these two classes of Na+ channels is a disputed 
experimental observation8,9,21,22 suggesting that other factors might contribute to 
functional differences between these types of channels. It is also worth bearing in mind 
that fluorination of phenylalanine at this site is a relatively minor perturbation of structure 
compared with mutating this residue into a cysteine.  Notably, only two amino acids 
distinguish the outer vestibule residues of NaV1.4, the TTX-sensitive channel studied 
here, and the TTX-resistant cardiac channel NaV1.5.  The latter isoform has a cysteine at 
the aligned position of Tyr401, and an arginine instead of an asparagine immediately 
adjacent to the outer ring of negative charge in D1.  The asparagine-to-arginine 
substitution of this residue by itself causes a tenfold decrease in Ca2+ block in a TTX-
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sensitive neuronal Na+ channel,3 suggesting another electrostatic determinant of the local 
concentration of Ca2+ ions in the outer vestibule.  The relative roles of these two residues 
will undoubtedly lead to insights into mechanisms of permeation and block in Na+ 
channels. 
 
Conclusion 
In summary, the study presented here demonstrates that an electrostatic cation-π 
interaction occurs between an aromatic side chain and Ca2+ ions within the outer mouth 
of a voltage-gated Na+ channel.  Using in vivo nonsense-suppression techniques to 
incorporate fluorinated-phenylalanine derivatives into NaV1.4 at Tyr401, the attraction of 
the cation and the electronegative face of the aromatic residue was experimentally tested 
by recording on the single mutant channels.  The cation-π interaction was found to be 
specific to the divalent cation Ca2+ and not the monovalent Na+ since no change was 
observed in the single-channel conductance in the same mutant channels.  High-level 
quantum mechanical calculations show that the interaction between Ca2+ and the 
aromatic ring is likely to occur with the hydrated cation. 
 
Methods 
The work in this chapter was a collaborative effort that included important contributions 
from Dr. Vincent Santarelli, Dr. Chris Ahern, and Dr. Richard Horn of the Jefferson 
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Medical College in Philadelphia, PA.  Detailed methods for the experiments discussed in 
this chapter that were not performed by the author can be found in Santarelli et al.51 
 
Unnatural Amino Acids and Molecular Biology 
Phenylalanine-dCA, 3,5-F2-phenylalanine-dCA, 3,4,5-F3-phenylalanine-dCA were 
obtained as described in chapter 2.  3-F-Phenylalanine was a gift from Dr. Niki 
Zacharias, a former graduate student in the Dougherty laboratory.  These aminoacylated 
dinucleotides were ligated to a modified tRNA from Tetrahymena thermophila, THG73, 
using T4 RNA ligase (New England Biolabs, Ipswich, MA).52,53 
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C h a p t e r  I V 
 
A CATION-π INTERACTION DISCRIMINATES AMONG SODIUM CHANNELS 
THAT ARE EITHER SENSITIVE OR RESISTANT TO TETRODOTOXIN BLOCK 
 
Voltage-gated Na+ channels control the upstroke of the action potential in excitable cells 
of nerve and muscle tissue, making them ideal targets for exogenous toxins that aim to 
squelch electrical excitability.  One such toxin, tetrodotoxin (TTX), blocks Na+ channels 
with nanomolar affinity only when an aromatic phenylalanine or tyrosine residue is 
present at a specific location in the external vestibule of the ion-conducting pore.  
Interestingly, this specific location is the same aromatic residue studied in chapter 3, 
NaV1.4 Tyr401.  In order to test the possibility that the guanidinium group of TTX is 
attracted to Tyr401 through a cation-π interaction, this aromatic residue was replaced 
with a series of fluorinated derivatives of phenylalanine using the in vivo nonsense-
suppression method.  Consistent with a cation-π interaction, increased fluorination of a 
phenylalanine incorporated at 401 caused a monotonic increase in the inhibitory constant 
for block.  Trifluorination of the aromatic ring disrupted TTX affinity by 50-fold, similar 
to that of outright replacement of phenylalanine at position 401 by the nonaromatic but 
comparably hydrophobic residue leucine.  Furthermore, an energetically equivalent 
cation-π interaction is shown to underlie both use-dependent and tonic block by TTX. 
Our results are supported by high-level ab initio quantum mechanical calculations 
applied to a model of TTX binding to benzene. These results are the first of their kind to 
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show the incorporation of unnatural amino acids into a voltage-gated Na+ channel and 
demonstrate that a cation-π interaction is responsible for the obligate nature of aromatics 
at this position in TTX-sensitive Na+ channels.  
 
Introduction 
Na+ channels control electrical excitability in muscle and nervous tissues by driving 
membrane depolarization during an action potential. These large (260 kDa) proteins have 
four homologous transmembrane domains that are arranged in a clockwise orientation 
around a central pore.1  Numerous Na+ channel isoforms exist and share the common 
traits of being exceptionally sensitive to voltage and highly selective for their conducting 
ion.2 They can, however, differ in expression patterns, inactivation time course, 
sensitivity to toxins, and effects of auxiliary subunits.  In terms of extracellular block by 
the toxin TTX, Na+ channels have been deemed binary in their sensitivity; they are either 
“TTX sensitive,” blocked by low nanomolar concentrations, or “TTX resistant” with 
blocking constants in the micromolar range.3  Members of the former class include 
isoforms expressed in brain (NaV1.1, NaV1.2 and NaV1.3), skeletal muscle (NaV1.4), and 
peripheral nervous system (NaV 1.6 and NaV 1.7); the latter class includes isoforms of 
cardiac muscle (NaV1.5) and sensory neurons (NaV1.8 and NaV1.9).  A number of point 
mutations in the external vestibule of the channel can substantially disrupt TTX binding,4-
8 yet many of these residues are conserved between sensitive and resistant isoforms and 
therefore cannot explain isoform-specific TTX sensitivity.  It has been established that a 
single aromatic residue conserved in the first homologous domain (DI) of TTX-sensitive 
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isoforms underlies isoform-specific block.9-11  Mutagenic replacement of this aromatic 
residue, Tyr401 in the rat skeletal muscle Na+ channel NaV1.4, with the homologous 
residue from NaV1.5, a cysteine, renders this isoform insensitive to TTX.10,11 More 
importantly, a high-affinity TTX site with nanomolar block can be generated in NaV1.5 
upon a single aromatic substitution at this site,9,11 confirming the importance for TTX 
block of phenylalanine or tyrosine at this position. This observation led to the proposal 
that a cation-π interaction would figure prominently in the binding of TTX to toxin-
sensitive channels.9,12  Here experimental evidence proves that a cation-π interaction 
involving Tyr401 in NaV1.4 contributes to high-affinity block by TTX.  
TTX block is enhanced by high-frequency stimulation of Na+ channels. This use 
dependence of block was first reported in TTX-resistant cardiac Na+ channels,13 but is 
also seen in highly toxin-sensitive preparations, such as the crayfish axon,14 and wild-
type and mutated Na+ channels heterologously expressed in oocytes.8,15,16  It has been 
proposed that the lower affinity for cationic TTX in the resting or “tonic” state might be 
due to electrostatic interference from a Na+ or Ca2+ ion trapped in the pore of the closed 
channel.14  Upon repeated depolarization, channel opening allows for the escape of the 
trapped ion, increasing the stability of the toxin-bound state. Experiments show that 
extracellular Ca2+ and Mg2+ ions compete with and inhibit TTX binding, further 
supporting the “trapped ion” mechanism.15,17  The relative effects of mutating pore 
residues on high- and low-affinity blocked states have not been examined in detail. 
Many pore blockers mimic a channel’s permeant ion and occlude conduction by taking 
its place in the permeation pathway.  In the present example, the charged guanidinium 
moiety of TTX may replace Na+ at the external mouth of the channel. Therefore an 
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understanding of block by TTX and other guanidinium toxins holds the promise of 
providing insight into the molecular architecture of the permeation pathway.  The Na+ 
channel selectivity filter has been hypothesized to be formed by the side chains of 
aspartate, glutamate, lysine, and alanine, one from each of the four homologous domains, 
DI-DIV respectively.18,19  The “DEKA” locus is assisted by an outer ring of negative 
charges that electrostatically “focus” Na+ ions toward the mouth of the selectivity 
filter.20,21  Mutation of residues in either the inner or outer ring decreases both TTX 
affinity and single-channel conductance,5 suggesting the TTX binding site overlaps with 
the extracellular entrance of the permeation pathway.  The aromatic residue of interest for 
the current work, Tyr401 in NaV1.4, is located between the two aforementioned charged 
rings, and its replacement with cysteine reduces single-channel conductance,11 further 
suggesting a role for this site in Na+ permeation. The homologous residue in the TTX-
resistant cardiac isoform NaV1.5, a cysteine, underlies sensitivity to extracellular pore 
block by heavy metals.10,22  
An aromatic side chain may interact with a large organic cation like TTX through a 
combination of forces, including an induced dipole in the toxin and the aromatic, donor-
acceptor, charge-transfer, and dispersion forces, as well as hydrophobic effects.23  
Electrostatic energy may also be provided by the attraction between the negative 
electrostatic potential on the face of the aromatic ring and the guanidinium moiety of 
TTX, an attraction termed the cation-π interaction.23,24  Traditional site-directed 
mutagenesis is not helpful in discriminating among the many energetic components of 
binding energy, because outright amino acid substitution tends to change hydrophobicity, 
structure, polarizability and electrostatics concurrently.  These shortcomings are readily 
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averted by employing in vivo nonsense suppression to incorporate unnatural amino acids 
with subtle structural changes.25  This method has been used previously to test for cation-
π interactions by incorporating a series of progressively fluorinated aromatic derivatives 
into the ligand-binding pockets of a variety of ion channels.26-29  We have also used this 
approach to explore extracellular block of potassium channels by cationic 
tetraethylammonium.30  The principle underlying this strategy is rather simple.  Each 
fluorine atom substitution progressively reduces the negative electrostatic potential on the 
face of the aromatic, thereby reducing the electrostatic component of binding affinity.  
For studies of this kind, unnatural amino acids are clearly superior to their traditional 
counterparts.  Serial fluorination does not substantially change the size, shape, 
polarizability, or hydrophobicity of the aromatic side chain,23,31 so any loss in binding 
energy is due to cation-π electrostatics. 
In the present study, the in vivo nonsense-suppression method was used to introduce a 
series of progressively fluorinated phenylalanine residues at position 401 in NaV1.4, and 
the resulting channels were assayed for their sensitivity to TTX.  Block was studied under 
both tonic and stimulated conditions, and both blocked states were found to rely heavily 
on a cation-π interaction at position 401. Specifically, stepwise fluorination 
monotonically increased the equilibrium binding constant, as observed in other known 
organic cation-π systems. Furthermore, complete neutralization of the negative 
electrostatic potential of the aromatic face by trifluorination of the aromatic side chain 
resulted in a TTX block that was similar to replacement of the residue at position 401 by 
leucine, suggesting that hydrophobicity alone cannot explain high-affinity block. 
Analysis of the blocking kinetics reveals that withdrawal of π electrons from the aromatic 
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face of phenylalanine at position 401 is manifested primarily as a decrease in the 
association rate constant for TTX block.  These results demonstrate that phenylalanine at 
position 401 interacts with TTX through a substantial cation-π interaction, which, along 
with other energetic contributions, supports high-affinity block in TTX-sensitive 
isoforms.  
 
Results 
TTX affinity is nearly 3 orders of magnitude higher in TTX-sensitive Na+ channels than 
in TTX-resistant isoforms, a difference that has been attributed to the lack of an aromatic 
residue in the external vestibule of the later class of channels. Specifically, high-affinity 
block requires the presence a tyrosine or phenylalanine at position 401 in the pore loop of 
domain DI of the rat NaV1.4 channel from skeletal muscle.9-11  Here the goal was to 
measure the energetic contribution of a cation-π interaction between TTX and the 
aromatic face of residue 401.  A substantial cation-π interaction would provide insight 
into both the orientation of this residue in the extracellular mouth of the channel and of 
TTX in its blocking site. To this end electron-withdrawing fluorine atoms were 
substituted for hydrogen atoms on the aromatic ring of residue 401, creating a series of 
fluorinated analogues of phenylalanine, as described in chapter 2.  The same fluorinated-
phenylalanine-dCA derivatives used in the study of tetraethylammonium (TEA) binding 
to the voltage-gated Shaker B K+ channel (ShB) were used in this study (see chapter 2 of 
this thesis). 
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The functional equivalence of phenylalanine and tyrosine at position 401 with respect to 
TTX block (table 4.1) allows us to employ analogs of phenylalanine in our analysis. This 
work represents the first attempt to directly test the contribution of the π electrons of the 
aromatic ring at position 401 in TTX binding.  
Table 4.1.  Affinity and kinetics of TTX block in tonic and stimulated states.* 
NaV1.4 
(Suppressed 
at 401) 
L
iK  
Tonic (nM) 
H
iK  
Stim (nM) 
L
offk  Tonic 
(s-1) 
H
offk  
Stim (s-1) 
onk  
(s-1*µM-1) 
WT 
(Tyr401) 
19 ± 6 (5) 6 ± 1 (5) 0.13 ± 
0.04 (5) 
0.037 ± 
0.002 (4) 
6.84 ± 
0.79 (9) 
Tyr401Phe 25 ± 2 (4) 5 ± 0.9 
(4) 
0.161 ± 
0.017 (4) 
0.033 ± 
0.001 (4) 
6.58 ± 
0.17 (4) 
Phe 25 ± 3 (6) 7 ± 0.9 
(6) 
0.1545 ± 
0.0128 (6) 
0.040 ± 
0.004 (5) 
6.13 ± 
1.04 (6) 
3-F-Phe 49 ± 7 (6) 10 ± 1 (6) 0.208 ± 
0.032 (5) 
0.040 ± 
0.002 (5) 
4.08 ± 
0.46 (5) 
3,5-F2-Phe 316 ± 32 
(6) 
93 ± 9 (6) 0.642 ± 
0.064 (6) 
0.181 ± 
0.019 (6) 
2.04 ± 
0.27 (6) 
3,4,5-F3-Phe 974 ± 61 
(6) 
350 ± 28 
(6) 
0.352 ± 
0.022 (6) 
0.134 ± 
0.032 (6) 
0.361 ± 
0.058 (6) 
Tyr401Leu 2070 ± 223 
(6) 
1006 ± 
104 (6) 
0.363 ± 
0.082 (4) 
0.171 ± 
0.031 (4) 
0.209 ± 
0.052 (4) 
Tyr401Cys 108,000 ± 
14,000 (4) 
108,000 ± 
14,000 (4) 
- - - 
 
An energy-minimized structure (A) and the electrostatic potential (B) of TTX are shown 
in figure 4.1.  Although a monovalent cation at neutral pH, TTX also has a large dipole 
moment of approximately 10 D, with an excess of positive charge (blue) near the 
guanidinium group, which would be expected to affect the orientation of TTX due to 
electrostatic interactions with its binding site.  
                                                
* Rate constants ( Hoffk , 
L
offk , and onk ) and equilibrium inhibitory constants (
L
iK  and 
H
iK ) were 
determined as described in Santarelli et al.32  The number of cells is enclosed in parentheses. The mutants 
indicated in red were generated by nonsense suppression. 
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Figure 4.1.  Structure of TTX.  A) Energy-minimized structure and B) surface rendering of TTX with 
electrostatic potential ranging from +100 kcal/mol (blue) to +40 kcal/mol (red). Note that the delocalized 
charge of TTX presents a substantial dipole moment, with positive charge concentrated near the 
guanidinium moiety. 
 
Figure 4.2 shows representative examples of inward Na+ currents elicited by 
depolarizations to −10 mV from a holding potential of −100 mV.  The Tyr401Phe mutant 
(figure 4.2A) was constructed by standard site-directed mutagenesis, while the remaining 
panels show currents for mutations introduced by nonsense suppression in which the 
cRNA encoding for NaV1.4 was identical, containing a UAG codon at position 401. 
Figures 4.2B-E show the similarity of Na+ currents coexpressing this cRNA construct 
with suppressor tRNAs ligated to the indicated derivatives of phenylalanine.  In addition, 
the peak current-voltage relationships from the fluorinated unnatural amino acids resulted 
in less than 5 mV shifts in activation compared with wild-type channels.  Injection of 
NaV1.4 Tyr401UAG cRNA without a complementary suppressor tRNA failed to produce 
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Na+ currents, allowing for the ruling out of enzymatic manipulation within the oocyte 
expression system resulting in the incorporation of unexpected and unwanted natural 
amino acids (figure 4.2F). As a further control, no Na+ current was seen when a tRNA 
lacking an appended amino acid (dCA-tRNA) was coinjected with the NaV1.4 
Tyr401UAG cRNA.  
 
Figure 4.2.  Representative current traces from either Tyr401Phe or channels constructed from coinjection 
of Tyr401TAG mRNA with a complementary tRNA appended with the indicated amino acid.  Families of 
Na+ currents are shown from depolarization from −30 to +20 mV in 5 mV increments and were elicited 
from a holding potential of −100 mV.  The voltage dependence and kinetics of currents of A) the 
Tyr401Phe point mutation are indistinguishable from B-E) those of both natural and unnatural 
substitutions.  Note the absence of currents upon injection of NaV1.4 Tyr401UAG mRNA alone.  Scale bars 
in each case are 5 ms and 1 µA. 
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Figure 4.3 demonstrates the effect of serial fluorination of the phenylalanine incorporated 
at position 401 on TTX affinity.  The red traces from the same cells were recorded in the 
presence of the indicated concentrations of TTX. The six panels show currents for a 
variety of mutations at NaV1.4 Tyr401.  Consistent with a cation-π interaction, increasing 
fluorination of the phenylalanine incorporated at position 401 correlates with a decreased 
affinity for TTX block, as shown by the TTX concentration ([TTX]) required to reduce 
the current moderately in each mutant. Note the similar current kinetics for all mutants.  
Insets in figure 4.3 show the indicated aromatic rings of the unnatural amino acids as 
electrostatic potentials. Note that serial fluorination reduces the negative electrostatic 
potential (red) on the aromatic face with a minimal change in the overall structure.  
 
Figure 4.3.  Fluorination of the phenylalanine at position 401 reduces TTX block. Normalized currents 
recorded during a 10 ms depolarization to −10 mV from a holding potential of −100 mV. Control (bath) 
traces in black, and TTX at the labeled concentration in red.  As phenylalanine is fluorinated sequentially, a 
higher [TTX] is required for channel block. The inserts represent electrostatic potentials of benzene with 
red negative (−20 kcal/mol), blue positive (+20 kcal/mol), and green neutral. Before normalization the peak 
inward currents were (in µA): Tyr401Phe, −1.92; Phe, −3.75; 3-F-Phe, −3.72; 3,5-F2-Phe, −2.43; 3,4,5-F3-
Phe, −5.29. 
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Extracellular block of Na+ channels by TTX is use dependent, with repeated stimulation 
enhancing TTX affinity. This increase has been suggested to be due to electrostatic 
repulsion between TTX and a trapped Na+ or Ca2+ ion within the pore, which is relieved 
upon channel opening during which the trapped ion is released.8,14,15  Figure 4.4A shows 
an example of a dose-response experiment that reveals both tonic (low-affinity) and 
stimulated (high-affinity) inhibition for 3,4,5-F3-phenylalanine. For each TTX 
concentration, the experiment consists of recording the current resulting from 100 
depolarizations, each a 10 ms depolarization to −10 mV given at 2 Hz after a 3 minute 
application of TTX. The first pulse in the train is used for determining the tonic 
inhibition, whereas the current elicited by the 100th pulse provides the stimulated block.  
TTX is perfused at the next higher concentration for 3 minutes to allow for the 
stimulated, TTX-bound state to reequilibrate into the low-affinity tonic state.15  After 
application of the highest [TTX], a concentration close to the inhibition constant iK  of 
block is applied, in this case 0.3 µM.  Under continuous 2 Hz stimulation to hold blocked 
channels in the stimulated state, TTX is removed from the bath altogether.  The time-
dependent increase of current during washout is fit with a single-exponential relaxation, 
which provides an estimate of the first-order dissociation rate constant Hoffk  for the high-
affinity stimulated state.  Figure 4.4B and C show inhibition plots for the indicated amino 
acids in the tonic and stimulated states, respectively. Each data set is fit by a single 
binding isotherm with a Hill coefficient of 1.  The trend for each condition is that serial 
reduction in electrostatic potential from the face of the aromatic ring at residue 401 leads 
to a monotonic increase in the inhibition constant iK  (table 4.1), with the trifluorinated 
 
94 
derivative increasing iK  by 50-fold.  Although the stimulated state consistently shows a 
higher affinity for TTX, both states are similarly affected by fluorination.  
 
Figure 4.4.  Effect of fluorination on the dose-response relationship for TTX block.  A) Cumulative dose-
response experiment and washout of TTX.  Peak currents simulated at 2 Hz in the presence of bath alone or 
bath + TTX. Three minutes were given between concentration exchange and stimulation, allowing the 
channels to recover to the tonic state (represented as hash marks).  Rate and equilibrium constants of block 
(table 4.1) were determined as described in Santarelli, et al.32  In most cases a full dose-response 
relationship was obtained for each oocyte. The washout rates were fit well by a single exponential 
relaxation.  B) TTX inhibition of Nav1.4 in the tonic state.  C) TTX inhibition of Nav1.4 in the stimulated 
high-affinity state. 
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Estimates of rate constants for TTX block derived from these experimental data are 
shown in table 4.1.  The association rate constant ( onk ) undergoes a 17-fold decrease as 
residue 401 is converted from phenylalanine to 3,4,5-F3-phenylalanine, whereas the 
dissociation rate constant ( offk ) increases threefold. The general direction of the change 
in each rate constant is consistent with the progressive loss in TTX affinity with 
successive fluorination.  Figure 4.5 shows the effect of fluorination on TTX binding 
energies derived from experimental iK  values, plotted against the relative TTX binding 
energies obtained from an ab initio model of TTX binding to an increasingly fluorinated 
benzene ring (table 4.2).  Consistent with a cation-π interaction, each added fluorine 
results in a stepwise increase in the relative free energy of the TTX-bound state, for both 
the experimental results and the theoretical model. The identical effect of fluorination on 
both tonic and stimulated states strongly suggests that both states involve the same 
physical interaction between TTX and the channel. The higher affinity of the stimulated 
state therefore represents a separate contribution to the binding energy, independent of 
the cation-π interaction we have been testing.  A parsimonious interpretation of the data 
is that the nanomolar affinity of TTX for NaV1.4 depends in part on a substantial cation-π 
interaction with an aromatic side chain at position 401. 
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Table 4.2.  Theoretical binding energies of TTX with fluorinated derivatives of benzene.*   
 
  Hydration Energies    
 ΔE (gas) TTX Fn-Benzene Complex ΔGsolv ΔGbinding ΔΔG 
Benzene  −7.91 −89.88 −1.59 −77.87 13.6 5.69 0 
3-F-Benzene −5.14 −89.88 −2.09 −79.95 12.02 6.88 1.19 
3,5-F2-Benzene −2.14 −89.88 −2.22 −81.51 10.59 8.45 2.76 
3,4,5-F3-Benzene 0.14 −89.88 −2.79 −82.96 9.71 9.85 4.16 
 
Discussion 
Guanidinium toxins like TTX are potent blockers of voltage-gated Na+ channels and have 
been invaluable both in the cloning of Na+ channels33,34 and in the exploration of 
mechanisms of cation permeation. Early studies proposed a model whereby the 
guanidinium moiety of TTX acts as a mimic of a Na+ ion and blocks at the outer entrance 
to the selectivity filter.35,36  In the absence of an atomic structure of a Na+ channel, the 
TTX binding site with its numerous contact points has been helpful in modeling both the 
external vestibule and the selectivity filter of voltage-gated Na+ channels. Many such 
pore models are based on existing K+ channel structures, which are refined further by 
                                                
* Calculations described in Santarelli et al.32 The geometry and orientation of TTX binding was set by a 
gas-phase optimization, followed by aligning TTX with the structure in Figure 4.6 to know which positions 
to fluorinate. All values are in kcal/mol.  ΔE is the binding energy of TTX to the benzene derivatives (Fn-
Benzene, where n = number of fluorines) calculated in the gas phase. The energy caused by fluorination at 
3-F-Benzene was calculated from the average energies of both meta-positions on the ring.  The hydration 
energies for TTX, benzene derivatives, and the TTX-benzene complex were calculated using a Poisson-
Boltzmann equation solver.  ΔGsolv is the change in solvation free energy caused by TTX binding to the 
benzene derivative. ΔGbinding =ΔE +ΔGsolv is the Gibbs free energy of TTX binding, and ΔΔG is the effect 
of fluorination on TTX binding. 
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consideration of the Na+ channel point mutations that affect permeation and pore 
block.1,37-40  Among the extracellular residues that affect toxin block, NaV1.4 Tyr401, and 
the homologous residue in other Na+ channels, plays a unique role in discriminating 
between TTX-sensitive and TTX-resistant channels.7,9-11  Only TTX-sensitive channels 
have an aromatic residue (phenylalanine or tyrosine) at this position.  While other 
residues in the extracellular vestibule of the pore, especially charged residues, may affect 
TTX block dramatically when mutated, they tend to be highly conserved among all Na+ 
channel isoforms. Although the importance of a phenylalanine or tyrosine residue at this 
discriminatory site is agreed universally, its energetic contributions to TTX binding are 
not well understood. Here it was asked whether a cation-π interaction involving residue 
401 contributes to TTX binding energy.  Because an optimal cation-π interaction requires 
a close approach of the cation to the face, not the edge, of the aromatic ring, evidence for 
such an interaction adds another layer of structural information, in that the aromatic must 
orient towards the permeation pathway where it may interact electrostatically with 
cationic pore blockers and permeant cations alike.  
The well-established strategy that was employed to test for a cation-π interaction 
involved the successive fluorination of the aromatic ring26-30,41 and depends on the 
assumption that the predominant effect of fluorine substitution is to decrease the negative 
electrostatic potential on the face of the aromatic residue.  The involvement of a cation-π  
interaction is in complete accord with our results.  As expected, each added fluorine atom 
impacts iK  with a roughly equal increase in the free energy of binding (figure 4.5).  The 
magnitude of the effect, 2.2 kcal/mol for trifluorinating the aromatic ring, is roughly half 
that observed in previous studies of organic ligands binding to ion channels.26,27,30  This 
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decrease may be a consequence of the delocalized charge of the relatively large TTX 
molecule—the diffuse positive charge would tend to have a reduced electrostatic 
attraction to the aromatic ring.  Although essential to high-affinity block, the cation-π 
component of binding cannot account for all of the binding energy, a fact evident from an 
examination of the consequence of trifluorinating the phenylalanine incorporated at 
position 401.  Earlier studies showed that trifluorobenzene is a good model for an 
aromatic that has little or no electrostatic binding ability,42,43 but the data presented here 
show that trifluorination of the phenylalanine at position 401 still results in a channel 
with low micromolar affinity for TTX.  This observation is unsurprising given the 
multitude of possible interactions between TTX and its binding pocket. 
In order to explore a hydrophobic contribution to TTX binding, the Tyr401Leu mutation 
was made.  Leucine is slightly more hydrophobic than phenylalanine.44  The Tyr401Leu 
mutant has a comparable affinity for TTX as that of the trifluorinated derivative of 
phenylalanine, 2.1 versus 0.97 µM, respectively, in the tonic state (table 4.1). This result 
suggests that hydrophobic contributions alone cannot generate a high-affinity binding site 
for TTX, and therefore the 50-fold increase of iK  caused by trifluorinating the 
phenylalanine incorporated at position 401 is due primarily to a loss of electrostatic 
attractiveness of the aromatic ring, namely a cation-π interaction. Note also that the 
effects of these two mutations are in stark contrast to the dramatic loss of TTX affinity 
seen by replacement with more polar amino acids such as cysteine with a iK  of 108 µM 
(table 4.1) or glutamate with a iK  of 170 µM.
7  This result may seem surprising at first 
glance, especially given that the monopole negative charge of glutamate might be 
expected to attract a cation at least as well as the quadrupole potential on the aromatic 
 
99 
face of phenylalanine. For example, a highly conserved ring of four basic residues, two 
glutamates and two aspartates, produces an electrostatic potential in excess of −100 mV 
in the extracellular mouth of Na+ channels.45  This ring of negative charge is believed to 
attract both permeant cations and positively charged blockers like TTX.  An additional 
glutamate at position 401 would also be expected to attract TTX.  Why, then, does the 
Tyr401Glu mutation reduce the affinity of TTX binding? 
For binding to be optimal, there has to be a balance between the electrostatic attraction 
between the toxin and the side chain and the energies of hydration of both TTX and its 
binding site.46,47  Certainly, the dehydration cost is much less for an aromatic side chain 
than for the anionic glutamate.  As such, the innately weaker TTX•••aromatic interaction 
could, after considering solvation, contribute more to binding than the instrinsically 
stronger TTX•••carboxlate interaction. Although this thermodynamic principle may 
account in part for TTX’s preference for tyrosine or phenylalanine over glutamate, it is 
not clear whether this argument can explain the low affinity for the Tyr401Cys mutant or 
whether, for example, some mutations of this residue produce local conformational 
changes that disrupt TTX binding.  Evidence for this possibility is that the Tyr401Cys 
mutant loses its use dependence (table 4.1). The possibility of conformational disruption 
of the binding site does not, however, invalidate the use of fluorinated phenylalanine side 
chains because of the subtle nature of the mutations, by comparison with Tyr401Cys for 
example, and the simple monotonic relationship between TTX binding energy and the 
number of fluorine atoms substituted onto the aromatic ring (figure 4.5).  
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Figure 4.5.  Effect of fluorination on free energy of TTX binding. TTX binding energy relative to 
unfluorinated phenylalanine at position 401 is plotted against the calculated TTX binding energy between 
TTX and a benzene ring (table 4.2). Fluorinating the aromatic ring monotonically increases the relative free 
energy of the bound state. The change in binding energy is nearly identical for both the low- and high-
affinity states. 
 
The effect of fluorination of the phenylalanine at position 401 was identical for the tonic 
and stimulated states in both the trend and magnitude of binding free energy (figure 4.5). 
Although few molecular details are available on the use-dependent mechanism of TTX 
block, this result suggests that the critical TTX:aromatic complex has the same structure 
in both states. The different affinities of the tonic and stimulated states are therefore due 
to other energetic factors, such as the electrostatic repulsion between the toxin and 
cations trapped within the permeation pathway.14,15 
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Kinetic analysis reveals that withdrawing electrostatic potential from the aromatic face of 
the aromatic at position 401 primarily affects the association rate constant onk  of TTX 
block (table 4.1). A similar conclusion was reached previously by conventional 
mutagenic analysis of this and most other residues in the external vestibule. That is, 
reduction of TTX affinity often (but not always) involves a reduction of onk  rather than 
an increase of offk .
7,8  Larger effects on onk  than offk  were also reported for block of ShB 
by the peptide charybdotoxin in response to charge-altering mutations.48  The principal 
similarity in these studies is that the mutations were designed to alter the electrostatics of 
block using either standard mutagenesis or, in this study, changes of electrostatic 
potentials on the surface of an aromatic ring.  Moreover, the empirical association rate 
constants in all of these studies are well below the Smoluchowski limit expected for 
diffusional collision between a small blocker and an ion channel,49 indicating that the 
observed blocking rate is not diffusion limited. The challenge in interpreting these results 
is that alteration of the electrostatic attraction between a ligand and its binding site might 
be expected to affect both association and dissociation rate constants.  
The role of a cation-π interaction in the blocking equilibrium is clear (figure 4.5), 
whether a TTX-aromatic complex is involved in the blocked state or in a transient 
intermediate.  The blocked state itself likely includes hydrogen bonds and other short-
range interactions.  Also, a recent study of toxin block of a K+ channel raises the 
possibility that the conformation of the binding site and the toxin might both change with 
the toxin binds.50  
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In figure 4.6 a snapshot of one possible configuration of the encounter complex was 
visualized.  The coordinates of the pore mouth for NaV1.4 from the model of  Lipkind 
and Fozzard were used.39  In an alternative model the aromatic ring of Tyr401 was not 
oriented to face the permeation pathway51 and was therefore inconsistent with the data in 
this chapter.  To model the configuration in figure 4.6, first the structure of TTX and its 
minimum-energy conformation in complex with benzene were optimized using high-
level ab initio calculations. The benzene of this complex was then aligned with the 
aromatic ring of Tyr401.  Because of sixfold symmetry of the ring, there are six possible 
orientations of the TTX-benzene complex with Tyr401. The minimum energy orientation 
was estimated using molecular mechanics.  This structure is shown from above (figure 
4.6A) and from the side (figure 4.6B).  Notice that the guanidinium group, besides being 
in close apposition to the aromatic face of Tyr401, is pointed downward towards the 
deeper residues of the selectivity filter.  Further study will reveal whether this complex 
prevents Na+ ion flux, either sterically or electrostatically, or whether the blocked state 
involves a subsequent movement of the toxin into a deeper position where it would plug 
the pore.  Our model of block nevertheless supports the idea that a fundamental role of 
the TTX-aromatic interaction is to orient the toxin optimally to block the channel. 
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Figure 4.6.  Model of TTX docking in the pore mouth of Nav1.4. A) Top view of TTX interacting with the 
pore loops of domains DI – DIV in the Lipkind-Fozzard model.39  This structure represents one possible 
configuration of the encounter complex. Note the guanidinium group of TTX in apposition with the face of 
the aromatic ring of Tyr401.  B) Side view of TTX in the pore. 
 
Conclusion 
The conclusions of the present study are threefold.  First, it was demonstrated that the 
high-affinity TTX block supported by a phenylalanine or a tyrosine at position 401 is 
energetically based on a cation-π interaction between the TTX and the aromatic face of 
the side chain. These results therefore serve to answer a long-standing puzzle regarding 
the conserved nature of a pore domain aromatic in high-affinity Na+ channel isoforms.  
Secondly, it was shown that the side chain at Tyr401 presents its aromatic face toward the 
permeation pathway where it can interact favorably with TTX and other cations. These 
results place geometric constraints on this side chain both in current structural models 
and in future atomic level structures of the sodium channel pore.  Lastly, though 
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presented in this thesis after chapter 3, in which Ca2+ was found to bind to NaV1.4 
through a cation-π interaction using similar techniques,52 these results actually represent 
the first published application of the in vivo nonsense-suppression method for the 
incorporation of unnatural amino acids into a voltage-gated Na+ channel.  This work 
therefore serves as proof of principle to pave the way for future experiments utilizing this 
powerful technique to explore a variety of structural and mechanistic issues concerning 
sodium channels, including the energetics that underlie cationic blockade by 
antiarrhythmia, antiepilepsy, and analgesic drugs. 
 
Methods 
The work in this chapter was a collaborative effort that included important contributions 
from Dr. Vincent Santarelli, Dr. Chris Ahern, and Dr. Richard Horn of the Jefferson 
Medical College in Philadelphia, PA.  Detailed methods for the experiments discussed in 
this chapter that were not performed by the author can be found in Santarelli et al.32 
 
Unnatural Amino Acids and Molecular Biology 
Phenylalanine-dCA, 3,5-F2-phenylalanine-dCA, and 3,4,5-F3-phenylalanine-dCA were 
obtained as described in chapter 2.  3-F-Phenylalanine was a gift from Dr. Niki 
Zacharias, a former graduate student in the Dougherty laboratory.  These aminoacylated 
dinucleotides were ligated to a modified tRNA from Tetrahymena thermophila, THG73, 
using T4 RNA ligase (New England Biolabs, Ipswich, MA).25,53 
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C h a p t e r  V 
 
ELECTROSTATIC CONTRIBUTIONS OF AROMATIC RESIDUES IN THE LOCAL 
ANESTHETIC RECEPTOR OF VOLTAGE-GATED SODIUM CHANNELS 
 
Antiarrhythmics, anticonvulsants, and local anesthetics target voltage-gated Na+ 
channels, decreasing excitability of nerve and muscle cells.  Channel inhibition by 
members of this family of cationic, hydrophobic drugs relies on the presence of highly 
conserved aromatic residues in the sixth pore-lining segment (S6) of the fourth 
homologous domain (D4) of the channel.  It was proposed that these aromatic residues 
functioned in channel inhibition though a cation-π interaction with lidocaine.  To test this 
hypothesis, the in vivo nonsense-suppression method was employed to incorporate a 
series of unnatural phenylalanine derivatives designed to systematically reduce the 
negative electrostatic potential on the face of the aromatic ring and thus decrease the 
favorable interaction between the aromatic and the cation.  In contrast to standard point 
mutations at the same sites, these subtly modified amino acids preserve the wild-type 
voltage dependence of channel activation and inactivation.  Although these phenylalanine 
derivatives have no effect on low-affinity tonic inhibition by lidocaine or its permanently 
charged derivative QX-314 at any of the substituted sites, high-affinity use-dependent 
inhibition displays substantial cation-π energetics for one residue only, Phe1579 in rat 
NaV1.4.  Suppression at Phe1579 with cyclohexylalanine, for example, strongly reduces 
use-dependent inhibition and speeds recovery of lidocaine-engaged channels. Channel 
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block by the neutral local anesthetic benzocaine is unaffected by the distribution of π 
electrons at Phe1579, indicating that our aromatic manipulations expose electrostatic 
contributions to channel inhibition.  These results fine tune our understanding of local 
anesthetic inhibition of voltage-gated Na+ channels and will help the design of safer and 
more salutary therapeutic agents.   
 
Introduction 
Voltage-gated Na+ channels underlie the upstroke and propagation of the action potential 
in excitable cells of nerve and muscle, making them ideal targets in pharmacological 
interventions for cardiac arrhythmias, epilepsy, and pain.  Antiarrythmics, 
anticonvulsants, and local anesthetics comprise a family of Na+ channel inhibitors that 
share chemical and structural similarity.  All Na+ channel isoforms, including the cardiac 
channel NaV1.5, are inhibited by these compounds,1-3 with differences in sensitivity 
largely attributed to divergent biophysical aspects of gating kinetics.3  At physiological 
pH these inhibitors are typically lipid-soluble cations that are highly efficacious in the 
treatment of hyperexcitability disorders due to their preference for inactivated channels, a 
conformational state that is prevalent during high-frequency firing of action potentials.  
This state-dependent inhibition is rationalized by models that propose that inactivation 
exposes a high-affinity binding site.   
A general deficiency of this class of compounds is their lack of specificity.  For example, 
the antiepileptic drug carbamezepine may adversely effect cardiac rhythms,4,5 but it has 
also been used for pain management.6  Multiple sites of action, whether expressly 
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intended or not, are common to many of these inhibitors and arise from the highly 
conserved nature of both the compounds and their binding site within the channel where 
the three aromatic residues of relevance for the present study are 100% conserved across 
eukaryotic voltage-gated Na+ channel isoforms.   
An abundance of experimental data implicates pore-lining residues of the S6 segment of 
D4 of the Na+ channel α subunit in the binding of local anesthetics.  Alanine scanning 
mutagenesis exposed the crucial role of two D4/S6 aromatics, Phe1579 and Tyr1586 (rat 
NaV1.4 numbering), in the block by the anticonvulsant etidocaine and the quaternary 
amine QX-314.2  Further study revealed a near universal importance of these two 
aromatic residues in the inhibition of Na+ channels by the class 1A and 1B antiarrhythmic 
drugs and anticonvulsants.7 
These two residues are ideally placed to interact with drugs that inhibit channel function.  
Na+ channel pore domain models based on the crystal structures of K+ channels predict 
that both residues face the inner vestibule of the permeation pathway where they could 
interact readily with cationic blockers and are in close proximity to the selectivity filter 
where they might influence Na+ permeation.8,9  The mechanistic details of local 
anesthetic action, while poorly resolved, may involve electrostatic repulsion of Na+ ions 
at the selectivity filter,10 pore occlusion,11 stabilization of nonconducting states of the 
channel, a combination of all three mechanisms, or other possibilities such as gating 
charge immobilization.12  The additional relevance of these aromatic residues to channel 
function is readily seen in experiments where outright side chain replacement, for 
example with either alanine or cysteine, not only disrupts inhibition by local anesthetics, 
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but also perturbs the biophysics of channel gating,2,13-15 possibly obscuring the 
interpretation of their involvement in channel inhibition.   
How do neutral aromatic residues contribute to channel inhibition by organic cations? 
One proposed but untested possibility is that local anesthetics have an electrostatic 
attraction to the negative electrostatic potential on the face of pore-lining aromatic side 
chains,1 a cation-π interaction.  This hypothesis can be tested directly using the in vivo 
nonsense-suppression method, which allows for the site-directed incorporation of subtly 
modified variants of the aromatic amino acid phenylalanine.16  If a cation-π mechanism 
contributes to the attraction between a cationic blocker and the aromatic side chain, 
reduction of π electron density on the face of the aromatic, for example by fluorinating 
the aromatic ring, will reduce the binding affinity.17  A benefit of this approach is that 
fluorination does not substantially alter the polarizability, size, shape, or hydrophobicity 
of the side chain.17,18  Therefore, this benign manipulation of side chain structure obviates 
the inconvenient functional consequences of standard mutagenesis.  This strategy has 
been applied successfully in Na+ channels to test for cation-π interactions between an 
extracellular aromatic residue and either tetrodotoxin19 or calcium ions.20 
In this study progressively fluorinated phenylalanine derivatives and cyclohexylalanine 
were incorporated at three positions of the D4/S6 segment of the rat NaV1.4 voltage-gated 
Na+ channel, and in each case channels showed robust expression with normal voltage 
dependence and kinetics of both activation and fast inactivation.  Only one site, Phe1579, 
exhibited a strong cation-π interaction with lidocaine.  Furthermore, it was found that 
channel inhibition by the neutral local anesthetic benzocaine was oblivious to 
manipulations that affected the electrostatic potential on the aromatic face of Phe1579.  
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These experiments establish a substantial electrostatic component in the binding energy 
between cationic local anesthetics and a single pore-lining aromatic. This careful 
dissection of the energetic factors underlying the binding of these inhibitory compounds 
to Na+ channels holds promise for the synthesis of more specific therapeutic agents for 
treatment of disorders of hyperexcitability. 
 
Results 
While a cation-π interaction has been proposed to occur between local anesthetics and 
D4/S6 aromatics,1 this hypothesis remains entirely unsubstantiated and was therefore 
targeted directly in this study.  Lidocaine, like most local anesthetics, can exist in two 
forms, neutral or cationic.  At physiological pH roughly three-quarters of lidocaine 
molecules are protonated, and this charged form is a stronger pore blocker than the 
neutral molecule.21-23  Figure 5.1A shows the protonated form of lidocaine and a color-
coded map of the electrostatic potential on the surface of the molecule.  The positive 
charge has an asymmetric distribution focused most strongly (blue) near the protonated 
nitrogen, positioned to the right in each panel of figure 5.1A.  
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Figure 5.1.   Lidocaine and the Na+ channel pore. A) Structure and the electrostatic surface of protonated 
lidocaine.  Left panel shows the structure of lidocaine optimized at the HF/6-31++G** level, with carbon, 
hydrogen, nitrogen and oxygen shown as grey, white, blue and red, respectively.  Right panel shows the 
results of an ab initio determination of the electrostatic surface of protonated lidocaine in water.  The red to 
blue spectrum shown on the scale bar corresponds to a range of 0 to +150 kcal/mol.  B) Side view of a 
putative local anesthetic receptor in a voltage-gated Na+ channel.  The image is adapted from the Na+ 
channel pore model of Lipkind and Fozzard,8 as described in the text. 
 
Figure 5.1B shows a side view of a portion of the putative local anesthetic binding site in 
a model of the voltage-gated skeletal muscle Na+ channel rat NaV1.4 adopted from 
Lipkind and Fozzard.8  The pore helices and extracellular pore loops of domains D2-D4 
and the opposing transmembrane S6 segments of domains D2 (silver) and D4 (orange) 
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are shown in an open-channel conformation.  Note the proximity of the residues Phe1579 
and Tyr1586 to each other and to the selectivity filter above them.  Figure 5.1B is 
intended to represent a side view of the aqueous vestibule in which lidocaine binds, and 
to illustrate that lidocaine is large enough (approximately 11 x 6 Å) to interact 
simultaneously with Phe1579 and Tyr1586 in this structural model.  By contrast Tyr1574 
is on the “backside” of the S6 segment facing away from the permeation pathway. 
Although standard point mutants of Phe1579 typically alter the channel’s biophysical 
properties,2,13,15 the unnatural mutants generated by in vivo nonsense suppression resulted 
in channels that were indistinguishable from wild-type NaV1.4 with respect to kinetics of 
activation and inactivation.  Figure 5.2A shows families of normalized Na+ currents from 
oocytes expressing wild-type NaV1.4 or channels with the indicated amino acid at 
position 1579.  Inward currents shown in figure 5.2A were elicited in increments of 5 mV 
depolarizations from −30 to +10 mV from a holding potential of −100 mV.  Figure 5.2A, 
lower right panel, shows that oocytes coinjected with Phe1579TAG cRNA and a tRNA 
lacking an appended amino acid (dCA-tRNA) did not generate measurable Na+ currents, 
ruling out counterfeit channel expression due to enzymatic manipulation of the coinjected 
tRNA within the oocyte.  Insets in figure 5.2A show the consequences of trifluorination 
on the electrostatic potential of benzene, where red and blue represent negative and 
positive, respectively, and green is neutral.  Peak conductance-voltage relationships for 
activation are shown in figure 5.2B for wild-type NaV1.4 or channels with the indicated 
amino acids at the 1579 position.  There was no change in either voltage dependence or 
slope of activation for any of the mutants (table 5.1).  Moreover, replacement of Phe1579 
with either serially fluorinated derivatives of phenylalanine or nonaromatic 
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cyclohexylalanine resulted in insignificant effects on steady-state inactivation (figure 
5.2C).  We also incorporated the same series of side chains at Tyr1586, a site roughly two 
turns downstream along the S6 α helix.  Like the 1579 site, the incorporation of unnatural 
amino acids was well tolerated, producing channels with healthy expression and normal 
gating (table 5.1).  
A phenomenological hallmark of local anesthetic action on Na+ channels is a 
hyperpolarizing shift of the steady-state inactivation relationship.21,22,24  To test a possible 
role for cation-π energetics at Phe1579, oocytes expressing the indicated channel type 
were incubated for 5 minutes in 200 µM lidocaine at −100 mV and then steady-state 
inactivation was measured (figure 5.2D).  Consistent with previous studies, incubation 
with lidocaine caused a roughly −8 mV shift for Phe1579 channels,24,25 but this effect 
was serially diminished with each added fluorine to a minimum of −2.5 mV for either 
3,4,5-F3-phenylalanine or cyclohexylalanine incorporated at position 1579 (inset).  These 
results suggest that the reduction of negative electrostatic potential on the aromatic face 
of the residue at position 1579 weakens the binding of lidocaine to inactivated channels.   
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Figure 5.2.  Unperturbed gating properties of NaV1.4 channels containing unnatural amino acids at 1579.  
A) Families of Na+ currents for the indicated channel types elicited by 5 mV steps from −30 to +25 mV 
from a holding potential of −100 mV, scale bar is 5 ms.  Insets show the electrostatic potentials of benzene 
and trifluorobenzene with red negative (−20 kcal/mol) and blue positive (+20 kcal/mol).  No currents were 
seen when cRNA from Phe1579TAG was coinjected with dCA-tRNA.  B) Peak conductance-voltage 
relationships for indicated side chains at the 1579 site.  C) Steady-state inactivation curves generated from 
the inset protocol. Holding potential −100 mV, 500 ms prepulse, 2 ms reset at −100 mV, −10 mV test 
potential. D) Same protocol as C, after a 5 minute incubation with 200 µM lidocaine.  Inset summarizes the 
shift in steady-state voltage dependence caused by lidocaine for the indicated channel types, asterisk 
indicates P < 0.05.  
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Table 5.1.  Boltzmann fits of normalized activation (figure 5.2B) and steady-state inactivation (figure 5.2C) 
for wild-type and mutant channels.* 
 G-V Steady-state Inactivation 
 V0.5 K V0.5 K 
NaV1.4 −23.5 ± 0.8 (8) 3.1 ± 0.2 −46.4 ± 1.1 (9) 4.3 ± 0.4 
Phe1579Phe −21.8 ± 0.9 (9) 3.4 ± 0.6 −46.4 ± 0.7 (9) 5.3 ± 0.3 
Phe1579F-Phe −21.0 ± 0.9 (9) 3.8 ± 0.5 −46.6 ± 0.9 (9) 5.1 ± 0.4 
Phe1579F2-Phe −19.8 ± 1.0 (7) 3.5 ± 0.4 −44.0 ± 0.8 (7) 5.6 ± 0.4 
Phe1579F3-Phe −23.0 ± 0.8 (10) 3.1 ± 0.2 −43.0 ± 0.6 (9) 5.3 ± 0.2 
Phe1579Cha −23.2 ± 0.6 (9) 3.2 ± 0.2 −42.8 ± 1.0 (4) 5.5 ± 0.3 
Tyr1586Phe −22.8 ± 0.5 (11) 3.6 ± 0.2 −46.9 ± 1.9 (5) 4.4 ± 0.7 
Tyr1586F-Phe −21.0 ± 0.7 (9) 4.1 ± 0.2 −46.9 ± 0.7 (6) 4.6 ± 0.9 
Phe1579F2-Phe −25.6 ± 0.7 (5) 3.2 ± 0.2 −49.8 ± 0.7 (4) 4.1 ± 0.2 
Tyr1586F3-Phe −24.5 ± 0.7 (5) 4.0 ± 0.6 −47.9 ± 2.0 (4) 4.6 ± 0.6 
Phe1579Cha −26.9 ± 0.6 (5) 4.9 ± 0.2 −49.1 ± 1.7 (5) 5.4 ± 0.4 
 
Tonic Inhibition 
Local anesthetics can interact with Na+ channels under either stimulated or resting 
conditions, the latter with lower affinity.  Systematic replacement of the equivalents of 
NaV1.4 Phe1579 and Tyr1586 in neuronal isoforms with nonaromatic residues reduces 
                                                
* Number of cells indicated in parentheses.  The normalized currents were fit by 
€ 
I(V )
Imax =
1
(1+ e
(V −V0.5 )k )
, where V is membrane potential, V0.5  is the midpoint, and k is a slope 
factor.  Perfusion of oocytes expressing wild-type NaV1.4 with 200 µM lidocaine resulted in a 8 mV 
hyperpolarizing shift in the V
0.5 
of steady-state inactivation from −46.0 ± 0.6 to −53.5 ± 1.6 mV (P = 0.006, 
t-test). This lidocaine-induced shift was eliminated in the trifluorinated mutant 3,4,5-F3-phenylalanine at 
position 1579, −43.0 ± 0.6 versus −45.0 ± 1.4 mV (P = 0.24), for control and lidocaine saline, respectively.  
No such relief was seen when 3,4,5-F3-phenylalanine was incorporated at position 1586 as 200 µM 
lidocaine exposure resulted in a 7 mV hyperpolarizing shift, V0.5 = −46.0 ± 1.2 versus −53.4 ± 1.5 mV (P = 
0.02), for control and 200 µM lidocaine saline, respectively. 
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resting affinity for the local anesthetics etidocaine2 and tetracaine.1  Therefore, the 
possibility of a contribution of cation-π energetics to this tonic inhibition was 
investigated, which was defined operationally as the fractional reduction of peak current 
in response to a low rate of depolarization (15 ms pulses to −20 mV at 0.05 Hz).  Figure 
5.3A shows representative Na+ currents before and after 5 minutes continuous perfusion 
of 200 µM lidocaine.  Wild-type NaV1.4 channels and those containing cyclohexylalanine 
at position 1579 showed indistinguishable tonic inhibition.  The results for all the side 
chains introduced at the 1579 position are shown in figure 5.3B and demonstrate that a 
cation-π interaction with this residue is not a factor in the tonic inhibition by lidocaine.  
The role of Tyr1586 was also investigated in tonic inhibition by lidocaine.  Consistent 
with a previous study,1 removal of the hydroxyl group by mutation to phenylalanine 
alleviated the tonic inhibition from 30 ± 6% to 19 ± 3%. Figure 5.3C shows that further 
manipulation of this side chain to withdraw electon density from the ring had no 
additional effect on the tonic inhibition.  These data show that while the hydroxyl group 
of Tyr1586 plays a role in inhibition, lidocaine does not interact directly with its aromatic 
face under resting conditions. 
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Figure 5.3.  Electrostatic contributions are not involved in tonic inhibition for Phe1579 and Tyr1586.  A) 
Normalized control and tonically inhibited currents (indicated by arrow) elicited by test pulses to −10 mV, 
holding potential −100 mV, scale bar is 5 ms.  Tonic inhibition reached equilibrium after 5 minute of 
continuous perfusion of 200 µM lidocaine as measured by 15 ms pulses every 20 sec.  B) Electrostatic 
potential of Phe1579 does not contribute to lidocaine binding (number of cells in parenthesis).  C) Mutation 
of Tyr1586 to phenylalanine relieves tonic block but any additional manipulation of the aromaticity has no 
consequence, asterisk indicates P < 0.05 versus wild-type NaV1.4. 
 
Use Dependence  
Use-dependent inhibition of Na+ channels is manifest as progressively reduced current 
with increased stimulation frequency.  Although experiments using site-directed 
mutagenesis show that use-dependent block by local anesthetics involves side chain 
contributions from residues in each of the four Na+ channel domains,2,26-28 the presence of 
an aromatic phenylalanine, tyrosine or tryptophan at the position aligned with 1579 is 
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required for use-dependent inhibition,1  suggesting that a cation-π interaction may play a 
substantial role at the binding site.  Figure 5.4A shows representative Na+ currents in 
response to 20 Hz depolarizations to −10 mV from a holding potential of −100 mV in the 
presence of 200 µM lidocaine.  In each example, the 1st and 50th pulses are labeled.  Note 
that the first pulse represents a channel inhibited in its resting state.  In the absence of 
lidocaine, Na+ currents are stable in response to 20 Hz stimulation with no run down in 
amplitude.  Quite dramatically, trifluorination of Phe1579 nearly abolishes the use-
dependent inhibition by lidocaine (figures 5.4A and 5.4B).  Similar results were obtained 
at a tenfold lower lidocaine concentration where tonic inhibition was negligible (figure 
5.5), eliminating a substantial role of rapid open-channel block.  
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Figure 5.4.  Use-dependent inhibition relies on a cation-π interaction between lidocaine and Phe1579, not 
Tyr1586. A) Normalized representative current traces in the presence of 200 µM lidocaine from repeated 
depolarizations to −10 mV from −100 mV for NaV1.4 or channels with 3,4,5-F3-phenylalanine at the 1579 
site.  The first ten and 50th trace of 50 total pulses are indicated.  B) Frequency profile for use-dependent 
inhibition for cyclohexylalanine and fluorinated phenylalanine derivatives.  C) Linear relationship between 
experimental data and theoretical predictions for a cation-π interaction.  Dissociation constants estimated at 
20 Hz were used to calculate the energetic effect of manipulating aromatic electrostatic potential at 
 
124 
Phe1579.  Binding energy is defined as ,mut ,wt0.58ln( )i iK K  kcal/mol, where ,mut ,wti iK K  is the 
fractional increase in the inhibitory constant caused by an unnatural mutant compared to 
benzene/phenylalanine. Theoretical data on the abscissa are based on the calculated interaction between a 
single Na+ ion and the indicated benzene derivative.29  D) Absence of a cation-π contribution at Tyr1586 to 
lidocaine inhibition.  Normalized representative traces shown as in figure 5.4A.  Complete loss of the 
negative electrostatic potential of the aromatic ring has no effect on use-dependent inhibition.  E) 
Frequency profile of use-dependent inhibition for the 1586 position, as in B. Arrow represents Tyr1586Phe. 
Inset shows the relief of inhibition for the Tyr1586Phe mutation at 20 Hz.  Neither serial fluorination nor 
replacement by cyclohexylalanine disrupts lidocaine block further.  F) Energy plot as in panel C details the 
complete lack of a cation-π phenotype at 1586. 
 
Evidence for a cation-π interaction between Phe1579 and lidocaine in the inactivated 
state is presented in figure 5.4B where monotonic relief of inhibition can be seen for each 
added fluorine, with cyclohexylalanine substitution producing almost complete relief.   
This effect is most apparent at high frequencies where inactivated states would be 
expected to dominate.  Although use-dependent inhibition by lidocaine is an obvious 
phenotype, it is an inherently complicated process and as such, the progressive current 
reduction seen in figures 5.4A and 5.4B is likely a combination of interaction of lidocaine 
with both inactivated and open states.  While acknowledging this caveat, an operationally 
defined inhibitory constant Ki was calculated from the fraction of current remaining at the 
completion of 50 pulses delivered at 20 Hz in the presence of 200 µM lidocaine.  This 
apparent inhibitory constant was used to calculate the loss in binding energy resulting 
from the serial fluorination of phenylalanine or outright replacement by 
cyclohexylalanine.  The result of this analysis is shown in figure 5.4C.  The abscissa is 
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derived from ab initio estimates of the energetic effect of fluorination on the cation-π 
interaction between benzene and a Na+ ion.17  As predicted for a cation-π interaction, a 
stepwise reduction in electrostatic potential on the face of the aromatic results in a 
monotonic reduction in lidocaine inhibition.30  Given the ambiguities presented by both 
the charge asymmetry of lidocaine and the interpretations of use dependence protocols, 
the linear relationship between our experimental results and the theoretical predictions for 
a canonical cation-π system is striking, confirming such an interaction between Phe1579 
and lidocaine.  
The results are remarkably different when the same series of phenylalanine derivatives 
are substituted into the nearby aromatic Tyr1586 (figure 5.4D).  The complete data set in 
figure 5.4E lacks both the trend and the magnitude of effect that was observed at 
Phe1579.  The inset of figure 5.4E shows the disruptive consequence of exchanging of 
phenylalanine for tyrosine, an effect greater than any further manipulation of the 
phenylalanine side chain.   Figures 5.4E and 5.4F show that, contrary to the situation for 
Phe1579 only 11 Å away, perturbation of the electron density on the face of an aromatic 
residue at Tyr1586 has little consequence on use-dependent lidocaine inhibition, ruling 
out a cation-π interaction at this site.   
 
126 
 
Figure 5.5. Cation-π influence on use-dependent inhibition at a low concentration (20 µM) of lidocaine. 
Lidocaine was applied 5 minutes before high-frequency stimulation. Tonic inhibition was negligible at this 
low concentration. A,B) Representative currents at −10 mV for 100 10 ms depolarizations from a holding 
potential of −100 mV, every 10th
 
trace shown for clarity.  Stimulation rate was either A) 20 Hz or B) 50 Hz.  
Currents were stable at 50 Hz in the absence of lidocaine.  Left panels are for wild type, right panels are for 
3,4,5-F3-phenylalanine incorporated at position 1579.  C) Fraction of control (P100/P1) after 100 
depolarizations for 5 wild-type and 3 mutant oocytes.  Two asterisks indicate P<0.005. 
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Next it was asked whether lidocaine might interact with a third D4/S6 aromatic residue, 
Tyr1574 (figure 5.1B) positioned roughly 10 Å upstream from Phe1579 but predicted to 
lie on the opposite face of the S6 helix.  Alanine substitution at this site results in a 
modest loss of both resting and use-dependent inhibition by etidocaine in NaV1.2,2 
suggesting that it may play a subtle role in stabilizing the inhibitor in its binding pocket.  
The unnatural amino acid 3,4,5-F3-phenylalanine was the only residue incorporated at 
this site because trifluorination effectively ablates the negative electrostatic potential of 
the face of an aromatic ring.19,30  As for the other two sites we examined, unnatural amino 
acid incorporation was well tolerated and produced channels with robust expression and 
voltage-dependent gating similar to that of wild-type NaV1.4 channels.  Trifluorination at 
this site had no effect on tonic (36 ± 6% versus 39 ± 8%) or use-dependent inhibition (84 
± 4% versus 74 ± 3% at 20 Hz stimulation; P=0.08) for NaV1.4 and for channels with 
3,4,5-F3-phenylalanine at site 1574, respectively. Therefore, only one of the three D4/S6 
aromatic residues, Phe1579, shows a robust cation-π interaction with lidocaine. 
 
Recovery 
Another experimental manifestation of lidocaine action is the emergence of a slow 
component in the recovery from fast inactivation.25  In fact, use-dependent inhibition is 
largely a consequence of slowed recovery from inactivation.  In the absence of lidocaine, 
all Phe1579 mutants recover rapidly from a 15 ms pulse to −10 mV (figure 5.6A), but 
clear differences arise in the presence of 200 µM lidocaine (figure 5.6B).  For each 
variant of Phe1579, the recovery time course can be fit by a double exponential 
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relaxation.  A plausible explanation for this biophysical behavior is that the fast and slow 
components represent unblocked and lidocaine-engaged channels, respectively.  Figures 
5.6C and D show that while the fast and slow time constants from the biexponential fits 
are the same across all channel types, the fractional weight of the fast, unblocked 
component is serially increased with fluorination and replacement by cyclohexylalanine. 
Therefore, fluorination appears to reduce the fraction of channels that trap lidocaine when 
they inactivate, whereas the recovery rate of the drug-modified channels is insensitive to 
the unnatural mutations. These results, like those describing use-dependent inhibition, 
demonstrate a cation-π interaction between lidocaine and Phe1579.  By contrast, neither 
fluorination of the phenylalanine derivatives incorporated at position 1586 nor 
replacement with cyclohexylalanine had a measurable effect on the recovery time course, 
consistent with the use-dependent inhibition experiments summarized in figure 5.4F.  
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Figure 5.6.  Recovery from lidocaine inhibition affected by a cation-π interaction with Phe1579. A) 
Recovery from inactivation in absence of lidocaine has an indistinguishable double-exponential time course 
among phenylalanine derivatives. B-D) Fluorination or cyclohexylalanine substitution increases the 
fractional amplitude of the fast component of recovery in 200 µM lidocaine without affecting the recovery 
time constants. 
 
Role of Charge 
To further test the role of electrostatics in the interaction between a local anesthetic and 
Phe1579, two nontitratable, structurally similar derivatives of lidocaine were studied, one 
neutral (benzocaine) and the other permanently charged (QX-314).  Both compounds are 
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postulated to have overlapping binding sites with other local anesthetics and, more 
importantly, to rely on the presence of an aromatic side chain at Phe1579.23,31  
Benzocaine does not cause use-dependent inhibition in Na+ channels.21,22,31  Replacement 
of the residue at position 1579 by either 3,4,5-F3-phenylalanine or cyclohexylalanine, 
both of which effectively abolish the negative electrostatic potential on the aromatic face 
of phenylalanine, had no effect on tonic inhibition by 1 mM benzocaine (fraction of 
inhibition was 0.49 ± 0.02, 0.46 ± 0.04, 0.44 ± 0.02, respectively, for wild type and the 
two unnatural mutants).  If benzocaine’s binding site overlaps that of lidocaine, the data 
suggest that the fundamental effect of these manipulations of the aromatic ring of 
Phe1579 involves electrostatics, leaving benzocaine inhibition unaffected. 
The lack of an effect of 3,4,5-F3-phenylalanine at position 1579 on tonic inhibition by 
lidocaine (figure 5.3) raises the possibility that lidocaine is deprotonated (uncharged) in 
its tonically inhibited state.  This possibility can be tested directly with permanently 
charged QX-314 that causes both tonic block and use-dependent inhibition.2,24,32  If the 
tonically blocked state involves an intimate interaction between QX-314 and Phe1579, 
then it should be substantially affected by trifluorination of the aromatic side chain.  QX-
314 was injected directly into voltage-clamped oocytes to yield an approximate 
cytoplasmic concentration of 0.5 mM.  This concentration produces dramatic resting-state 
and use-dependent (1 Hz) inhibition in wild-type channels, and only the use-dependent 
component is ameliorated when 3,4,5-F3-phenylalanine is incorporated at position 1579 
(figure 5.7A), similar to our results with lidocaine. The time course of use dependence 
and extent of block for the two oocytes shown in figure 5.7A are plotted in figure 5.7C.  
The summarized data in figures 5.7E and F show that trifluorinating Phe1579 has a 
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similar effect on binding energy for lidocaine and QX-314, suggesting comparable modes 
of inhibition.  The faster rate of use-dependent inhibition in the unnatural mutant suggests 
an increased dissociation rate for QX-314 in the drug-bound inactivated state.  The results 
further show that the tonically blocked state does not involve a close interaction between 
the blocker and Phe1579, yet a substantial cation-π interaction underlies use-dependent 
inhibition by QX-314.  
By contrast with Phe1579, trifluorophenylalanine incorporated at position 1586 causes a 
mild (<0.5 kcal/mol) stabilization of QX-314 block in both the tonic and stimulated states 
(figures 5.7D-F). The effect on stimulated-state inhibition is energetically 
indistinguishable for lidocaine and QX-314 (figure 5.7F). 
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Figure 5.7.  Use-dependent and tonic block by QX-314.  A) Control is a representative trace at −10 mV (0.1 
Hz) after which 25 nL of 20 mM QX-314 was injected to give an estimated final concentration of 0.5 mM 
QX-314, assuming a 1 µL volume for the oocyte.  The oocyte was held at −100 mV for 5 min without 
depolarization to allow for diffusion, followed by 100 1 Hz, 15 ms depolarizations, the first of which 
represents the tonic block. Right panel is from an oocyte expressing trifluorinated Phe1579.  B) 
Comparable experiments for residue Phe1586. C,D) Normalized peak currents from records in panels A & 
B.  Arrow indicates time of QX-314 injection.  Time break is 5 minutes.  E,F) Effect of trifluorination on 
both lidocaine and QX-314 binding energy (number of cells in parentheses). Lidocaine data from figures 
5.3 and 5.4. 
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Discussion 
Three D4/S6 aromatic residues were mutated to determine if any contributed to local 
anesthetic block through the electrostatic allure of their aromatic π electrons.  In contrast 
with previous studies using traditional site-directed mutagenesis, incorporation of 
unnatural amino acids at each site resulted in channels with normal gating, substantially 
simplifying the interpretation of their role in pore block.  A cation-π interaction with 
lidocaine during use-dependent inhibition was observed for only one site, Phe1579, while 
ablation of the negative electrostatic potential on the face of either Tyr1574 or Tyr1586 
had relatively little consequence.   The roles of these tyrosine residues in block cited by 
previous reports may therefore be due to the fact that replacement with a nonaromatic 
amino acid is a more drastic alteration of side chain chemistry, and often changes the 
channel’s biophysical properties.2,13-15  Fluorination of phenylalanine, by contrast, has no 
effect on channel gating at any of the three D4/S6 positions.  Although these results 
suggest that cationic blockers have an electrostatic attraction for the electron density on 
the face of residue 1579, it may be surprising that replacement of this aromatic residue 
with negatively charged glutamate or aspartate obliterates use-dependent inhibition by 
lidocaine.10  A possible explanation for these apparently contradictory observations is that 
in an aqueous milieu an organic cation typically has a higher affinity for an aromatic ring 
than an acidic residue,33 due to the substantial energetic penalty for dehydrating the acidic 
residue. 
This study provides several structural insights into the local anesthetic binding site in the 
high-affinity state created by high-frequency stimulation. The cation-π interaction at 
Phe1579 suggests that lidocaine’s positive charge, concentrated in the vicinity of its 
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titratable amine group, is situated near the aromatic face of Phe1579 in the inactivated 
state.  By contrast, Tyr1574 and Tyr1586 have neither cation-π interactions nor π-π 
stacking34 interactions with lidocaine, as either would be disrupted by fluorination of the 
aromatic ring.  Furthermore, cyclohexylalanine lacks the quadrupole moment of an 
aromatic, and therefore its substitution should reduce any attraction with lidocaine’s 
aromatic moiety through π-π stacking, ruling out this type of attraction between the 
blocker and the tyrosine residues. 
Electrostatic manipulations of Phe1579 affect use-dependent, but not tonic, inhibition.  
This exception contrasts with the interaction between the cationic Na+ channel blocker 
tetrodotoxin and an extracellular pore aromatic, Tyr401, in NaV1.4.19  In the case of 
tetrodotoxin, both the tonic and use-dependent block are weakened identically with serial 
fluorination, implying that a similar physical interaction is present in both states.  The 
results in the present study suggest that tonic and use-dependent block either represent 
differences in the lidocaine binding site or arise from differences in the charged state of 
lidocaine (protonated versus deprotonated).  The latter possibility is ruled out by our 
experiments with the permanently charged QX-314 (figure 5.7).  Both tonic and use-
dependent block are observable with QX-314, but trifluorination of Phe1579 only 
alleviates use-dependent block. The composite results show not only that tonic and 
stimulated states represent distinct conformations, but also that in the tonic state lidocaine 
is not close to any of the three aromatic residues examined.  While lack of a cation-π 
interaction does not rule out other energetic attractions (e.g., hydrophobic, charge 
transfer, or induced dipoles in the aromatic), an intimate contact between an aromatic 
side chain and a charged blocker would be expected to be affected by the dramatic 
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manipulations of electrostatic potential introduced (changes of >600 mV within 2 Å of 
the aromatic ring.19   
What, then, accounts for the differences between tonic and use-dependent inhibition? 
Because the two inhibited states have the same voltage dependence, equivalent to a 
blocker residing 70% of the way into the electric field from the cytoplasmic side,35 it was 
assumed that lidocaine occupies a comparably deep site within the pore in both states.  A 
cation-π interaction only appears between Phe1579 and a charged blocker during 
repeated depolarizations, indicating that stimulation moves this side chain closer to the 
blocker.  The electrostatic invisibility of Phe1579 in the tonic state suggests that its side 
chain does not point into the aqueous cavity of the pore, and that it is unveiled, for 
example, by a rotation of the D4/S6 helix during a conformational transition that 
accompanies inactivation.26,36-38  Note that this mechanism contrasts with a previous 
proposal in which the pore lining remains stationary while the blocker moves.35  Future 
experiments should resolve the gating motions that underlie the exposure of a high-
affinity receptor.  
 
Conclusion 
In this chapter three aromatic residues found in the pore domain of NaV1.4 were probed 
to determine if they were involved in a cation-π interaction with anesthetics such as 
lidocaine.  Fluorinated-phenylalanine derivatives and the nonaromatic cyclohexylalanine 
were incorporated into NaV1.4 at the three sites of interest using the in vivo nonsense-
suppression methodology.  Only one residue, Phe1579 in S6 of D4, was found to make a 
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cation-π interaction with lidocaine and the permanently cationic QX-314, but only during 
high-affinity use-dependent channel block by the anesthetic.  Low-affinity channel block 
and block by the neutral anesthetic benzocaine were not affected by any of the mutations. 
These results suggest that when the channel goes from the tonic blocked state to the use-
dependent blocked state, the channel moves in a manner that brings Phe1579 closer to the 
blocker.  When the blocker is cationic, the appearance of the electronegative face of the 
aromatic ring allows it to bind tightly to the channel, but the same is not necessary when 
the blocker is neutral. 
 
Methods 
The work in this chapter was a collaborative effort that included important contributions 
from Dr. Chris Ahern and Dr. Richard Horn of the Jefferson Medical College in 
Philadelphia, PA.  Detailed methods for the experiments discussed in this chapter that 
were not performed by the author can be found in Ahern et al.39 
 
Unnatural Amino Acids and Molecular Biology 
Phenylalanine-dCA, 4-F-phenylalanine, 3,5-F2-phenylalanine-dCA, 3,4,5-F3-
phenylalanine-dCA, and cyclohexylalanine were obtained as described in chapter 2.  
These aminoacylated dinucleotides were ligated to a modified tRNA from Tetrahymena 
thermophila, THG73, using T4 RNA ligase (New England Biolabs, Ipswich, MA).16,40 
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C h a p t e r  V I 
 
ATTEMPTS TO INCORPORATE D-AMINO ACIDS INTO ION CHANNELS USING 
NONSENSE SUPPRESSION 
 
All ribosomally encoded chiral amino acids are L-amino acids.  D-Amino acids have to 
be incorporated into proteins in nature through nonribosomal peptide synthesis or from 
the conversion of an L-amino acid by various posttranslational mechanisms.  Glycine, the 
only achiral encoded amino acid, can mimic the backbone propensities of a D-amino acid 
because of its flexibility, and therefore act as an encoded D-amino acid surrogate.  One 
example where a glycine has the backbone structure favorable for a D-amino acid is the 
first glycine in the well-known G-Y-G selectivity filter of K+ channels.  We hypothesized 
that this glycine could be substituted with D-alanine and still result in functional 
channels, and we intended to test this hypothesis using in vivo nonsense suppression.  The 
challenge with using this method is that it relies on the natural translational machinery for 
successful incorporation.  All of the previously published attempts to incorporate D-
amino acids using nonsense suppression failed, but, to our knowledge, the combination of 
the tRNA THG73 and the Xenopus laevis protein translational machinery had never been 
tested.  A positive result in one of the negative controls prevented the initial in vivo 
nonsennse-suppression experiments in the Shaker B K+ channel (ShB) from providing 
any data, but a shift to the nAChR gave promising D-alanine suppression results for both 
in vitro and in vivo nonsense suppression with predictable results from the controls.  
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Unfortunately, the successful suppression experiments in the nAChR were ultimately 
attributed to the contamination of the D-Ala-tRNA with a small amount of L-Ala-tRNA.  
The slight racemization of the D-alanine was determined to have occurred during the 
coupling of the amino acid to dCA, the analog of the aminoacylated end of the tRNA.  
Preliminary tests attributed the cause of the racemization to the counter ion used to make 
the dCA soluble in the reaction, but no definitive patterns or solutions were identified.  
Since the purity of the D-Ala-tRNA was questionable, since neither the THG73 tRNA 
nor the Xenopus laevis translational machinery showed exceptional potential for D-amino 
acid incorporation into proteins, and since the goal hypothesis was proven true by 
MacKinnon and Muir through the incorporation of D-alanine into KcsA using expressed 
protein ligation semisynthesis,1 these studies were not continued into more depth. 
 
Introduction 
Nature plays favorites when it comes to the building blocks of proteins.  Nineteen of the 
twenty coded amino acids have the same general backbone structure:  centering around 
the α-carbon, with the amine group on the left and the carboxylic acid on the right, the 
bulky sidechain always presents itself forward and the subtle hydrogen hides in the back.  
The achiral glycine is the only exception.  Amino acids with the described structure are 
denoted L-amino acids after their similarity to L-glyceraldehyde, which was given the 
“L” notation due to its levorotatory optical activity (figure 6.1A).  The “L” notation for 
amino acids is a misnomer since all L-amino acids do not rotate light counterclockwise as 
L-glyceraldehyde does.  But, the terminology does allow for consistency.  If the “R” or 
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“S” configuration rules were used instead, cysteine, with the SH of its sidechain 
outweighing the carboxylic acid of its backbone, would represent the lone “R” amino 
acid.  
 
Figure 6.1.  The structure of D-amino acids.  A)  The physical differences of L-amino acids and D-amino 
acids and their relationship with L (−) glyceraldehyde and D (+) glyceraldehyde.  B) The proposed 
mechanism for amino acid isomerases.  C)  The structure of demorphin as compared with the less potent 
morphine.  All “D” structures are shown in red. 
 
Amino acids with the opposite orientation, D-amino acids (figure 6.1A), are never used in 
ribosomal protein synthesis.  Instead, these amino acids are only found in nature through 
conversion of an L-amino acid with an amino acid isomerase (figure 6.1B),2,3 through 
A) 
B) 
C) 
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nonribosomal peptide synthesis, and through posttranslational modifications.4  Common 
places where nature uses D-amino acids include bacterial cell walls, spider venom, and 
neurologically active peptides.  The neurologically active peptides are an interesting 
example on which to pause since the overarching theme of this thesis is the chemical-
scale exploration of neurobiological targets.  One such example, demorphin, is a hepta-
peptide excreted from the skin of the South African tree frog Phyllomedusa sauvagei 
(figure 6.1C).  Demorphin targets the same G-protein coupled receptor in the brain as 
morphine, the µ-opioid receptor, but demorphin is a vastly more potent analgesic than 
morphine and shows reduced tolerance and use dependence than morphine does.5  
Interestingly, the second residue of demorphin is D-alanine (red, figure 6.1C), which is 
likely converted from the L-amino acid posttranslationally.  The presence of this D-
alanine is critical to the activity of the peptide:  when the second amino acid is L-alanine, 
the typical analgesic properties of the peptide are not seen in mice.  This example shows 
the power of disrupting nature’s bias.  The conversion from L-alanine to D-alanine, the 
simple shift of a single methyl group from one orientation to another, enables this peptide 
to bind to a neuroreceptor and results in potent pain-relieving downstream events. 
 
The Use of Glycine as a D-Amino Acid Surrogate 
The achiral glycine is the natural amino acid that is best suited to be genetically encoded 
at sites where the backbone structural constraints of a D-amino acid would be 
appropriate.  Glycine’s α-carbon has two hydrogen atoms instead of a hydrogen atom and 
an alkyl side chain.  This feature allows it to encompass many possible combinations of φ 
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and ψ angles, including angles that are heavily favored for D-amino acids (figure 6.2).  
These glycines are often found in loops and turns.  McDonnell and Imperiali studied the 
role of D-amino acids in the hinge region of the synthetic ββα peptide BBAT1, a peptide 
that forms a trimer when a glycine is located at the hinge between the α-helix and the β-
hairpin.6  The authors made unnatural amino acid substitutions to this important hinge 
site using solid phase peptide synthesis.  Both β-alanine and L-alanine disrupted trimer 
formation, but substitution to D-alanine retained the trimeric oligomerization.  
Substituting the glycine for other D-amino acids, such as D-serine and D-asparagine, also 
retained the trimeric oligomerization, while the large, hydrophobic amino acids D-leucine 
and D-phenylalanine resulted in tetrameric protein association.  Certain other D-amino 
acids, such as charged residues, still disrupted oligomerization.  The authors predict that 
glycine allows for dihedral angles favorable for oligomerization of the peptide monomer, 
while D-amino acids, such as D-alanine, actually lock the protein in the geometry 
necessary for oligomerization.  A similar study by Anil et al. focused on several glycine 
residues with positive φ angles in two different globular proteins:  Gly24 and Gly34 of 
NTL9, both located in loops, and Gly331 of UBA domain, located at the turn at the end 
of an α-helix.7  This study found that replacing these specific glycines with D-alanine 
using solid-phase peptide synthesis increased the stability of the protein.  They reasoned 
that D-alanine stabilized the folded state by decreasing the entropy of the unfolded state.  
Thus, in each of these sites in these proteins, glycine was essentially acting as a surrogate 
D-amino acid, conforming to dihedral angles not possible for L-amino acids.   
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Figure 6.2.  Ramachandran plots for L-amino acids, glycine, and D-amino acids.  Favorable angle 
combinations are shown in blue, and allowed angle combinations are shown in green.  The rotatable bonds 
that equate to φ and ψ are shown below the plots.  Adapted from Valiyaveetil et al.1   
 
More relevant to this thesis, the high-resolution crystal structure of the bacterical K+ 
channel KcsA showed that the first of the famous glycines in the G-Y-G motif is in a left-
handed helical conformation,8 which is favorable for D-amino acids but not L-amino 
acids.  The G-Y-G motif is an important feature of the selectivity filter, which consists of 
the highly conserved T-X-X-T/S-X-G-Y-G sequence.8  Incorporating L-amino acids at 
this site fails to give functional channels.9  We hypothesized that substituting D-alanine at 
this site would give functional channels because the dihedral angles are correct and 
because the side chain would produce the smallest steric perturbation of the familiar 
chiral amino acids.  The method we pursued to test this hypothesis was in vivo nonsense 
suppression.   
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The Exclusion of D-Amino Acids from Ribosomal Translation 
Nature’s bias shows up in quality control mechanisms used by the protein translational 
machinery (figure 6.3).  These checkpoints are invoked to maximize proper and efficient 
protein synthesis,10 and each checkpoint will be described in more detail below.  The use 
of nonsense suppression bypasses the first of these checkpoints, the aminoacylation of the 
tRNA by the synthetase, but every other checkpoint must still be passed.  
 
Figure 6.3.  The quality control mechanisms that occur during translation.  Images adapted from 
http://www.rpi.edu/dept/bcbp/molbiochem/MBWeb/mb2/part1/translate.htm. 
 
To ensure translational fidelity, each tRNA must be properly aminoacylated with its 
specific amino acid.  Therefore, editing mechanisms have evolved to hydrolyze off 
incorrect amino acids.  It was determined from in vitro studies that D-amino acids can be 
misacylated onto tRNAs by certain synthetases.11  These tRNAs can be recycled by an 
enzyme called the D-amino acid deacylase, which recognizes D-amino acids that have 
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been improperly added to tRNA and removes them from the tRNA. This enzyme was 
discovered by Calendar and Berg when they determined that extracts from E. coli, yeast, 
rabbit reticulocyte lysate, and rat liver could rapidly and selectively hydrolyze the ester 
linkage of E. coli D-Tyr-tRNA.12  The deacylase gene has been found in many organisms 
through both experiment and sequence alignment,13-15 making this enzyme’s prevalence 
important to the study of D-amino acid incorporation using nonsense suppression. In this 
chapter the potential D-amino acid deacylase is never addressed in our experiments, but 
one could imagine that if the Xenopus laevis produced D-amino acid deacylase, then as 
soon as the D-aminoacyl-tRNA was injected into the oocyte, the D-amino acid would be 
stripped from the tRNA by the enzyme. Our experiments are reliant on the lack of the 
deacylase in Xenopus or on overwhelming of the deacylase in the cytosol with the 
amount of injected tRNA.  
The answer to incorporating D-amino acids into proteins is not as simple as removing the 
D-amino acid deacylase.  Work done by Cornish and co-workers testing the functionality 
of D-amino acids appended to a designed E. coli tRNA in an in vitro system that lacked 
D-amino acid deacylase did not detect any incorporation of D-amino acids into their 
model tripeptides.16  Thus, at least in E. coli, removal of the D-amino acid deacylase does 
not allow for ribosomal D-amino acid incorporation. 
Next, the aminoacylated tRNA (aa-tRNA) must bind to an elongation factor, EF1A in 
bacteria and eEF1A in eukaryotes, in a ternary complex with GTP for proper delivery of 
the tRNA to the ribosome. Together each cognate aa-tRNA has approximately the same 
affinity for EF1A,17 but Uhlenbeck and co-workers found that the relative affinities for 
certain tRNAs and certain amino acids for EF1A vary over a large range.18-21  Thus, a 
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model of thermodynamic compensation was proposed.18  This model states that an amino 
acid with a strong affinity must pair with a tRNA with a weak affinity, and vice versa, so 
that each combined aa-tRNA has the same relative affinity for EF1A.  If two strong 
partners are paired, the aa-tRNA binds too tightly to the EF1A, and if two weak partners 
are paired, then the aa-tRNA does not bind tightly enough to the EF1A.  Protein synthesis 
is limited in both of the nonideal cases.  
The affinity of D-amino acids for eEF1A is not known, but the difference in 
conformation likely puts them into the weak-binding amino acids category.  Therefore, 
according to the model, a tight tRNA-EF1A binding interaction would be crucial for the 
delivery of the D-aa-tRNA to the ribosome.  In practice the model of thermodynamic 
compensation does not limit the effectiveness of the nonsennse-suppression method.  A 
large variety of both natural and unnatural amino acids can be incorporated into proteins 
using a single tRNA.22  The work discussed in this chapter relies on this trend to continue 
and include D-alanine. 
Finally, the aminoacylated tRNA must be able to enter the ribosome at the acceptor site, 
the A site, undergo the peptidyl transferase reaction by accepting the growing peptidyl 
chain, and then move to the donor site, the P site, to continue the synthesis of the protein.  
The ribosome is compatible with a variety of different amino acids and hydroxy acids as 
seen through the many residues incorporated with nonsense suppression.  But, D-amino 
acids have exhibited low compatibility to date.23-25  D-Amino acids have been shown to 
bind in both the A and P sites of the ribosome.26,27  Using the model of puromycin, an 
analog of the aminoacyl end of tRNA that enters the A site of the ribosome, participates 
in the peptidyltransferase reaction, and therefore halts further protein synthesis, Starck et 
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al. showed that D-puromycin can also inhibit protein translation through its participation 
in the peptidyltransferase reaction, though it is 150 times less potent than its natural L-
analog.28  This result, along with the fact that D-amino acid dipeptides have been made in 
vitro,29,30 argues that D-amino acids should be able to function in at least the first step of 
ribosomal synthesis. 
Unfortunately, to date D-amino acids have not been shown to be competent for ribosomal 
incorporation into larger peptides or proteins with wild-type ribosomes.  Work by Hecht 
and coworkers showed that certain mutant E. coli ribosomes incorporate D-amino acids 
into full proteins.24,31  The critical mutations occurred in the 23S rRNA in the 
peptidyltransferase center (PTC) and in helix 89.  These mutations were thought to alter 
the ribosome conformation around the PTC in a manner conducive for D-amino acids to 
be accepted into protein synthesis.  Since mutations in the PTC cause the ribosomes to 
form peptide bonds at a reduced rate and since these mutated ribosomes are only viable in 
in vitro protein synthesizing systems,32-34 this approach is not compatible with in vivo 
nonsense suppression.   
Qualitatively viewing each checkpoint in protein synthesis individually, the bias against 
D-amino acids looks small and indirect.  Quantitatively, the L-enantiomer is favored over 
the D-enantiomer by a factor of 25 for aminoacylation,35,36 25 for ternary complex 
formation, 10 for EF1A-promoted binding to the A site of the ribosome, and 5 for 
peptidyl transfer.29  Therefore, when viewed together, translation favors L-amino acids by 
a factor of 3x104, which means if the L-enantiomer is present, the D-amino acid is 
virtually excluded from ribosomal protein synthesis.   
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Testing D-Amino Acids in the Xenopus laevis System 
Our first goal was to ascertain whether D-amino acids could be incorporated into proteins 
in Xenopus laevis oocytes using in vivo nonsense suppression.  Many early in vitro 
nonsennse-suppression studies attempted to incorporate D-amino acids into proteins.25,37-
39  Since the nonsennse-suppression method involves tRNA chemically aminoacylated to 
the unnatural amino acid, aminoacylation by the synthetase is not a competing factor.  
Also, by coupling pure D-amino acid to tRNA, the favoritism for the L-enantiomer is 
removed.  These studies were repeatedly unsuccessful, but E. coli and rabbit reticulocyte 
lysate translational machineries were the only systems studied.  To our knowledge, the 
ability of the Xenopus laevis translational system to incorporate D-amino acids through 
the in vivo nonsennse-suppression method had never been probed.  Herein the results of 
our study are discussed.  Preliminary data looked promising until it was discovered that 
the amino acid chirality was compromised in one of the last steps of the synthesis of the 
aminoacylated tRNA.   
During the course of this thesis, the glycine-to-D-alanine substitution in the G-Y-G of the 
selectivity filter of KcsA was shown to give function channels by MacKinnon and Muir 
using expressed protein ligation semisynthesis.1  They proved the hypothesis intended to 
be tested in this work by determining that a D-amino acid is functionally accepted at this 
site in a K+ channel. 
The combination of the literature precedent for the failure of the incorporation of D-
amino acids into large proteins by nonsense suppression, the racemization that was seen 
in coupling reactions, and the success of the expressed protein ligation semisynthesis 
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method deterred the continuation of this project much beyond the preliminary 
examination of the coupling reaction for the cause of the small amount of observed 
racemization. 
 
Results and Discussion 
Synthesis of L- and D-Alanine-tRNA 
The D-amino acid of interest was D-alanine since its minimal size makes it most 
appropriate for study in the G-Y-G of the K+ channel.  It is the least sterically hindered of 
all the chiral amino acids, which should minimize any steric clash that might result from 
the inverted stereochemistry during translation and protein folding.  The synthesis of L- 
and D-alanine is shown in scheme 6.1.40-42  The amine was first protected with the 
nitroveratryloxycarbonyl (NVOC) photolabile protecting group.43  Next, the acid was 
activated as a cyanomethyl ester.  This compound was then coupled to the 
tetrabutylammonium salt of dCA.  At this point, the amino acid can be attached to either 
the 2’ or the 3’ hydroxyl of dCA since it is thought to rapidly sample both sites.  Finally, 
the aminoacylated dCA was ligated to THG-73 using T4 RNA ligase. 
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Scheme 6.1.  General method for the synthesis of aa-tRNAs. 
 
The First Test System for D-Amino Acid Incorporation:  The Shaker B K+ Channel 
The first target protein to test for D-amino acid incorporation was ShB.  This protein was 
chosen not for the study of its G-Y-G motif but because a relatively straightforward test 
for incorporation was envisioned.  As introduced in chapter 1, ShB is a voltage-gated K+ 
channel that is made up of four identical subunits.  The first twenty amino acids of each 
subunit make up a channel-blocking “ball” that is connected through a “chain” of the next 
twenty amino acids (residues 23 through 40) to the channel.  N-type channel inactivation 
occurs when one of the four balls of the homotetrameric channel swings up and plugs the 
channel.44-47  
Previously published unnatural amino acid studies using in vivo nonsense suppression 
have targeted two sites in the chain of this receptor, Leu47 and Pro64, both denoted with 
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the * in figure 6.4.48 These sites were selected for study in this work for several reasons.  
First, since these two sites are part of the chain, a region thought to be loosely organized 
due to its ability to rapidly move to block the channel, it was predicted that incorporation 
of a D-amino acid here would not cause any negative folding effects to the main 
transmembrane region the channel.  Second, since these sites occur at the beginning of 
the protein sequence, if the D-amino acid is not incorporated, synthesis of the channel 
subunit will be ceased before the bulk of the channel has been made, eliminating the 
possibility of a functional truncated channel.  Finally, the DNA with the necessary TAG 
codon at these two sites was already available.  If any currents from ShB were seen, then 
it would be likely that D-amino acids were accepted by the Xenopus oocyte protein 
translational machinery.  
S1 S2 S3 S4 S5 P  S6 S1 S2 S3 S4 S5      S6
+ 
+ 
 
+
+ 
+ 
 
+
open inactivated
 
Figure 6.4.  Schematic of a ShB subunit with the ball and chain highlighted in green.  The * marks the 
approximate site of unnatural amino acid incorporation. 
 
Experiments were done on Xenopus oocytes in a two-electrode voltage-clamp 
configuration using a voltage-jump protocol that began at −80 mV and increased in 25 
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mV increments to +70 mV (figure 6.5, “Representative Voltage Jumps”).  General 
published procedures for whole cell recording on the ShB were followed.48  Upon 
membrane depolarization, a wild-type ShB opens, allowing potassium ions to pass out of 
the cell until the N-terminal inactivating “ball” blocks the channel from conducting.  This 
response is seen as a steep rise in current followed by a slightly less steep decrease in 
current to a steady state during the entire period of depolarization (figure 6.5, wild type).  
Larger channel currents are seen with larger depolarizations.  Thus, typically at +70 mV, 
the Imax, or maximal current, is obtained.  The typical experiments included recording 
from oocytes injected 24 hours previously with (a) ShB wild-type mRNA; (b) ShB 
lacking the N-terminal “ball” (ShB Inactivation Removed or ShIR); ShB Leu47TAG 
mRNA (c) with L-Ala-tRNA, (d) with D-Ala-tRNA, (e) with unaminoacylated-tRNA 
(tRNA that had been ligated to unaminoacylated-dCA), and (f) by itself; and ShB 
Pro64TAG mRNA (g) with L-Ala-tRNA, (h) with D-Ala-tRNA, (i) with 
unaminoacylated tRNA, and (j) by itself.  The wild-type mRNA (a) and ShIR mRNA (b) 
were used as positive controls to determine how well the oocytes were expressing the 
injected mRNA.  Large currents seen here correlated with successful nonsennse-
suppression experiments.  The L-Ala-tRNA experiments (c, g) are positive controls for 
the success of the nonsennse-suppression experiment.  The unaminoacylated-tRNA 
experiments (e, i) were negative controls for reaminoacylation of the tRNA.  The injected 
unaminoacylated-tRNA mimics the state of the aa-tRNA once it has been used in protein 
synthesis or once the amino acid is removed (through a chemical event or from a cellular 
editing mechanism).  Any current seen in these negative controls is from the tRNA being 
recognized by cellular synthetases, reaminoacylated with a natural amino acid, and then 
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being used in protein synthesis.  Since it is necessary for the experiment that 
reaminoacylation be kept to a minimum so that the protein being expressed has the 
desired amino acid, the current seen in this negative control must be negligible compared 
to the amount of current seen in the nonsennse-suppression experiment.  The mRNA only 
experiments (f, j) were negative controls for the amount of read through seen with the 
TAG codon at the specific site in the ShB.  If current is seen here, then the translational 
machinery has essentially read through the designed stop codon as it is synthesizing the 
protein and produced a functional protein without the desired amino acid incorporated 
into it.  
 
Figure 6.5.  Representative traces for the suppression at both Leu47TAG and Pro64TAG.  The specific 
suppression experiments were recorded from Pro64TAG mRNA. 
 
Unfortunately, the incorporation of D-alanine could not be confirmed since there was 
substantial current seen in the unaminoacylated-tRNA negative control (figure 6.5).  The 
current was not due to read through since injecting only the TAG-containing mRNA 
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leads to negligible current.  This susceptibility to reaminoacylation by THG73 has been 
shown to be problematic in other studies.49  Since current was seen here, it is presumed 
that these two sites can contain a variety of natural amino acids, the leucine or proline 
originally encoded, the alanine used in this study, and glutamine, the likely residue added 
through reaminoacylation,50 and still gate in response to voltage changes and still N-type 
inactivate.  Incidentally, this promiscuity is one of the reasons these sites were chosen as 
good sites for incorporation of D-amino acids.  An explanation for why the 
reaminoacylation current was larger than the current seen in the D-alanine studies is 
because the reaminoacylation of injected unaminoacylated-tRNA is more facile than the 
eventual reaminoacylation of aa-tRNA.49,51   
Sequencing the DNA showed that the genetic sequence was as expected at the N-
terminus, and remaking the mRNA and tRNA did not improve the results.  Controlling 
the amount of tRNA, mRNA, or incubation time was not attempted, though studies have 
shown that these factors can reduce THG73 reaminoacylation.52  Studies have also shown 
that using a four-base codon suppression approach can limit reaminoacylation,49,53 but the 
incorporation of D-alanine was never tested with the available ShB masked gene 
containing the Pro64GGGU mutation and the tRNA YFaFS.49  Instead, this region of this 
protein was abandoned as a test system for D-amino acid incorporation. 
 
D-Amino Acid Incorporation In Vitro Using Rabbit Reticulocyte Lysate 
Rabbit reticulocyte lysate is an in vitro translation system used to quickly test whether an 
unnatural amino acid is translationally competent.  Since the incorporation of D-alanine 
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into ShB could not be confirmed, rabbit reticulocyte lysate was used as a rapid test of D-
alanine suppression in vitro.  Rabbit reticulocyte lysate has been unsuccessful at 
incorporating D-amino acids in previously published studies,54 but no studies have ever 
attempted the in vitro synthesis with the suppressor tRNA THG73.  Protein synthesis was 
visualized using Western blotting techniques, using previously published methods.55  The 
muscle nicotinic acetylcholine receptor (nAChR) was chosen as the protein construct in 
this in vitro study because of its extensive use in the Dougherty laboratory in rabbit 
reticulocyte lysate experiments.  This receptor will be discussed in more detail below.  
Specifically, nAChR α1Leu250UAG mRNA containing a hemagglutinin (HA) epitope 
between residues 347 and 348 was used.  Western blotting was preformed using a mouse 
antibody against the HA sequence and a chemiluminescent goat-anti-mouse antibody and 
showed full length protein in the in vitro experiment containing mRNA and L-alanine 
charged tRNA and, most importantly, in the in vitro experiment containing mRNA and 
D-alanine charged tRNA (figure 6.6).   
 
Figure 6.6.  Western blot showing D-alanine suppression. 
The amount of protein in the D-Ala experiment was estimated to be 10% of that in the L-
alanine experiment.  Though the amount of protein suppression was greatly reduced 
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between L- and D-alanine, this result was exciting as it was the first evidence of D-amino 
acid incorporation into a protein. 
 
The Second Test System for D-Amino Acid Incorporation:  The Muscle nAChR 
Because of the positive results in the rabbit reticulocyte lysate in vitro system with the 
muscle nAChR, this same receptor was chosen as the second test system for D-amino 
acid incorporation.  Sites in the α subunit were targeted with the goal of finding one 
where both D-alanine and L-alanine would not only express but also show distinctive 
differences in channel function.  An assortment of sites was selected based on easily 
available DNA:  α1Ala122, α1Ile123, α1Pro236, and α1Leu250 (the same site used in 
the in vitro experiments above).  These sites are highlighted in figure 6.7.  The first two 
are found in a β-sheet in the extracellular domain, and the latter two are found in α-
helices in the transmembrane domain.  These sites are not ideal for D-amino acids due to 
their rigid structures, but it was hoped that they would show obvious changes in channel 
function if D-amino acids were incorporated.  
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Figure 6.7. A representation of the muscle nAChR with the sites studied in this chapter highlighted and 
shown as space-filling (light blue = carbon, red = oxygen, blue = nitrogen), adapted from the cryoelectron 
microscopy homology model of the nAChR 2BG9.56 
 
Whole-cell recordings were made on the OpusXpress workstation.  This instrument 
allows multiple oocytes to be studied in parallel through automatic impalement, fluidics, 
voltage clamp, and data acquisition.  The data collected were the nAChR’s responses to 
agonist concentrations from 1 to 1000 µM ACh.  The binding of agonist to the nAChR 
causes a conformational change that opens a central pore in the transmembrane domains 
of the channel, which allows an influx of cations into the cell.  This gating response is 
seen as a downward current.  An increase in agonist concentration correlates with an 
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increase in current response.  The range of agonist concentrations specified above was 
chosen because the lowest ACh concentrations stimulated no response, and the highest 
ACh concentrations stimulated maximal response from the receptor.  
Suppression of both L-alanine and D-alanine at α1Ala122TAG gave whole-cell currents 
(figure 6.8), and no current was seen in the negative controls (same as above, mRNA 
injected with unaminoacylated-tRNA or by itself).  The L-alanine experiment was 
essentially a wild-type recovery experiment, since the naturally encoded amino acid is 
alanine.  Here, current began with the addition of 5 µM ACh, and the maximum current 
(approximately 10 to 15 µA) was seen around 500 µM ACh.  In the case of D-Ala 
suppression, expression seemed to confirm the results seen in the in vitro Western blot 
experiments.  Current began with the addition of 25 µM ACh, and the maximum current 
(approximately 1 to 5 µA) was seen around 500 µM ACh.  There was a small upward 
current seen at low agonist concentrations in the D-alanine suppression experiments 
(figure 6.8, D-alanine suppression with 5 µM ACh) that was an artifact attributed to the 
change in fluidics from bath solution to agonist solution that is only seen in recordings on 
oocytes with low nAChR expression. 
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20 s
5 µM ACh 50 µM ACh 500 µM ACh
0.2 µA
20 s
5 µM 50 µM ACh 500 µM ACh
  
Figure 6.8.  Representative current traces for suppression at nAChR α1Ala122.  A)  L-Alanine suppression.  
B)  D-Alanine suppression. 
 
The current responses of both L-alanine and D-alanine at α1Ala122UAG were then 
normalized and plotted against the concentration of agonist used on a log scale, 
producing the dose-response curve seen in figure 6.9.   
 
Figure 6.9.  Dose-response curve from L-alanine and D-alanine suppression at α1Ala122TAG. 
A) B) 
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These data were further analyzed by obtaining an EC50 value and a Hill coefficient (h) 
from fitting the current response (I) versus agonist concentration (A) to the Hill equation.   
 
€ 
I = ImaxA
h
EC50h + Ah
  
The EC50 value is the agonist concentration that stimulates half-maximal current 
response, and it reflects the receptor’s sensitivity for a given agonist.  This value is not a 
true binding constant; rather it is a composite value incorporating the equilibrium for both 
agonist binding and channel gating.57  The Hill coefficient is a measure of the 
cooperativity a receptor displays in binding multiple ligands.  Data analysis was 
completed for the suppression of L- and D-alanine at α1Ala122TAG and also for the 
various other α1 nAChR sites probed during this study (table 6.1).  The only other 
successful suppression experiment was L-alanine at α1Ile123.  Current was seen upon 
suppression of D-alanine at α1Ile123, but no interpretable trend was established between 
the amount of current and the concentration of agonist.  No current was seen for either L- 
or D-alanine at α1Pro236 or α1Leu250.  
The EC50 value obtained from the wild-type recovery experiment with L-alanine 
suppression was 51.1 ± 3.5 µM with a Hill coefficient of 1.65 ± 0.16 (n = 9) (table 6.1).  
This EC50 value is within error of 49 µM, the EC50 previously published by Dougherty 
and coworkers for wild-type muscle nAChR.40  Surprisingly, the EC50 value and Hill 
coefficient obtained from the D-alanine suppression experiment were within error of L-
alanine:  56.3 ± 4.5 µM and 1.63 ± 0.19 (n = 5).  According to our hypothesis, the 
incorporation of D-alanine into a β-sheet at α1Ala122 in the muscle nAChR should 
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impact channel function, but our data show that D-alanine is essentially the same as L-
alanine.  The similarity between the EC50 and Hill data obtained for the incorporation of 
L- and D-alanine led us to speculate that our pure D-alanine tRNA was not actually 
pure—that sometime during the synthesis of the aminoacylated-dCA, the enantiopurity of 
D-alanine had been compromised.  These studies were halted, and the focus of the work 
became the analysis of the enantiopurity of the D-alanine analog.   
 
Table 6.1.  Data obtained for incorporation of L- and D-alanine at various sites in the α1 subunit of the 
muscle nAChR.* 
Site Amino Acid EC50 (µM) Hill 
α1Ala122TAG L-Ala 51.1 ± 3.5 1.65 ± 0.16 
  D-Ala 56.3 ± 4.5 1.63 ± 0.19 
α1Ile123TAG L-Ala 24.6 ± 2.7 1.64 ± 0.24 
  D-Ala ND ND 
α1Pro236TAG L-Ala NR NR 
  D-Ala NR NR 
α1Leu250TAG L-Ala NR NR 
  D-Ala NR NR 
 
Analysis of Unnatural Amino Acid Chirality 
One method of quantitatively measuring the stereochemical purity of a compound is 
chiral column chromatography using high-performance liquid chromatography (HPLC).58  
Chiral HPLC columns contain single enantiomers immobilized on their stationary phase.  
Resolution of enantiomeric organic compounds is due to the formation of transient 
                                                
* ND = No interpretable data.  NR = No response. 
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diastereomers on the surface of the column; the enantiomer that forms the most stable 
diastereomer will be retained longer than the opposite enantiomer.   
The goal was to analyze N-nitroveratryloxycarbonyl (NVOC) alanine cyanomethyl ester 
6.2a and 6.2b both prior to the dCA coupling reaction and after the unreacted portion was 
recovered from the dCA coupling reaction, since these two points would reflect the 
stereochemical purity of the general NVOC-protection and cyanomethyl ester activation 
reactions and of the coupling reaction.  A racemic mixture of 6.2a and 6.2b was found to 
separate using a Chiralcel OD-H column with 12% ethanol in hexanes.  The OD-H 
column is cellulose tris(3,5-dimethylphenyl) carbamate on a 5 µm silica-gel substrate. 
Both 6.2a and 6.2b were individually run on the chiral HPLC and were found to be pure 
enantiomers (figure 6.10).  Thus, neither the NVOC protection nor the cyanomethyl ester 
activation compromised the α-stereocenter.  To determine whether the coupling of these 
derivatives to dCA destroyed the enantiomeric purity, the unreacted amino acid starting 
material from each coupling was recovered and run on the chiral HPLC.  The D-alanine 
reaction was allowed to run for 2 hours, whereas the L-alanine reaction was allowed to 
run for 20 hours.  In both the D-alanine and the L-alanine reactions, roughly 5 to 10% of 
the recovered starting material was the opposite enantiomer, which proved that the 
conditions used in the dCA coupling reaction led to compromised enantiopurity, but not 
total racemization.   
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Figure 6.10.  Representative chrial HPLC traces showing the difference between the enantiopurity of the 
NVOC-alanine cyanomethyl ester before (6.2b red, 6.2a blue, both pure) and after (6.2b orange, 6.2a 
green, both contain small amounts of the opposite enantiomer) entering the coupling reaction.  The racemic 
mixture of 6.2a and 6.2b is shown in purple.  The identity of the third peak in the orange trace (25.810 
minutes) was never determined, but it is likely NVOC-D-alanine. 
 
Our typical dCA coupling uses 3.0 equivalents of the NVOC-protected cyanomethyl 
ester, 2.4 equivalents of the tetrabutylammonium counter ion, and 1.0 equivalent of dCA 
in DMF at room temperature.  Prior to this work, these conditions had never been tested 
for racemization in our laboratory.  To determine what was compromising the 
stereochemical purity of the amino acid, each component of the coupling reaction was 
analyzed.  Taking the variables in the coupling reaction as time, solvent, dCA, and 
identity of counter ion salt, we isolated each one to determine if any could be linked to 
the racemization of 6.2a and 6.2b.  The reactions that were set up are listed in table 6.2.  
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Table 6.2.  The various reaction conditions tested for racemization.* 
NVOC-Ala-CME (eq) Time (h) Solvent dCA (eq) Salt (eq) Racemization 
1 0 0 0 0 0 0.0% 
3 1 DMF 1 TBA 2.4 3.8% 
3 24 DMF 1 TBA 2.4 6.3% 
3 48 DMF 1 TBA 2.4 4.9% 
1 48 DMF 0 0 0 0.0% 
1 48 H2O 0 0 0 0.0% 
7 48 DMF 1 0 0 0.0% 
1.25 48 DMF 0 TBA-OAc 1 6.0% 
1.25 720 DMF 0 TBA-OAc 1 3.9% 
1.25 48 DMF 0 TBA-Cl 1 0.0% 
1.25 48 DMF 0 TBA-I 1 0.1% 
1.25 48 DMF 0 Na-OAc 1 0.1% 
1.25 48 DMF 0 TEA-OAc 1 6.2% 
 
The first variable, time, was tested by altering the length of the coupling reaction from 1 
hour to 24 hours to 48 hours.  No significant trend was seen between the amount of 
racemization and the length of time the reaction was allowed to run.  Next, the variable of 
solvent was added.  Either 6.2a or 6.2b was dissolved in either DMF or H2O, stirred for 
48 hours, and then purified on the preparatory HPLC.  In both cases, no racemization was 
observed.  These two experiments also eliminated the method of purification, preparatory 
HPLC, as being the cause of the racemization.  Next, dCA was added to the mixture to 
determine its effects on racemization.  When NVOC-D-alanine-cyanomethyl ester 6.2b 
and unsalted dCA were stirred in DMF for 48 hours, no racemization was observed.  
Unfortunately, no aminoacylated-dCA coupling product was formed either.  Since dCA is 
not very soluble in DMF without a counter ion, it may be that the dCA never went into 
solution and thus never encountered NVOC-D-alanine-cyanomethyl ester 6.2b. 
                                                
* Reactions are grouped based on similarity with the major differences highlighted in red. 
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Finally, the role that the counter ion plays in the coupling reaction was addressed.  In 
each of these tests, either 6.2a or 6.2b and the noted salt were dissolved in DMF and 
stirred for at least 48 hours.  Approximately the same amount of racemization was seen 
from a solution of either 6.2a or 6.2b and tetrabutylammonium acetate in DMF that was 
stirred at room temperature for both 48 hours and one month.  The racemization was 
eliminated if the acetate was exchanged with either chloride or iodide or if the 
tetrabutylammonium was exchanged with sodium.  Equivalent racemization was 
observed when tetraethylammonium acetate was tested.   
The data are not clearly suggestive of one mechanism for racemization, but the presence 
of the counter ion salt is sufficient.  The data trend towards racemization when either the 
negatively charged phosphates on dCA or the negatively charge acetate are countered by 
either tetrabutylammonium or tetraethylammonium.  Unfortunately, the 
tetrabutylammonium counter ion is necessary for the dCA to be soluble in DMF at room 
temperature.59   Having greater than two equivalents of this counter ion also enhances the 
coupling reaction.59 
This chapter is not the first account of racemization occurring during the coupling 
reaction.  In 1991 Robertson, Schultz, et al. reported on the degree of racemization 
caused by similar conditions.59  They determined that 5.0 equivalents of the NVOC-
protected cyanomethyl ester and 2.2 equivalents of the tetrabutylammonium counter ion 
for 1.0 equivalent of dCA when reacted for 2.5 hours at room temperature led to no 
racemization.  An aside in the work suggests that no racemization means less than 5% 
was seen.  They further state that lowering the equivalents of the NVOC-protected 
cyanomethyl ester from 5.0 to 1.5 leads to 2% to 5% racemization.  They hypothesize 
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that this value is due to the longer reaction time necessary to get an efficient yield with 
these conditions, but our data suggest that time is not a crucial component to the amount 
of racemization seen in the coupling reaction.  Our preliminary studies did not address 
the equivalents of NVOC-protected cyanomethyl ester.  The only case where we 
increased the equivalents of NVOC-protected cyanomethyl ester was when we did not 
include a counter ion in the reaction mixture.  It may be that the increase in equivalents of 
NVOC-D-alanine-cyanomethyl ester 6.2b to dCA favored a decrease in racemization—
an interpretation that follows the data presented by Robertson, Schultz, et al.59  Further 
work would be needed to expound this hypothesis. 
 
Conclusion 
This study explored the Xenopus laevis ooctye’s translational machinery using the tRNA  
THG73 that was chemically aminoacylated with D-alanine.  A positive result in one of 
the negative controls prevented the initial in vivo nonsennse-suppression experiments in 
ShB from providing any data, but preliminary results from suppression in the α1 subunit 
of the nAChR looked promising through both in vitro and in vivo nonsense suppression.  
Initially, the difference in the amount of protein seen in the Western blot from in vitro 
suppression of D-alanine and the low current size from channel activity from the in vivo 
suppression of D-alanine were attributed to lower suppression efficiency of the D-amino 
acid.  Later, the lower efficiency was attributed to a small amount of L-alanine 
contamination in the D-alanine tRNA, as it was discovered that the amino acid chirality 
was compromised in one of the last steps of the synthesis of the aminoacylated tRNA.  
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Any positive D-alanine suppression results from the Western blots and the in vivo 
nonsennse-suppression method are attributed to the L-amino acid contamination that 
resulted from the coupling of the NVOC-protected D-alanine cyanomethyl ester to dCA. 
Therefore, the D-alanine-tRNA present was either effectively removed or outcompeted 
by the L-alanine-tRNA.  Through the lack of any other suppression results, this study 
supports previous studies that found that D-amino acids were difficult to incorporate into 
proteins using nonsense suppression.  The most important result found from this study 
was that the conditions normally used in our lab for the coupling of unnatural amino 
acids to dCA compromise the enantiopurity of the amino acid.  
Ideally, we will eventually be able to modify the methods of nonsense suppression to be 
able to incorporate D-amino acids at will.  This ability will allow us to test the 
importance of conformation and φ and ψ angles in structure-function relationships in ion 
channels.  The first goal will be to determine coupling conditions that retain the 
enantiopurity of the NVOC-protected cyanomethyl ester.  In this study we did not address 
the equivalents of the various coupling reaction components thoroughly.  If the 
observations of Robertson, Schultz, et al. hold true,59 increasing the amount of NVOC-
protected cyanomethyl ester to that of dCA may eliminate the racemization.  Otherwise, 
modifying the methods of Starck et al. in their use of L-amino acid oxidase to remove 
impurities28 may also be a viable solution that avoids altering conditions in the already 
optimized coupling reaction. 
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Methods 
Synthesis 
All reactions were performed at ambient temperature and pressure unless otherwise 
noted.  All reactions involving potentially air-sensitive compounds were conducted under 
an inert atmosphere using Schlenk techniques.  Solvents were purified by passage 
through alumina.60  Unless otherwise noted, all chemicals and reagents were used as 
received without further purification.  Flash chromatography was performed using EMD 
(Gibbstown, NJ) silica gel 60 (particle size 0.040-0.063 mm).  Thin-layer 
chromatography (TLC) was performed using EMD (Gibbstown, NJ) silica gel 60 F254 
precoated plates (0.25 mm) and visualized by UV and potassium permanganate.  Nuclear 
magnetic resonance spectroscopy (NMR) was preformed on either a Varian (Palo Alto, 
CA) Mercury 300 instrument, and NMR resonances are reported relative to Me4Si (δ 0.0) 
or CD3OD (δ 3.31).  Data for 1H NMR spectra are reported as follows: chemical shift (δ 
ppm), integration, multiplicity, and coupling constant (Hz).  Mass spectroscopy (MS) 
spectra were obtained from the Caltech Mass Spectrometry Lab.  Electrospray ionization 
mass spectrometry (ESI-MS) was preformed on an LCQ Classic ion trap 
(ThermoFinnigan, Waltham, MA) in direct infusion mode.  HPLC was preformed using 
Waters (Milford, MA) equipment and software (510 HPLC pumps and 996 Photodiode 
Array Detector) and reverse-phase Nova-Pak 18C columns (3.9 × 150 mm analytical 
column, 7.8 × 300 mm preparatory column). 
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NVOC-D-alanine 6.1b:  D-Alanine (0.32 g, 3.6 mmol, 1 eq) was added to a round-
bottom flask and dissolved in 10% (w/v) sodium carbonate in water (14 mL).  To this 
solution was added dioxane (14 mL) at 0 °C, followed by the slow addition of 
nitroveratryloxycarbonyl chloride (1.0 g, 3.8 mmol, 1.1 eq).  The mixture was allowed to 
warm to room temperature while stirring for 4 hours.  The mixture was then poured into 
distilled water (200 mL) and washed with ether (3×).  Under vigorous stirring, the 
aqueous solution was adjusted to pH 2 by slowly adding 5 M HCl.  Once an orange-
yellow precipitate began to form, the solution was refrigerated overnight to encourage the 
formation of more solid.  The subsequent day the precipitate was filtered to afford 
NVOC-D-alanine 6.1b as a yellow solid (0.99 g, 3.0 mmol, 83% yield).  Rf = 0.24 (1% 
AcOH in EtOAc); 1H NMR (300 MHz, CD3OD, 298 K) δ 7.72 (1H, s), 7.17 (1H, s), 5.52 
(1H, d, J = 15.3 Hz), 5.36 (1H, d, J = 15.3 Hz), 4.19 (1H, q, J = 7.2 Hz), 3.96 (3H, s), 
3.86 (3H, s), 1.40 (3H, d, J = 7.2 Hz). 
 
NVOC-D-alanine cyanomethyl ester 6.2b:  NVOC-D-alanine 6.1b (0.21 g, 0.63 mmol) 
was added to a round-bottom flask under Ar (g) and dissolved in DMF (2 mL).  
Chloroacetonitrile (2 mL) and then triethylamine (0.25 mL) were added to the solution.  
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The mixture was stirred at room temperature for 75 minutes and then the solvent was 
removed under vacuum.  The residue was purified by flash column chromatography 
(CH2Cl2, then 5% EtOAc in CH2Cl2 once the yellow product started eluting) to afford 
NVOC-D-alanine cyanomethyl ester 6.2b as pale yellow crystals (0.17 g, 0.46 mmol, 
73% yield).  Rf = 0.44 (17% EtOAc in CH2Cl2); 1H NMR (300 MHz, CDCl3, 298 K) δ 
7.68 (1H, s), 6.98 (1H, s), 5.56 (1H, d, J = 15.6 Hz), 5.43 (1H, d, J = 14.7 Hz), 4.78 (2H, 
q, J = 15.6 Hz), 4.45 (1H, m), 3.99 (3H, s), 3.93 (3H, s), 1.48 (3H, d, J = 7.2 Hz). 
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NVOC-D-alanine-dCA 6.3b:  NVOC-D-alanine cyanomethyl ester 6.2b (0.020 g, 0.054 
mmol, 3 eq) was added to a round-bottom flask under Ar (g) and dissolved in DMF (1 
mL).  This solution was transferred to another round-bottom flask under Ar (g), which 
contained dCA (0.020 g, 0.017 mmol, 1 eq) as a tetrabutylammonium salt (2.4 eq).  The 
reaction was stirred at room temperature for 18 hours while being monitored by reverse-
phase analytical HPLC with a linear solvent gradient from 5% acetonitrile in 25 mM 
NH4OAc buffer pH 4.5 to 100% acetonitrile.  The crude product was purified using 
reverse-phase semipreparative HPLC with the same linear solvent gradient.  The fractions 
containing the NVOC-D-alanine-dCA 6.3b were combined, and the solvent was removed 
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by lyophilization.  The solid was redissolved in 10 mM acetic acid and reconcentrated via 
lyophilization (3×) to afford NVOC-D-alanine-dCA 6.3b as a white powder (0.0053 g, 
0.0056 mmol, 33% yield).   FAB-MS m/z calc’d for C32H41N10O20P2 [M−H]:  947.2; 
found:  947.1. 
 
Nonsense Suppression In Vivo 
The site-directed mutagenesis of TAG mutants, gene construction, synthesis of 
suppressor tRNA, and ligation of aminoacyl-tRNA to tRNA have been described 
previously.40,48,61,62  Plasmid DNAs were linearized with Not1, and mRNA was 
transcribed using the T7 mMESSAGE mMACHINE kit (Ambion, Austin, TX). 
Oocytes from Xenopus laevis were isolated and maintained at 18 °C in ND96 solution 
(96 mM sodium chloride, 2 mM potassium chloride, 1.8 mM calcium chloride, 1 mM 
magnesium chloride, 5 mM HEPES, 2.5 mM sodium pyruvate, 0.5 mM theophyline, 10 
µg/mL gentamycin at pH 7.5) according to published procedures.63  Each oocyte was 
microinjected with 50 nL of a 1:1 mixture of mRNA (0.04 ng/nL for ShB and 0.5 ng/nL 
of a 20:1:1:1 α:β:γ:δ for nAChR) and tRNA (1 µg/µL) or unaminoacylated dCA-tRNA (1 
µg/µL).  NVOC-protected aminoacylated tRNA was deprotected prior to injection by 
irradiating the sample for 5 minutes with a 1000 W Hg/Xe arc lamp (Oriel, Irvine, CA) 
operating at 400 W equipped with WG-335 and UG-11 filters (Schott, Duryea, PA).42 
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Electrophysiology 
Electrophysiological recordings were carried out 24 to 48 hours after injection.  Whole-
cell currents from oocytes were measured using a Geneclamp 500 amplifier (ShB) or an 
OpusXpress (nAChR) and pCLAMP software (Axon Instruments, Foster City, CA) in the 
two-electrode voltage-clamp configuration.  Microelectrodes were filled with 3 M 
potassium chloride and had resistances ranging from 0.5 to 1.5 MΩ.  Oocytes were 
continuously perfused with a nominally calcium-free bath solution consisting of 96 mM 
sodium chloride, 2 mM potassium chloride, 1 mM magnesium chloride, and 5 mM 
HEPES at pH 7.5.  In the ShB experiments, the currents from ShB expressing oocytes 
were measured during depolarizing jumps from the holding potential to +70 mV in 25 
mV increments.  In the nAChR experiments, microscopic ACh-induced currents were 
recorded in response to bath application of ACh at a holding potential of −80 mV. 
 
Nonsense Suppression In Vitro 
Translation was carried out using rabbit reticulocyte lysate translation system (Promega, 
Madison, WI) according to manufacturer’s protocol.  Lysate mix (8.75 µL), amino acid 
mix (0.35 µL), RNAse inhibitor (0.25 µL), H2O (1.75 µL), mRNA (0.5 µL, 1 µg/µL for 
suppression experiments and 0.3 µg/µL for wild-type experiments), and either tRNA (1 
µL, 1 µg/µL) or water (1 µL, for mRNA-only negative control) were combined and 
incubated at 30 °C for 106 minutes.  The in vitro translation mix was then kept at −80 °C 
until further use. 
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To prepare for gel loading, the in vitro translation mix (2.5 µL) was added to 4% sodium 
dodecyl sulfate (SDS) (2.5 µL) and then that mixture was added to 10% SDS (2 µL), H2O 
(7 µL), and 2× SDS loading buffer (100 mM tris chloride at pH 6.8, 4% SDS, 0.2% 
bromophenol blue, 20% glycerol) (14 µL).  Samples were loaded in 5 µL aliquots into 
prepoured 12% tris chloride gels (Bio-Rad, Hercules, CA) for SDS-polyacrylamide gel 
electrophoresis (PAGE).  Western blotting was preformed using nitrocellulose transfer, a 
mouse anti-HA primary antibody, and a goat anti-mouse secondary antibody conjugated 
to horseradish-peroxidase.  Protein was detected by chemiluminescence. 
 
Analysis of Enantiopurity of NVOC-Alanine Cyanomethyl Ester 
A mixture of NVOC-alanine cyanomethyl ester 6.2a and 6.2b (1 mg/mL in ethanol) was 
found to separate via chiral HPLC using a Chiralcel OD-H column with an elution of 
12% ethanol in hexanes.  The OD-H column is cellulose tris(3,5-dimethylphenyl) 
carbamate on a 5 µm silica-gel substrate.  The peak for 6.2b appeared approximately 2 
minutes prior to the appearance of 6.2a, approximately 22 minutes and 24 minutes, 
respectively, for a 60 minute run.  Each chiral HPLC run included a 20 minute prewash 
and 20 minute postwash of 100% isopropanol. 
Generally, each reaction for testing by chiral HPLC was set up as follows:  NVOC-
alanine cyanomethyl ester 6.2a or 6.2b (0.19g, 0.050 mmol, equivalents as listed in table 
6.2) was added to a round-bottom flask under Ar (g) and dissolved in N,N-dimethyl 
formamide or water (0.4 mL).  To this solution was added either dCA (equivalents as 
listed in table 6.2) or counter ion salt (identity and equivalents as listed in table 6.2) or 
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both.  The reaction was then allowed to stir at room temperature for the amount of time 
listed in table 6.2.  The components of the mixture were then separated using reverse-
phase semipreparative HPLC with a linear solvent gradient from 5% acetonitrile in 25 
mM ammonium acetate (pH 4.5) to 100% acetonitrile.  The desired fractions containing 
the unreacted NVOC-alanine cyanomethyl ester 6.2a or 6.2b were combined, and the 
solvent was removed by lyophilization.  The resulting white solid was dissolved in 
ethanol (1 mg/mL) and analyzed for enantiopurity by the chiral HPLC method described 
above. 
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C h a p t e r  V I I 
 
EXPANDING THE REPERTOIRE OF AROMATIC UNNATURAL AMINO ACIDS 
USEFUL FOR STRUCTURE-FUNCTION STUDIES OF ION CHANNELS 
 
In this chapter three separate studies, all tied together due to their focus on unnatural 
aromatic amino acids, are discussed.  The first section describes the synthesis of four 
novel fluorescent methanethiosulfonate compounds for use in fluorescence resonance 
energy transfer (FRET) studies on ion channels.  Each of these compounds can create a 
fluorescent amino acid in situ by covalent attachment to a cysteine residue.  The second 
section focuses on the unnatural amino acid 3,5-dimethylphenylalanine in the voltage-
gated Shaker B K+ channel (ShB).  This residue was designed to explore whether the 
cationic tetraethylamine (TEA) interacted with the 3-position of the aromatic ring at 
position 449 instead of the face of the aromatic as expected for a cation-π interaction.  
Unfortunately, this residue did not provide any clarity on the importance of the 
substituent at this position, but in studying the effects of methyl-substituents, 4-methyl-
phenylalanine was found to further support a cation-π interaction at this site. The third 
section describes attempts to enhance the cation-π interaction through the use of 4-amino-
phenylalanine.  ShB was the initial target, but the GABAC receptor and the nicotinic 
acetylcholine receptor (nAChR) were also studied.  No cation-π enhancement was seen 
for 4-amino-phenylalanine at any channel.  Several attempts were made to investigate 
whether 4-amino-phenylalanine was being modified, which proved that the 
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nitroveratryloxycarbonyl (NVOC) deprotection step was not altering the aniline but did 
not conclusively determine if any modifications were occurring to the aniline while the 
amino acid was in the Xenopus laevis oocyte. 
 
Development of Novel Fluorescent Conjugates for Use in Fluorescence Resonance 
Energy Transfer (FRET) Studies of Ion Channels 
Fluorescent amino acids can be extremely useful probes of structural changes during the 
gating of ion channels.  Their fluorescence can relay information about their 
environment.  For example, the hydrophobicity of the environment surrounding 
rhodamine determines the intensity of its fluorescence emission.  Because of this intrinsic 
feature, incorporating a fluorophore into an ion channel and monitoring its fluorescence 
during gating allows for real time analysis of the changes in the environment that 
encompass the fluorophore.  
Work is currently ongoing in the Dougherty and Lester laboratories to incorporate 
fluorescent amino acids into proteins in vivo, but our laboratories and others have already 
sidestepped the ribosome by creating fluorescent amino acids in situ through site-specific 
labeling of cysteine residues with thiol-reactive fluorescent probes such as 
sulforhodamine methanethiosulfonate (MTSR), tetramethylrhodamine (TMRM), and 
Alexa Fluor 546 maleimide (AF546) (figure 7.1).1-7 These fluorescent cysteines have 
allowed for changes in the local environment around the voltage sensor of a K+ 
channel,1,2 the extracellular region of the GABAC ρ1 receptor,4 the pore-lining helix of 
the muscle nAChR,5 the ligand-binding domain of the GABAA receptor,6 and the pore-
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lining helix of the glycine α1 receptor7 during gating to be explored.  These studies were 
able to identify regions of the channels that underwent molecular rearrangements during 
gating, and they were also able to identify differences between the effects of various 
agonists and antagonists on the structural dynamics of the channels.  Although these 
results are informative, this method is limited since it cannot be used to quantitate how 
far the fluorophore moves during the gating process.  
 
Figure 7.1.  Structures of three thiol-reactive fluorescent probes.   
 
The distance a specific site moves during channel gating can be determined from two 
fluorescent moieties through a process called FRET, which occurs when two 
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chromophore-containing compounds with overlapping spectral properties come into close 
proximity.  Because of the properties of the FRET system, the distance between the two 
compounds can be calculated based on fluorescence measurements.  FRET begins with 
the absorption of light by one fluorophore, called the donor.  If there is a second 
chromophore nearby, typically within 1 to 10 nm, whose absorption properties overlap 
with the emission properties of the donor, a radiationless transfer of energy from the 
excited donor molecule to the acceptor chromophore will occur.  Interestingly, the energy 
passes from the donor to the acceptor through long-range dipole-dipole interactions.  If 
the acceptor is a fluorescent compound, then FRET is seen as the quenching of the donor 
fluorescence and the appearance of the acceptor fluorescence.  The extent of the energy 
transfer between the donor and the acceptor is relayed in the intensity of the acceptor 
fluorescence and is dependent on the distance between the two compounds.  Thus, the 
occurrence of FRET and even changes in FRET intensity can be quantified into distances 
between the two chromophores. 
The Lester laboratory has appended yellow fluorescent protein (YFP) and cyan 
fluorescent protein (CFP) to nAChR subunits to determine through FRET if two subunits 
colocalize in a receptor in vivo,8,9 but these large proteins would not be able to answer 
questions about how far a specific site moves during channel gating.  The small 
fluorophores that were used to study the local environment, as described above, are more 
appropriate.  The Lester laboratory has used the thiol-reactive fluorophores MTSR and 
TMRM (figure 7.1).5,7  In order to take advantage of these two compounds in FRET 
studies, chromophores with spectra overlapping the absorption or emission spectra of 
these compounds are needed.  Fortunately, there were already well-established FRET 
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partners for both MTSR and TMRM: 7-nitro-2,1,3-benzoxadiazol-4-yl (NBD)10 and 
fluorescein, respectively (figure 7.2).  
 
Figure 7.2.  A depiction of FRET between the fluorophores discussed in the text. 
 
Three FRET pairs were designed to allow for versatility in experimentation.  If one FRET 
pair did not work well, potentially because one partner was incapable of reacting with the 
desired thiol or because the sterics of their local environment did not allow the pair to 
orient correctly for FRET, then another pair could be tried. 
To illustrate the spectral overlap between the donor and the acceptor, the absorption and 
emission spectra of a rhodamine similar to MTSR (red) and the absorption and emission 
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spectra of a NBD derivative (blue) are shown in figure 7.3A.  The region on the plot that 
is important for FRET is the overlap of the emission of NBD (solid blue line) and the 
absorption of the rhodamine (dashed red line).  The fluorescein derivative Oregon Green 
488 (green) is shown along with its FRET partner TMR (black) in figure 7.3B.  Oregon 
Green 488 was chosen over fluorescein because it is more photostable and less pH 
sensitive at physiological pH (pKa approximately 4.7) than its parent compound 
(fluorescein has a pKa of approximately 6.4).11  Again, the important region is the 
overlap between the emission of the Oregon Green 488 and the absorption of the TMR.  
The third donor-acceptor spectra pair shown in figure 7.3C is for a coumarin (purple) and 
Oregon Green 488 (green).   These two compounds have less spectral overlap than the 
others, but there is still enough overlap for FRET to occur. 
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Figure 7.3.  Absorption (dashed lines) and emission (solid lines) spectra for the various FRET pairs.  
Figures made at www.invitrogen.com using compounds similar to those in the text.  A)  NBD 
aminohexanoic acid in methanol (blue) and sulforhodamine 101 in ethanol (red).  B)  Oregon Green 488 
goat anti-mouse IgG antibody I pH 8.0 buffer (green) and TMR goat anti-mouse IgG antibody in pH 8.0 
buffer (black).  C)  7-Hydroxy-4-methylcoumarin in pH 9.0 buffer (purple) and Oregon Green 488 goat 
anti-mouse IgG antibody I pH 8.0 buffer (green). 
 
A) 
B) 
C) 
NBD Sulforhodamine 
OG488 
OG488 
TMR 
7-Hydroxy-4-methylcoumarin 
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Synthesis of Fluorescent Methanethiosulfonate Compounds 
Before the in vivo FRET studies could begin, the methanethiosulfonate-derivatized FRET 
partners had to be synthesized. 7-Dimethylaminocoumarin-4-acetic acid (DMAC), 6-(N-
(NBD)amino)hexanoate (extended NBD), and Oregon Green 488 were commercially 
available as succinimidyl esters, allowing for the conversion to the methanethiosulfonate 
using the method by Gruber et al. (scheme 7.1).12  To our knowledge, this work 
represents the first such synthesis of these compounds.  Since the extended NBD could 
potentially occupy a wide breadth of space, its accuracy at quantifying distance was 
questioned.  Thus, an NBD with a shorter tether (compact NBD) was synthesized.  The 
same conditions used for the conversion of the succinimidyl ester promoted nucleophilic 
aromatic substitution on NBD-chloride. 
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Scheme 7.1.  The syntheses of four novel fluorescent methanethiosulfonates:  DMAC 7.1, extended NBD 
7.2, compact NBD 7.3, and Oregon Green 488 7.4. 
 
Thiol-Labeling of nAChRs 
These fluorescent methanethiosulfonates were to be used by Dr. Mohammed Dibas in the 
Lester laboratory for FRET studies on the muscle nAChR.  The specific receptor was 
only going to have two cysteine residues, one on the extracellular domain and one at 
β1Ala272, the 19’ residue used previously by Dahan et al.5  The labeling procedure was 
going to be similar to that described by Dahan et al. except instead of washing first with 
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10 mM sodium (2-sulfonatoethyl)methanethiosulfonate to block all endogenous surface 
thiol groups,5 one of the FRET partners would instead be washed over the oocyte.  This 
wash would likely add the fluorescent moiety to many proteins, but since the 
fluorescence from FRET would be the only fluorescence analyzed, the nonspecific 
binding of the fluorophore to other proteins would be eliminated from the study.  The 
second wash would then be 10 mM sodium (2-sulfonatoethyl)methanethiosulfonate to 
block any remaining surface thiols.   The final wash would be a mixture of the other 
FRET partner with 100 µM acetylcholine (ACh).  The application of ACh would open 
the channel and expose the 19’ cysteine to the fluorescent tag.  Once the protein was 
labeled with both fluorophores, the changes in fluorescence from FRET at various points 
during channel activation would be observed, and the resulting data could then be 
quantified into changes in distances between the two fluorophores.  Unfortunately, the in 
vivo studies were never performed.  Since FRET studies could provide valuable 
information about the specific movements that occur during the gating of the muscle 
nAChR and other ion channels, hopefully this project will gain momentum and be 
continued by future graduate students in either the Dougherty or the Lester laboratories. 
 
Probing the Sterics Around Phenylalanine Residues Using the Unnatural Amino 
Acid 3,5-Dimethylphenylalanine 
TEA is a well-known blocker of K+ channels that was introduced in this thesis in chapter 
2.  In that chapter the cationic TEA was experimentally shown to bind to and block ShB 
through a cation-π interaction when an aromatic residue was present at position 449 at the 
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top of the channel pore, through the incorporation of fluorinated-phenylalanine 
derivatives using in vivo nonsense-suppression techniques.13.  Though there was 
precedent for this type of interaction based on previous experimental work,14 this result 
was controversial since a cation-π binding motif was not present in the crystal structure 
of the related K+ channel KcsA when complexed with the TEA analogue TEAs 
(2BOC).15  Instead of TEAs interacting with the electronegative face of Tyr82, the 
residue in KcsA homologous to ShB Thr449, the static picture showed TEAs in van der 
Waals contact with the side of the aromatic ring—“edge on” not “en face” (figure 7.4).  
Specifically, the 3-position of the ring was closest to the blocker, which argued that 
hydrophobics, shape, and size of the ring were what was important to TEA block of K+ 
channels. 
 
Figure 7.4.  A portion of the 2BOC crystal structure focusing on KcsA Tyr82 and TEAs.  The yellow lines 
highlight the points of closest proximity between the two, which clearly involves the 3-position of the ring.  
Adapted from Lenaeus et al.15 
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This controversy was addressed in chapter 2 through the computational modeling of the 
energetic differences between TEA and the various incorporated fluorinated 
phenylalanine derivatives that were used in the study.  The calculations made from the 
reduced system that included only TEAs and the four phenylalanine derivatives, with 
their coordinates taken from 2BOC,15 clearly demonstrated that if the edge-on interaction 
represented what occurred between TEA and the channel in vivo, the addition of fluorine 
atoms at the 3- and 5-positions of the phenylalanine should enhance TEA block (figure 
2.5).  The added negative electrostatic potential at these sites would attract the cationic 
blocker instead of repelling it as predicted by the cation-π interaction. Experimental work 
showed that the incorporation of 3,5-F2-phenylalanine at ShB position 449 decreased the 
blocking efficiency of TEA, better coinciding with an en face, cation-π interaction than 
the edge-on hydrophobic interaction.  Together the computational data and the 
experimental data suggest that the still image seen in the 2BOC crystal structure is not 
relevant for TEA binding to and blocking ShB. 
The addition of the fluorine atoms at the 3- and 5-positions of the aromatic ring were 
designed to test the significance of the cation-π interaction, not the importance of the 
substituents at these positions. Designing a phenylalanine derivative with larger 
substituents at the 3- and 5-positions was anticipated to further investigate the relevance 
of the crystal structure 2BOC for its depiction of TEA block of ShB.  3,5-
Dimethylphenylalanine was chosen since the methyl groups were anticipated to be 
sterically disruptive to the binding of the TEA blocker, due to the increase in size from 
that of a hydrogen atom or fluorine atom, in an edge-on, but not an en face, orientation 
(figure 7.5).  
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Figure 7.5.  The structures and representative electrostatic potential surfaces of phenylalanine, the 
fluorinated phenylalanine derivatives used in the cation-π study in chapter 2, and 3,5-
dimethylphenylalanine.  The electrostatic potential surfaces were calculated using HF 6-31G*, where red 
and blue correspond to −20 and 20 kcal/mol, respectively. 
 
Synthesis of 3,5-Dimethylphenylalanine 
The synthesis of 3,5-dimethylphenylalanine began with the bromination of mesitylene 
using N-bromosuccinimide.16  This compound was then condensed with N-
(diphenylmethylene)glycine tert-butyl ester to yield the protected, racemic 3,5-
dimethylphenylalanine 7.6.  The protecting groups were removed, and then the amine 
was reprotected with the NVOC photolabile protecting group.17  Next, the acid was 
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activated as a cyanomethyl ester and coupled to the tetrabutylammonium salt of dCA to 
afford 7.10.  At this point the amino acid can be attached to either the 2’ or the 3’ 
hydroxyl of dCA since it is thought to rapidly sample both sites.  Finally, the 
aminoacylated dCA was ligated to THG-73 using T4 RNA ligase. 
 
Scheme 7.2.  Synthesis of 3,5-dimethylphenylalanine-tRNA. 
 
Evaluating the Effects of 3,5-Dimethylphenylalanine on TEA Block 
3,5-Dimethylphenylalanine was incorporated into ShB using the same Thr449UAG 
cRNA as in chapter 2.13  As stated above studying the ability of TEA to block this mutant 
channel was expected to give more evidence as to how TEA interacts with the channel in 
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vivo.  Therefore, the IC50 for TEA and the dimethyl-containing channel was expected to 
be similar to that for ShB Thr449Phe if the TEA interacted with the aromatic in an en 
face, cation-π favorable manner.  Conversely, TEA was expected to be much less 
effective at blocking the mutant channel, and thus have a higher IC50, if the edge-on 
interaction with the ring was as important as predicted by the crystal structure.15  
Surprisingly, the IC50 for TEA block of the dimethyl-containing mutant channel did not 
follow either expected trend.  As can be seen in figure 7.6, the IC50 for ShB with 3,5-
dimethylphenylalanine incorporated at position 449 is just slightly less than the IC50 
when 3,5-F2-phenylalanine is incorporated.  Thus, the addition of the methyl substituents 
at the 3- and 5-positions of the aromatic ring is less disruptive than when the fluorine 
atoms are there, although the methyl groups were predicted to be more disruptive in the 
edge-on orientation because of their larger size or not disruptive at all in the en face 
orientation.  Since the addition of the methyl substituents does have an adverse effect on 
the binding of the TEA that was not predicted by a pure cation-π interaction between the 
blocker and the aromatic side chain, an intermediary interaction with the substituents at 
these positions on the aromatic ring, either with TEA or with the channel, could be 
important for block. 
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Figure 7.6. Dose-response curves for channels with three different amino acids incorporated at position 449 
in ShB by nonsense suppression.   
 
To test whether all of the position on the aromatic ring were as sensitive to the addition of 
a methyl group as the 3- and 5-positions were, 4-methyl-phenylalanine-tRNA (made from 
a dCA analog that was previously synthesized by a past member of the Dougherty 
laboratory) was incorporated into position 449 of ShB.  The IC50 for the 4-methyl-
phenylalanine-containing channel was 0.26 ± 0.1 mM TEA, similar to that expected if the 
cation-π interaction controlled the binding of TEA to the channel (figure 7.7).  The 
methyl group is slightly electron donating, therefore it is expected to have a slightly 
enhanced cation-π interaction with TEA, as is seen.  The incorporation of 4-methyl-
phenylalanine was exciting in that it further substantiated that the cation-π, en face 
orientation dominanted in vivo for ShB.  But, this result also confirmed that the location 
of the methyl substituents at the 3- and 5-positions were specific for the slight disruption 
of receptor function in the earlier work.  
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Figure 7.7. Data collected for 4-methyl-phenylalanine in ShB.  A)  IC50 curve for 4-methyl-phenylalanine at 
ShB position 449.  B)  Cation-π plot for ShB Thr449 mutations.  The line represents the best fit for all of 
the points, y = −0.16x + 4.5 and R2 = 0.96.  
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Cha 
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To ensure that the addition of the two methyl groups at the 3- and 5-positions was not 
disruptive for all cation-π interactions in the same degree as was seen in ShB, 3,5-
dimethylphenylalanine was incorporated into the voltage-gated Na+ channel NaV1.4 in 
place of Phe1579.  Note that this channel and residue are involved in a cation-π 
interaction with lidocaine, as discussed in chapter 5.18  As seen in figure 7.8, the 
additional methyl groups do not negatively impact the cation-π interaction between the 
aromatic residue and lidocaine.  Thus, the shift in IC50 for TEA and ShB with 3,5-
dimethylphenylalanine incorporated at position 449 is specific for this blocker and this 
mutant channel.  Somehow the addition of the methyl groups decreases the affinity of 
TEA for the channel, thus lowering its ability to block, but not in a manner that firmly 
discredits either model. 
 
Figure 7.8.  Frequency profile for use-dependent block for three different amino acids incorporated at 
position 1579 of NaV1.4. 
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Even though 3,5-dimethylphenylalanine did not provide conclusive results in this study, 
it has been useful in studies interested in understanding the sterics around phenylalanine 
residues in two other ion channels.  Walrati (Kay) Limapichat, a current graduate student 
in the Dougherty laboratory, has used this residue to understand the steric environment 
around the conserved FPF sequence in the α1 subunit of the muscle nAChR.  She found 
that its incorporation at Phe166 lowered the EC50 of ACh tenfold from that of the wild-
type channel.  Comparison with the EC50 values for mutant channels with 4-methyl-
phenylalanine, 4-F-phenylalanine, and 3,5-F2-phenylalanine incorporated at this site 
suggested that the decrease in EC50 correlated with the size and location of the 
substituents on the aromatic ring.  Kiowa Bower, another graduate student in the 
Dougherty laboratory, has used 3,5-dimethylphenylalanine to probe the importance of 
sterics around the aromatic residues located in the ligand-binding region of the dopamine 
D2 G-protein coupled receptor (GPCR).  Again, at certain sites he found trends that ran 
linearly with the size and location of the substituents on the aromatic ring.  These two 
examples are only a small sampling of the possible sites for incorporation of 3,5-
dimethylphenylalanine.  In the future, this unnatural amino acid should continue to 
provide valuable information about the sterics around important phenylalanines in ion 
channels. 
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Attempts to Enhance the Binding Affinity of Cationic Ligands for their Receptors 
Using the Unnatural Amino Acid 4-Amino-Phenylalanine 
As seen throughout the literature,19 this thesis (chapters 2, 3, 4, 5),13,18,20,21 and earlier this 
chapter, the cation-π interaction is a motif commonly employed by proteins to bind 
cationic ligands.  Currently, the method used to confirm the presence of a cation-π 
interaction between a ligand and a receptor is through the incorporation of fluorinated 
phenylalanine or tryptophan residues in place of the aromatic residue proposed to donate 
the “π” portion of the interaction.  The addition of the electronegative fluorine atoms 
withdraws electron density from the face of the aromatic, reducing the ability of the 
residue to bind cations.  Other electron withdrawing substituents, such as a bromine atom 
or a cyano group, have also been shown to decrease the binding ability of the mutant 
receptor for a cationic ligand.22  To date the unnatural amino acid 4-O-methyl-
phenylalanine is the only published example of a slightly strengthened cation-π 
interaction in a receptor.23  When Lummis et al. incorporated 4-O-methyl-phenylalanine 
at position 198 of the GABAC receptor, the EC50 was lower than that of the 
phenylalanine-containing receptor.23  Earlier in this chapter another example of a slight 
enhancement of the cation-π interaction was seen in the ShB channel with 4-methyl-
phenylalanine incorporated at position 449. 
Both the O-methyl and the methyl strengthen the ability of the aromatic to bind a cation 
through the donation of electron density to the aromatic ring.  An even stronger electron 
donating group is the amino group.  For example, 5-amino-trypotphan has a cation-π 
binding ability of 36.4 kcal/mol, up from the 32.6 kcal/mol of tryptophan.22  These 
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energy values represent the binding of a Na+ to the noted aromatic as calculated from 
their optimized geometry using HF 6-31G**.24  Unfortunately, when Zhong et al. 
incorporated 5-amino-tryptophan into the muscle nAChR at its cation-π interaction site, 
α1Trp149, the predicted decrease in EC50 was not seen.22  Instead the EC50 increased 
over fivefold, from 50 to 280 µM ACh.  The authors note that the increase could be from 
adverse interactions of the 5-amine with the receptor or because the amine may be 
protonated when in the receptor.  As for the former explanation, 5-methyl-tryptophan has 
a wild-type EC50,22 which argues against a purely steric clash with the receptor when a 
bulky group is added at this position.  The 5-methyl group cannot account for the 
possibility that the 5-amino group could electrostatically clash with the receptor due to 
the added amine dipole, as seen in a study by Cashin, Torrice, et al. of the same receptor 
with the α1Asp89Asn mutant.25  Incorporation of 5-amino-tryptophan could also have a 
destabilizing effect on the receptor, as seen when it was incorporated into barstar, an 
inhibitor of ribonuclease barnase from Bacillus amyloliquefaciens.26  Potentially the 
difference in hydrophobicity of the amine-containing residue from the natural tryptophan 
could disrupt the formation of the aromatic binding box in the nAChR, resulting in a 
more poorly functioning receptor.  As for the latter explanation, no conclusions were ever 
published that addressed whether the amine was protonated.  
4-Amino-phenylalanine also has a cation-π binding ability greater than its natural analog 
phenylalanine.  The addition of the amino group raises the binding energy from 27.1 
kcal/mol (phenylalanine) to 31.8 kcal/mol (4-amino-phenylalanine).  This residue has 
been incorporated into the muscle nAChR in place of several tyrosines in the binding box 
to study how the shift from a hydroxyl group to an amino group alters the function of the 
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channel,27 and it has been incorporated into myoglobin by a completely autonomous 
bacterium,28 but it has not yet been incorporated at any cation-π binding sites.  The 
cation-π binding site in ShB provided a perfect location for the incorporation of 4-amino-
phenylalanine.  The initial goal of this study was twofold.  First, if incorporation of 4-
amino-phenylalanine at postion 449 of ShB enhanced the ability of TEA to block the 
channel, this result would add another point to the trend line shown in chapter 2 (figure 
2.5A) and earlier in this chapter (figure 7.7), which would further support the hypothesis 
that a cation-π interaction occurs between TEA and the aromatic residue at position 449 
and that the en face geometry is representative of the channel in vivo.  Second, this work 
would stand as the first example of the strong enhancement of the cation-π interaction in 
an ion channel in vivo.  Unfortunately, the results were not as predicted, and the project 
was expanded to other receptors in an attempt to understand the properties of 4-amino-
phenylalanine in vivo. 
 
Synthesis of 4-Amino-Phenylalanine-tRNA 
Initially, 4-amino-phenyalalnine-tRNA was synthesized with two NVOC protecting 
groups (scheme 7.3).  The synthesis did not differ much from the one described above for 
3,5-dimethylphenylalanine.  
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Scheme 7.3.  Synthesis of di-NVOC-4-amino-phenylalanine-tRNA. 
 
The NVOC group is generally removed by irradiating a sample of NVOC-protected 
amino acyl tRNA with approximately 320 nm light from a 1000 W Hg/Xe arc lamp for 
five minutes just prior to injecting the solution into Xenopus laevis oocytes, which are 
used as the protein expression system.  Typically, an NVOC group is only present on the 
α-amine.  To ensure that both NVOC groups on 4-amino-phenylalanine-tRNA were 
removed during photolysis, a sample of di-NVOC-4-amino-phenylalanine-dCA was 
irradiated and then analyzed by reverse-phase analytical high-pressure liquid 
chromatography (HPLC).  The dCA derivative was used since its size and polarity were 
well suited for the reverse-phase column, and it would give distinct UV absorption 
signals for both the protected (absorbances at 260 and 350 nm) and deprotected 
compounds (absorbance only at 260 nm).  After five minutes of irradiation, a small 
amount of starting material was still seen, but after ten minutes of irradiation, no starting 
material remained.  Thus, for all of the experiments described below in which this doubly 
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NVOC protected 4-amino-phenylalanine was incorporated into a channel, the tRNA was 
irradiated for ten minutes prior to its injection into Xenopus oocytes. 
 
No Cation-π Enhancement in ShB 
Unfortunately, incorporation of 4-amino-phenylalanine at position 449 in ShB did not 
enhance the cation-π interaction.  Instead of lowering the IC50 as compared to that of a 
receptor with phenylalanine incorporated at the same site, the IC50 was raised over 
fivefold from 0.39 mM TEA (phenylalanine) to 2.1 ± 0.3 mM TEA (4-amino-
phenylalanine) (figure 7.9).  This fivefold difference is familiar from the functional 
change seen in the muscle nAChR in going from tryptophan to 5-amino-tryptophan. 
 
Figure 7.9.  Dose-response curves for phenylalanine (red) and 4-amino-phenylalanine (blue) incorporated 
at ShB Thr449. 
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This result was very surprising since published crystal structures of related K+ 
channels15,29-33 predict that this site is located at the top of the channel pore with its side 
chain pointing out into solution.  Thus, no steric or dipole clash should occur between 
this residue and the rest of the channel. To try to understand more about why 4-amino-
phenylalanine did not enhance the cation-π in ShB, another system was sought in order to 
repeat the experiment. 
 
No Cation-π Enhancement in the GABAC Receptor 
In 2005 the first cation-π interaction between a ligand and a tyrosine was reported.  
ρ1Tyr198 in the GABAC receptor was found to bind GABA through a cation-π 
interaction.  Thus, this receptor offered another opportunity to probe whether 4-amino-
phenylalanine could enhance the cation-π interaction.  4-Amino-phenylalanine was 
incorporated into GABAC ρ1Tyr198, and an EC50 of 145 ± 24 µM GABA was obtained 
from the average of seven oocytes with a Hill coefficient of 1.2 ± 0.2 (calculated as 
described in chapter 6) (figure 7.9).  Expression of the mutant receptor on the surface of 
the Xenopus oocyte was low, with the maximum amount of current reaching 100 nA, but 
the low expression was typical of a surpressed GABAC receptor.  Because it is a 
homopentamer, the unnatural amino acid is present in each subunit in the receptor.  This 
requirement tends to lower the number of functional receptors that get expressed on the 
surface of a Xenopus oocyte. 
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Figure 7.10.  Dose-response curve for 4-amino-phenylalanine incorporated at ρ1Tyr198. 
 
Surprisingly, this EC50 value was higher than Lummis et al. found for mutant receptors 
with phenylalanine, tyrosine, and even 4-F-phenylalanine incorporated at this site (table 
7.1).23  They do note the one example that falls off the trend:  the EC50 for a receptor with 
tyrosine is roughly fourfold lower than what would be predicted from the phenylalanine 
residues and their cation-π binding energies.  Thus, the hydroxyl group at the 4 position 
of the ring enhances the ability of GABA to activate the receptor.  Potentially, the 
features that favor a hydroxyl group at the 4-position of the aromatic are not compatible 
with an amino group there.  Lummis et al. propose that the hydroxyl group donates a 
hydrogen bond to another component of the system,23 which would effectively enhance 
its cation-π binding energy.34  But, the amino group of 4-amino-phenylalanine should be 
roughly equally as effective of a hydrogen bond donor as tyrosine.  Lummis et al. also 
propose that GABA could make a favorable electrostatic interaction with the hydroxyl 
group on tyrosine, but they state that this possibility is less likely since the same 
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functional enhancement is not observed with 4-methoxy-phenylalanine, which also has 
an oxygen-containing substituent at the 4-position.23  Neither proposal adequately 
explains why 4-amino-phenylalanine does not enhance the cation-π interaction as 
predicted in the GABAC receptor.  
 
Table 7.1.  The data collected for the GABAC ρ1Tyr198 cation-π site.*  
Tyr198X, where X = Cation-π Binding 
Energy (kcal/mol) 
EC50 (µM) [Hill Coeff.] 
4-Amino-phenylalanine 31.8 145 ± 24 [1.2 ± 0.2] 
4-Methoxy-phenylalanine* 28.6 6.6 [1.6] 
Phenylalanine* 27.1 9.5 [1.6] 
Tyrosine* 26.9 2.1 [1.6] 
4-F-Phenylalanine* 22.0 34 [1.9] 
3,5-F2-Phenylalanine* 17.1 1700 [1.4] 
3,4,5-F3-Phenylalanine* 12.9 8400 [1.5] 
 
Another explanation for the functional disruption of the receptor caused by 4-amino-
phenylalanine is that the aniline is getting modified either during the NVOC deprotection 
step or after injection by the Xenopus oocyte.  The additional steric bulk could create a 
poorly functioning receptor.  A third system was sought to further explore the effects of 
4-amino-phenylalanine. 
 
No Cation-π Enhancement in the Muscle nAChR 
Despite the differences in size and shape between tryptophan and phenylalanine, the 
muscle nAChR was chosen as another target for 4-amino-phenylalanine due to the 
                                                
* Reported by Lummis et al.23 
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prevalence of this receptor in the Dougherty laboratory.  The expectation was not that 4-
amino-phenylalanine incorporated in place of α1Trp149 would produce a wild-type 
receptor, but instead it was simply that 4-amino-phenylalanine would create a better 
nAChR than the mutant receptor that contained phenylalanine at this site.  It has 
previously been published that the muscle nAChR with α1Trp149Phe has an EC50 100 
times higher than wild type.22  Because 4-amino-phenylalanine should be able to more 
strongly bind ACh, it was predicted that this residue would be able to partially rescue 
receptor function. 
Unfortunately, the desired result was not seen.  When 4-amino-phenylalanine was 
incorporated into α1Trp149 in a channel that also consisted of the subunits β1, δ, and γ, 
the EC50 was too high to accurately measure, reminiscent of a receptor that contains 
α1Trp149Phe.22  In order to quantitiate the effect of incorporating 4-amino-
phenylalanine, its EC50 was lowered by making a mutation in the pore lining helix of the 
β1 subunit. When β1Leu262, the famous 9’ residue that is part of a hydrophobic band of 
residues that forms the narrowest point in the pore of the channel, is mutated to the more 
polar residue serine, the channel is more easily opened.  With a receptor that includes 
β1Leu9’Ser, the EC50 for 4-amino-phenylalanine incorporated at position 149 in the α1 
subunit was found to be 160 ± 12 µM for ACh with a Hill coefficient was 1.8 ± 0.2.  
Surprisingly, this value was identical to that found for phenylalanine; its EC50 was 154 ± 
24 µM, and its Hill coefficient was 1.7 ± 0.3 (figure 7.11).  Therefore, 4-amino-
phenylalanine does not rescue any of the receptor function lost upon phenylalanine 
incorporation.  For reference, the wild-type EC50 for this nAChR is around 0.8 µM.35 
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Figure 7.11.  Dose-response curves for 4-amino-phenylalanine and phenylalanine incorporated at 
α1Trp149 in the muscle nAChR containing the β1Leu9’Ser, δ, and γ subunits. 
 
Two explanations were proposed to account for the similarity in EC50 values between 
phenylalanine and 4-amino-phenylalanine in the nAChR.  First, the amine could be 
modified after being deprotected in such a way as to reduce its cation-π binding ability or 
add inappropriate steric bulk.  Second, the change in size and shape of the side chain in 
the receptor’s binding site from the wild-type indole to a six-member ring could be the 
dominant factor in the reduction of receptor function.  In this case the cation-π binding 
ability of the aromatic six-member ring was inconsequential due to its lack of necessary 
volume.  In either case, the question as to whether 4-amino-phenylalanine could enhance 
the cation-π interaction was still unanswered. 
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The NVOC-Deprotection Conditions Do Not Modify the Aniline 
If 4-amino-phenylalanine-tRNA were being altered, the modification could either occur 
during NVOC deprotection or by a cellular pathway once in the Xenopus oocyte.  
Because 4-amino-phenylalanine was successfully incorporated into a protein in a 
bacterial system without being further modified, as proved by protein sequencing,28 the 
cellular environment seemed the less likely of the two possibilities.  Therefore, the 
deprotection step was investigated first.  Three different strategies were undertaken to 
determine whether the aniline was stable to photolysis.  The first involved trapping the 
photolysis byproducts, the second involved identifying the mass of the major photolysis 
product, and the third avoided photolysis altogether. 
Irradiation of di-NVOC-4-amino-phenylalanine-tRNA produces not only deprotected 
tRNA, but also an aldehyde (figure 7.12).  This aldehyde could react with the aniline to 
form an imine, creating a large and sterically bulky amino acid that could affect the 
receptor in unpredictable ways. 
 
Figure 7.12.  Deprotection of di-NVOC-4-amino-phenylalanine-tRNA produces an aldehyde that could 
react with the aniline. 
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To prevent the possibility of imine formation, di-NVOC-4-amino-phenylalanine tRNA 
was photolyzed in the presence of an excess of hydroxylamine prior to injection of the 
mixture into a Xenopus oocyte.  The hydroxylamine should react with the aldehyde to 
produce a stable oxime.  The resulting mutant nAChR channels made with this directed 
to the cation-π binding site had the same high EC50 values as reported above for the 
muscle nAChR with 4-amino-phenylalanine without the β1Leu9’Ser mutation.  As a 
control, NVOC-tryptophan-tRNA was photolyzed in the presence of hydroxylamine and 
then injected into an oocyte with the intention of incorporating the residue at the same 
site as above.  The wild-type recovery experiment was not affected by the 
hydroxylamine.  The control proves that the photolysis with hydroxylamine did not 
negatively affect the experiment.  These results suggest that imine formation was not a 
contributing factor to the functional response of the channel to 4-amino-phenylalanine 
incorporation. 
In parallel, matrix-assisted laser desorption/ionization (MALDI)-mass spectrometry (MS) 
was used to analyze the photolysis products after irradiation of di-NVOC-4-amino-
phenylalanine-dCA.  The mass of the major photolysis product, given as its mass-to-
charge ratio (m/z), was 799.3, which is the expected ratio of the aniline-dCA associated 
with a hydrogen atom ([M+H] m/z = 799.2).  Although MS cannot confirm the structure 
of a product or relay quantitative information about how prevalent a compound is in 
solution, the fact that the m/z ratio with the largest abundance agreed with that predicted 
for the expected product is very encouraging. 
The third strategy took a different pathway:  it sidestepped the deprotection step 
altogether through the synthesis of 4-amino-phenylalanine-tRNA without any NVOC 
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protecting groups.  The synthesis of deprotected 4-amino-phenylalanine-tRNA began by 
protecting the aniline amine of Nα-tBoc-4-amino-phenylalanine with another tBoc 
group36 and activating the acid as a cyanomethyl ester.  The acid-labile protecting groups 
were removed following the coupling of the amino acid to dCA according to the protocol 
that was developed by a former postdoctoral researcher in the Dougherty laboratory, Dr. 
Pamela England, for the deprotection of tert-butyl silyl protected α-hydroxy acid-dCA 
compounds.37  Ligation to THG73 produced deprotected 4-amino-phenylalanine-tRNA. 
 
Scheme 7.4.  Synthesis of deprotected 4-amino-phenylalanine-tRNA 
 
Synthesized amino acyl tRNAs are generally proctected on their α-amine to decrease the 
negative inductive effect of the free amino on the stability of the complex.  To minimize 
the degradation of the deprotected tRNA, it was divided up into small aliquots prior to 
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storage at −80 °C.  Each aliquot was thawed immediately proceeding injection into 
Xenopus oocytes, and no added disadvantage from the lack of storage with the NVOC 
group was ever observed.  As above with the hydroxylamine studies, the EC50 values for 
the GABAC receptor with this 4-amino-phenylalanine incorporated into its cation-π 
binding site gave the same values as reported for the di-NVOC version, 153 ± 32 µM 
GABA with a Hill coefficient of 1.1 ± 0.2. 
Together these three separate experiments confirmed that the deprotection of di-NVOC-
4-amino-phenylalanine-tRNA by irradiation was not disruptive to the aniline structure.  
Thus, what was considered the most likely explanation for the unpredicted results was 
eliminated.  The possibility still remained though that the aniline was getting modified 
once inside the cell.  
 
Attempts to Form 4-Amino-Phenylalanine In Situ 
To eliminate the possibility that a cellular component in the Xenopus oocyte was 
modifyng the aniline, two unnatural amino acids were designed to either reveal or 
chemically convert to 4-amino-phenylalanine in situ upon the addition of an outside 
stimulus.  The stimulus would be applied immediately prior to recording whole-cell 
currents from the mutant channels, minimizing the amount of time the aniline would be 
exposed to the cellular environment.  The first unnatural amino acid was a caged aniline 
that was responsive to UV light, and the second was 4-nitro-phenylalanine, which upon 
exposure to a reducing agent, should become the 4-amino compound. 
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The synthesis of the caged 4-amino-phenylalanine-tRNA began by protecting the aniline 
amine of Nα-tBoc-4-amino-phenylalanine with NVOC (scheme 7.5).  Next, the tBoc 
group was removed, and then the α-amine was reprotected with the orthogonal 4-
pentenoate (4PO) group.  The rest of the synthesis progressed as described above. 
 
Scheme 7.5.  Synthesis of Nα-4PO-4-amino(NVOC)-phenylalanine-tRNA. 
 
The 4PO protecting group was removed prior to injecting the tRNA into a Xenopus 
oocyte by exposing the protected tRNA to a saturated, aqueous iodine solution.  Since the 
NVOC group is resistant to these conditions, it allowed for the aniline to remain 
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protected during protein translation.  Immediately prior to recording the oocytes were 
exposed to UV light from a 288 W Hg lamp (see chapter 8), which was anticipated to 
decage the aniline.  There was precedent for this type of decaging experiment from 
unnatural amino acids such as tyrosine-O-nitrobenzyl, cysteine-S-nitrobenzyl, and 
nitrophenylglycine.38-41 Since earlier results proved that the aldehyde photolysis by-
product that is produced from the NVOC deprotection does not appear to affect the 
aniline, no precautionary measures were taken here. 
Unfortunately, no whole-cell currents were ever seen from this caged aniline.  To explore 
whether this amino acid was compatible with ribosomal translation, attempts were made 
to incorporate the residue into a protein in vitro using rabbit reticulocyte lysate and 
α1Leu250UAG mRNA with an hemagglutinin (HA) epitope tag between residues 347 
and 348.  No protein was ever seen by Western blot, despite the success of the positive 
controls.  One possible explanation for the lack of protein expression could be the 
inadequate deprotection of the 4PO group from the α-amine.  If the 4PO group were not 
effectively removed, then the unnatural amino acid-tRNA would not be able to 
participate in translation.  This explanation did not seem likely though as the same 
deprotection methods were used to prepare 4PO-tyrosine-O-nitrobenzyl for in vivo 
nonsense suppression in chapter 8, and whole-cell currents were produced there.  It 
should be noted though that no side-by-side controls were run in this study.  Another 
explanation for the lack of protein could be that the size of the unnatural amino acid was 
too large for the ribosome.  A study by Sisido and co-workers on the incorporation of 
large, aromatic unnatural amino acids was successful incorporating amino acids similar in 
size to the caged aniline using an in vitro E. coli translation system.36  These results gave 
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precedent to our design and suggested that the caged aniline should be ribosomally 
competent.  Since the Sisido study used E. coli ribosomes, it could still be that the 
Xenopus laevis ribosome is more discriminatory with amino acid size and was selecting 
against the caged aniline.   
The second attempt to form 4-amino-phenylalanine in situ was through the reduction of 
4-nitro-phenylalanine by dithionite.  The reaction was modeled after the quenching of the 
fluorescent NBD by dithionite (see figure 7.2 for the structure of NBD).42  Angeletti and 
Nichols showed that when dithionite was applied to NBD-labeled lipid vesicles, the 
reduction of the nitro group to the amine eliminated the fluorescence of the compound.42 
To ensure that dithionie could reduce the nitro group of 4-nitro-phenylalanine to an 
amino group, the UV spectra of tBoc-4-nitro-phenylalanine and Nα-tBoc-4-amino-
phenylalanine were analyzed via reverse-phase analytical HPLC before and after at least 
20 minute exposure to 100 mM sodium dithionite in 100 mM phosphate buffer pH 7.4.  
Prior to dithionite treatment the nitro and amino compounds had very different UV 
spectra, but after treatment, the UV spectra of the nitro compound had changed to 
resemble the amine compound (figure 7.13).  The resulting UV spectra were taken as 
evidence that dithionite could reduce 4-nitro-phenylalanine to 4-amino-phenylalanine in 
situ.  Therefore, 4-nitro-phenylalanine-tRNA was synthesized following steps similar to 
those described above (scheme 7.6).   
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Figure 7.13.  UV spectra of 4-nitro-phenylalanine and 4-amino-phenylalanine before and after exposure to 
100 mM dithionite in 100 mM phosphate buffer pH 7.4 for the time indicated in the parentheses. 
 
Scheme 7.6.  Synthesis of NVOC-4-nitro-phenylalanine-tRNA. 
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4-Nitro-phenylalanine was incorporated into ShB at position 449 and produced an IC50 
for TEA of 0.95 ± 0.1 mM TEA (figure 7.14A).  Because dithionite would also reduce 
important elements of the electrophysiology rig, like the AgCl pellet in the bath solution, 
the Xenopus oocytes used in this study were placed in a solution of either 100 mM 
dithionite in 100 mM phosphate buffer pH 7.4 or 24 mM dithionite in 50 mM phosphate 
buffer pH 7.4 for varying amounts of time prior to recording.  This second solution of 
dithionite was much lower in concentration than that used in the model studies, but it was 
chosen because its osmolarity was equivalent to that of the typical bath solution used for 
oocytes (ND96, 209.4 mM ions).  Whole-cell recordings were attempted after exposure 
to dithionite, but no reliable data were obtained, presumably due to a decrease in health 
from the time in the dithionite solution.  The addition of calcium to the dithionite solution 
(to aid the health of the oocytes) was not possible because calcium phosphate just 
precipitated out of the solution.  
 
Incorporation of 4-Acetamido-Phenylalanine 
One possible way in which the cell could be modifying 4-amino-phenylalanine could be 
the addition of an acetyl group, producing 4-acetamido-phenylalanine.  To explore this 
possibility, 4-acetamido-phenylalanine was synthesized (scheme 7.7) and incorporated 
into ShB at position 449. 
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Scheme 7.7.  Synthesis of NVOC-4-acetamido-phenylalanine-tRNA. 
 
Surprisingly, the IC50 for the mutant channel with 4-acetamido-phenylalanine at the 
cation-π site was 2.1 ± 0.4 mM TEA—identical to the value obtained for 4-amino-
phenylalanine (2.1 ± 0.3 mM TEA) (Fgure 7.14A). The cation-π binding energy for 
acetamino-benzene was calculated to be 21.4 kcal/mol with optimized geometry using 
HF 6-31G*.  When this EC50 value was plotted against the cation-π binding (chapter 2),13 
it reasonably fit the cation-π trend-line (figure 7.14B).  This result provided the first 
glimpse of understanding into the questions that had arisen around 4-amino-
phenylalanine. 
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Figure 7.14.  Data collected for 4-acetamido-phenylalanine in ShB.  A)  Dose-response curves for 4-
acedamido-phenylalanine and 4-nitro-phenylalanine incorporated at ShB position 449 (phenylalanine and 
4-amino-phenylalanine repeated from above).  B)  Cation-π plot for ShB Thr449 mutations.  The line 
represents the best fit for all of the points, y = −0.16x + 4.5 and R2 = 0.96.  
Cha 
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Unfortunately, the result could not be repeated in either the nAChR or the GABAC 
receptor.  Only three oocytes were found to express 4-acetamido-phenylalanine at the 
cation-π site of the muscle nAChR (with the β1Leu9’Ser muation), but their EC50 values 
varied from 2.5 µM to 8.3 µM to 31.1 µM ACh, and their EC50 curves even gave the 
slight impression that they were biphasic.  None resembled the 160 µM ACh EC50 of 4-
amino-phenylalanine.  No whole-cell currents were ever seen for 4-acetamido-
phenylalanine incorporated at GABAC ρ1Tyr198, while reliable expression had been 
observed for 4-amino-phenylalanine.  Therefore, the data obtained from these two 
receptors did not support that 4-amino-phenylalanine was being acylated by the Xenopus 
oocyte prior to channel recording. 
 
Future Directions 
Future work towards the understanding of 4-amino-phenylalanine should consider 
incorporating the residue at the cation-π sites that have been recently published in the 
NaV1.4 channel (see chapters 3, 4, and 5)18,20,21 and the GABAA receptor.43  These two 
receptors use tyrosines and phenylalanines in cation-π interactions and would hopefully 
supply an explanation as to why 4-amino-phenylalanine did not enhance the cation-π 
interaction in ShB, GABAC, or nAChR. 
Another possible direction for this project would be to conclusively determine whether 4-
amino-phenylalanine was in fact being incorporated into the desired receptor using an 
aniline-specific tag.  The exposed cation-π site of ShB is anticipated to be an ideal 
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location for such an experiment.  Francis and co-workers developed an aniline-specific 
tag that takes advantage of the oxidative coupling of anilines,44 but since this specific 
tagging of anilines requires an oxidant such as sodium meta-periodate, conditions would 
need to be optimized for use of this tag with the Xenopus oocyte. 
 
Methods 
Synthesis 
All reactions were performed at ambient temperature and pressure unless otherwise 
noted.  All reactions involving potentially air-sensitive compounds were conducted under 
an inert atmosphere using Schlenk techniques.  Solvents were purified by passage 
through alumina.45  Unless otherwise noted, all chemicals and reagents were used as 
received without further purification.  Flash chromatography was performed using EMD 
(Gibbstown, NJ) silica gel 60 (particle size 0.040-0.063 mm).  Thin-layer 
chromatography (TLC) was performed using EMD (Gibbstown, NJ) silica gel 60 F254 
precoated plates (0.25 mm) and visualized by UV, ceric ammonium molybdate, 
ninhydrin, and potassium permanganate.  Nuclear magnetic resonance spectroscopy 
(NMR) was preformed on a Varian (Palo Alto, CA) Mercury 300 instrument, and NMR 
resonances are reported relative to Me4Si (δ 0.0), CD3OD (δ 3.31), CD3CN (δ 1.94), D2O 
(δ 4.79), or d6-DMSO (δ 2.50).  Data for 1H NMR spectra are reported as follows: 
chemical shift (δ ppm), integration, multiplicity, and coupling constant (Hz).  MS spectra 
were obtained from the Caltech Mass Spectrometry Lab. Electrospray ionization (ESI)-
MS was preformed on an LCQ Classic ion trap (ThermoFinnigan, Waltham, MA) in 
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direct infusion mode.  MALDI-MS was performed on a Voyager-DE PRO 
BioSpectrometry Workstation (PerSeptive Biosystems, Foster City, CA).  HPLC was 
preformed using Waters (Milford, MA) equipment and software (510 HPLC pumps and 
996 Photodiode Array Detector) and reverse-phase Nova-Pak 18C columns (3.9 × 150 
mm analytical column, 7.8 × 300 mm preparatory column).  
O
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7.1  
DMAC-MTSEA 7.1: 7-Dimethylaminocoumarin-4-acetic acid succinimidyl ester (0.0019 
g, 0.0057 mmol, 1 eq) was placed in a round-bottom flask under Ar (g) in the dark and 
dissolved in DMF (1 mL).  To this solution was added 2-aminoethyl 
methanethiosulfonate hydrobromide (0.075 g, 0.45 mmol, 79 eq) and 
diisopropylethylamine (0.060 mL, 0.33 mmol, 58 eq).  After stirring for 5 minutes, the 
reaction was halted by freezing in N2 (liq), and the solvent was removed under vacuum.  
The crude product was purified using reverse-phase semipreparative HPLC with a linear 
solvent gradient from 5% acetonitrile in H2O with 1% AcOH to 100% acetonitrile.  The 
fractions containing the DMAC-MTSEA 7.1 were combined, and the solvent was 
removed by lyophilization.  1H NMR (300 MHz, CDCl3, 298 K) δ 7.45 (1H, d, J = 8.7 
Hz), 6.62 (1H, dd, J = 9.0, 2.7 Hz), 6.52 (1H, m), 6.06 (1H, s), 3.65 (2H, s), 3.60 (2H, q, 
J = 6.3 Hz), 3.32 (3H, s), 3.27 (2H, t, J = 6.0 Hz), 3.06 (6H, s), 2.85 (4H, s); ESI-MS m/z 
calc’d for C16H20N2O5S2 [M+Na]:  407.1, found:  406.9. 
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Extended NBD-MTSEA 7.2:  The procedure described above for 7.1 was repeated using 
succinimidyl-6-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)hexanoate (0.022 g, 0.0057 
mmol, 1 eq) as the starting material to afford extended NBD-MTSEA 7.2.  1H NMR (300 
MHz, CDCl3, 298 K) δ 8.51 (1H, d, J = 8.4 Hz), 6.19 (1H, d, J = 8.7 Hz), 4.17 (1H, q, J = 
6.9 Hz), 3.65 (2H, m), 3.54 (2H, q, J = 6.0 Hz), 3.39 (3H, s), 3.35 (2H, m), 2.28 (2H, m), 
1.80 (6H, m); ESI-MS m/z calc’d for C15H21N5O6S2 [M−H]:  430.1, found:  430.0. 
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Compact NBD-MTSEA 7.3:  The procedure described above for 7.1 was repeated using 
4-chloro-7-nitrobenzofurazan (0.011 g, 0.0057 mmol, 1 eq) as the starting material to 
afford compact NBD-MTSEA 7.3.  1H NMR (300 MHz, CDCl3, 298 K) δ 8.53 (1H, d, J 
= 8.4 Hz), 6.36 (1H, d, J = 8.7 Hz), 3.97 (2H, q, J = 6.3 Hz), 3.51 (2H, t, J = 6.6 Hz), 
3.43 (3H, s); ESI-MS m/z calc’d for C9H10N4O5S2 [M−H]:  317.0, found:  316.8. 
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Oregon Green-MTSEA 7.4:  The procedure described above for 7.1 was repeated using 
Oregon Green 488 carboxylic acid 5-isomer succinimidyl ester (0.0030 g, 0.0057 mmol, 
1 eq) as the starting material to afford Oregon Green-MTSEA 7.4. 1H NMR (300 MHz, 
CDCl3, 298 K) δ 8.43 (1H, s), 8.01 (1H, m), 7.31 (1H, d, J = 8.1 Hz), 6.69 (2H, d, J = 7.2 
Hz), 6.60 (2H, d, J = 11.1 Hz), 3.74 (2H, t, J = 6.9 Hz), 3.43 (2H, t, J = 7.2 Hz), 3.40 
(3H, s); ESI-MS m/z calc’d for C24H17F2NO8S2 [M−H]:  548.0, found:  548.0.  
7.5
Br
 
Bromomesitylene 7.5:  Mesitylene (7.30 mL, 52.4 mmol, 1.1 eq), N-bromosuccinimide 
(8.90 g, 50.0 mmol, 1 eq), and benzoyl peroxide (0.050 g, 0.20 mmol, 0.004 eq) were 
placed in a round-bottom flask under Ar (g) and dissolved in carbon tetrachloride (20 
mL).  The reaction was allowed to reflux for 1 hour.  The solution was then filtered (5×) 
to remove the solid precipitate and concentrated to afford bromomesitylene 7.5 (4.0902 g,  
20.5 mmol, 739% yield).  Rf = 0.56 (11% EtOAC in hexanes); 1H NMR (300 MHz, 
CDCl3, 298 K) δ 7.02 (2H, s), 6.95 (1H, s), 4.45 (2H, s), 2.32 (6H, s). 
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N-(Diphenylmethylene)dimethylphenylalanine tert-butyl ester 7.6:  Bromomesitylene 7.5 
(0.597 g, 3.00 mmol, 1 eq), N-(diphenylmethylene)glycine tert-butyl ester (0.975 g, 3.30 
mmol, 1.1 eq), and KI (0.054 g, 0.33 mmol, 0.11 eq) were placed in a round-bottom flask 
under Ar (g) and dissolved in dioxane (27 mL).  The solution was cooled to 10 °C and 
then charged with the dropwise addition of benzyltrimethylammonium hydroxide (40% 
solution in H2O, 0.4 mL).  The reaction changed color from yellow to white as it was 
stirred for 3 hours.  It was then quenched with H2O, extracted with toluene (6×), washed 
with H2O, and dried over CaCl2 (s).  The now yellow solution was concentrated under 
vacuum, and the crude product was purified by flash column chromatography (5% 
EtOAc in hexanes) to yield N-(diphenylmethylene)dimethylphenylalanine tert-butyl ester 
7.6 (0.880 g,  2.13 mmol, 70% yield).  Rf = 0.48 (11% EtOAC in hexanes); 1H NMR (300 
MHz, CDCl3, 298 K) δ 7.82 (1H, d, J = 6.9 Hz), 7.61 (2H, m), 7.50 (2H, m), 7.31 (4H, 
m), 6.79 (1H, s), 6.67 (2H, s), 4.11 (1H, m), 3.17 (2H, m), 2.19 (6H, s), 1.48 (9H, s); ESI-
MS m/z calc’d for C28H31NO2 [M+H]:  414.2, found 414.0. 
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Dimethylphenylalanine 7.7:  N-(Diphenylmethylene)glycine tert-butyl ester 7.6 (0.440 g,  
1.06 mmol) was added to a round-bottom flask and dissolved in 6 N HCl (20 mL).  The 
reaction was refluxed for 6 hours.  The solution was then washed with ether, and the 
aqueous layer was concentrated by lyophilization to yield dimethylphenylalanine 7.7 
(0.052 g, 0.27 mmol, 25% yield).  1H NMR (300 MHz, D2O, 298 K) δ 7.04 (1H, s), 6.92 
(1H, s), 4.17 (1H, dd, J = 7.5, 5.7 Hz), 3.01 (2H, m), 2.11 (6H, s). 
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NVOC-dimethylphenylalanine 7.8:  Dimethylphenylalanine 7.7 (0.0515 g, 0.270 mmol, 1 
eq) was added to a round-bottom flask and dissolved in 10% (w/v) sodium carbonate in 
H2O (1.03 mL, 0.972 mmol, 3.6 eq).  To this solution was added dioxane (1 mL).  The 
mixture was stirred in an ice bath and nitroveratryloxycarbonyl chloride (0.078 g, 0.283 
mmol, 1.1 eq) was added slowly.  The mixture was allowed to warm to room temperature 
while stirring for 4 hours.  The mixture was then poured into distilled H2O (200 mL) and 
washed with ether (3×).  Under vigorous stirring, the aqueous solution was adjusted to 
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pH 2 by slowly adding 5 M HCl and then the solution was extracted with ether, dried 
over MgSO4 (s), and concentrated to afford NVOC-dimethylphenylalanine 7.8 as a 
yellow oil (0.0728 g, 0.170 mmol, 63% yield).  1H NMR (300 MHz, CD3OD, 298 K) δ 
7.73 (1H, s), 7.17 (1H, s), 7.08 (1H, s), 6.85 (2H, s), 5.42 (2H, m), 4.39 (1H, m), 3.89 
(3H, s), 3.84 (3H, s), 3.14 (1H, m), 2.84 (1H, m), 2.24 (6H, s); ESI-MS m/z calc’d for 
C21H24N2O8 [M+Na]:  455.2, found 455.0.   
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NVOC-dimethylphenylalanine cyanomethyl ester 7.9:  NVOC-dimethylphenylalanine 7.8 
(0.72 g, 0.17 mmol) was added to a round-bottom flask under Ar (g) and dissolved in 
DMF (0.5 mL).  Chloroacetonitrile (0.5 mL) and then triethylamine (0.07 mL) were 
added to the solution.  The mixture was stirred at room temperature for 90 minutes and 
then the solvent was removed under vacuum.  The residue was purified by flash column 
chromatography (5% EtOAc in hexanes) to afford NVOC-dimethylphenylalanine 
cyanomethyl ester 7.9 as white crystals (0.0166 g, 0.0352 mmol, 21% yield). 1H NMR 
(300 MHz, d6-DMSO, 298 K) δ 7.69 (1H, s), 7.11 (1H, s), 6.84 (3H, s), 5.33 (2H, m), 
5.00 (2H, s), 4.33 (1H, m), 3.86 (3H, s), 3.85 (3H, s), 2.92 (2H, m), 2.20 (6H, s). 
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NVOC-dimethylphenylalanine-dCA 7.10:  NVOC-dimethylphenylalanine cyanomethyl 
ester 7.9 (0.011 g, 0.025 mmol, 3 eq) was added to a round-bottom flask under Ar (g) and 
dissolved in DMF (0.5 mL).  This solution was transferred to another round-bottom flask 
under Ar (g), which contained dCA (0.010 g, 0.0085 mmol, 1 eq) as a 
tetrabutylammonium salt (2.4 eq).    The reaction was stirred at room temperature for 18 
hours while being monitored by reverse-phase analytical HPLC with a linear solvent 
gradient from 5% acetonitrile in 25 mM NH4OAc buffer pH 4.5 to 100% acetonitrile.  
The crude product was purified using reverse-phase semipreparative HPLC with the same 
linear solvent gradient.  The fractions containing the NVOC-dimethylphenylalanine-dCA 
7.10 were combined, and the solvent was removed by lyophilization.  The solid was 
redissolved in 10 mM acetic acid and reconcentrated via lyophilization (3×) to afford 
NVOC-dimethylphenylalanine-dCA 7.10 as a white powder (0.0019 g, 0.0020 mmol, 
25% yield).   ESI-MS m/z calc’d for C40H48N10O20P2 [M−H]:  1049.3; found:  1049.4.  
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Di-NVOC-4-amino-phenylalanine 7.11:  L-4-Amino-phenylalanine (0.65 g, 3.6 mmol, 1 
eq) was added to a round-bottom flask and dissolved in 10% (w/v) sodium carbonate in 
H2O (28 mL).  To this solution was added dioxane (28 mL) at 4 °C, followed by the slow 
addition of nitroveratryloxycarbonyl chloride (2.0 g, 7.6 mmol, 2.1 eq).  The mixture was 
allowed to warm to room temperature while stirring for 18 hours.  The mixture was then 
poured into distilled H2O (200 mL) and ether (50 mL), and the solid precipitate was 
filtered to afford di-NVOC-4-amino-phenylalanine 7.11 as a solid (1.80 g, 2.7 mmol, 
76% yield).  Rf = 0.56 (1% AcOH in EtOAc); 1H NMR (300 MHz, d6DMSO, 298 K) δ 
9.9 (1H, b), 7.7 (1H, s), 7.6 (1H, s), 7.3-7.0 (6H, m), 6.8 (1H, d), 5.4 (4H, s), 5.2 (1H, d), 
3.9 (12H, m), 3.1-2.7 (2H, m); ESI-MS m/z calc’d for C29H30N4O14 [M−H]:  657.2; 
found:  656.8. 
 
233 
O
O NO2
O N
H
O
O
O
7.12
H
N O
O
O2N O
O
N
 
Di-NVOC-4-amino-phenylalanine cyanomethyl ester 7.12: The procedure described 
above for 7.9 was repeated using di-NVOC-4-amino-phenylalanine 7.11 (0.41 g, 0.63 
mmol) as the starting material.  The reaction was stirred at room temperature for 75 
minutes, and then a small amount of H2O was added to the flask.  The resulting 
precipitate was filtered to afford di-NVOC-4-amino-phenylalanine cyanomethyl ester 
7.12 (0.19 g, 0.20 mmol, 44% yield).  Rf = 0.91 (17% EtOAc in CH2Cl2); 1H NMR (300 
MHz, d6DMSO, 298 K) δ 9.9 (1H, b), 8.2 (1H, d), 7.72 (1H, s), 7.69 (1H, s), 7.4-7.1 (6H, 
m), 5.44 (2H, s), 5.3 (2H, d), 5.01 (2H, s), 4.4 (1H, m), 3.90 (3H, s), 3.87 (3H, s), 3.85 
(3H, s), 3.84 (3H, s), 3.1-2.8 (2H, m); ESI-MS m/z calc’d for C31H31N5O14 [M+K]:  
736.3; found:  736.0. 
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Di-NVOC-4-amino-phenylalanine-dCA 7.13:  The procedure described above for 7.10 
was repeated using di-NVOC-4-amino-phenylalanine cyanomethyl ester 7.12 (0.017 g, 
0.025 mmol, 3 eq) as the starting material, except that the reaction was only stirred at 
room temperature for 1 hour, to afford di-NVOC-4-amino-phenylalanine-dCA 7.13 as a 
white powder (0.00052 g, 0.00041 mmol, 5% yield).   ESI-MS m/z calc’d for 
C48H54N12O26P2 [M−H]:  1275.3; found:  1275.4. 
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Di-tBoc-4-amino-phenylalanine 7.14:  Nα-(tert-Butoxycarbonyl)-4-amino-phenylalanine 
(1.0 g, 3.5 mmol, 1 eq) was placed in a round-bottom flask and dissolved in dioxane (15 
mL) and 4% NaHCO3 (aq) (15 mL) at 4 °C.  To this solution was added di-tert-
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butyldicarbonate (1.2 mL, 7.0 mmol, 1.5 eq).  The opaque white reaction was stirred at 4 
°C for 2 hours, and then it was allowed to come to room temperature, at which point the 
reaction turned opaque orange, and stirred for another 20 hours.  At the end of the 
reaction, the orange solution had become clear.  The solvent was removed under vacuum, 
and then the crude product was resuspended in 5% KHSO4 (aq), extracted with EtOAc, 
washed with brine, dried over MgSO4 (s), and concentrated to afford di-tBoc-4-amino-
phenylalanine 7.14 as a pale yellow solid (1.3 g, 3.5 mmol, 97%). Rf = 0.25 (100% 
EtOAc); 1H NMR (300 MHz, CD3OD, 298 K) δ 8.71 (1H, b), 7.19 (2H, d, J = 8.4 Hz), 
7.01 (2H, d, J = 8.7 Hz), 4.19 (1H, m), 2.98 (1H, dd, J = 14.1, 5.1 Hz), 2.74 (1H, dd, J = 
14.0, 9.0 Hz), 1.40 (9H, s), 1.28 (9H, s); ESI-MS m/z calc’d for C19H28N2O6 [M−H]:  
379.2; found:  379.1. 
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Di-tBoc-4-amino-phenylalanine cyanomethyl ester 7.15: The procedure described above 
for 7.9 was repeated using di-tBoc-4-amino-phenylalanine 7.14 (0.25 g, 0.66 mmol) as 
the starting material.  The crude product was purified by flash column chromatography 
(CH2Cl2, then 5% EtOAc in CH2Cl2 once the yellow product started eluting) to afford di-
tBoc-4-amino-phenylalanine cyanomethyl ester 7.15 (0.20 g, 0.47 mmol, 78% yield).  Rf 
= 0.82 (17% EtOAc in CH2Cl2); 1H NMR (300 MHz, CDCl3, 298 K) δ 7.3-6.8 (4H, m), 
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6.47 (1H, b), 4.70 (2H, m), 4.6 (1H, m), 3.05 (2H, d, J = 7.2 Hz), 1.51 (9H, s), 1.42 (9H, 
s); ESI-MS m/z calc’d for C21H29N3O6 [M+Cl]:  454.7; found:  454.1. 
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4-Amino-phenylalanine-dCA 7.16:  The procedure described above for 7.10 was repeated 
using di-tBoc-4-amino-phenylalanine cyanomethyl ester 7.15 (0.011 g, 0.025 mmol, 3 
eq) as the starting material, except that the reaction was allowed to stir for 48 hours 
before purification by HPLC.  The HPLC fractions containing the di-tBoc-4-amino-
phenylalanine-dCA were combined, the solvent was removed by lyophilization, and the 
solid was redissolved in trifluoroacetic acid (0.10 mL) at 4 °C.  After 20 minutes the 
solvent was removed by bubbling Ar through the solution to afford 4-amino-
phenylalanine-dCA 7.16 as a white powder (0.00018 g, 0.00027 mmol, 3% yield).   ESI-
MS m/z calc’d for C28H36N10O14P2 [M+H]:  799.2; found:  800.5. 
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Nα-tBoc-4-amino(NVOC)-phenylalanine 7.17:  The procedure described above for 7.8 
was repeated using Nα-(tert-Butoxycarbonyl)-4-amino-phenylalanine (1.0 g, 3.6 mmol, 1 
eq) to afford Na-tBoc-4-amino(NVOC)-phenylalanine 7.17 (0.48 g, 0.9 mmol, 26% 
yield). 1H NMR (300 MHz, CD3OD, 298 K) δ 7.77 (1H, s), 7.38 (2H, m), 7.25 (1H, s), 
7.16 (2H, d, J = 8.4 Hz), 5.54 (2H, s), 4.30 (1H, m), 3.91 (3H, s), 3.88 (3H, s), 3.11 (1H, 
dd, J = 14.0, 5.1 Hz), 2.86 (1H, dd, J = 13.8, 9 Hz). 1.38 (9H, s). 
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4-Amino(NVOC)-phenylalanine 7.18: Nα-tBoc-4-amino(NVOC)-phenylalanine 7.17 
(0.48 g, 0.9 mmol) was placed in a round-bottom flask under Ar (g) and dissolved in 
trifluoroacetic acid (16 mL) at 0 °C.  After 30 minutes the solvent was removed under 
vacuum to afford 4-amino(NVOC)-phenylalanine 7.18. 1H NMR (300 MHz, CD3OD, 
298 K) δ 7.76 (1H, s), 7.47 (2H, d, J = 8.7 Hz), 7.24 (2H, d, J = 2.7 Hz), 7.21 (1H, s), 
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5.54 (2H, s), 4.21 (1H,dd, J = 7.5, 5.1 Hz), 3.95 (3H, s), 3.91 (3H, s), 3.25 (1H, m), 3.11 
(1H, m). 
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Nα-4PO-4-amino(NVOC)-phenylalanine 7.19:  4-Amino(NVOC)-phenylalanine 7.18 
(0.38 g, 0.90 mmol, 1 eq) and N,N-diisopropylethylamine (0.18 mL, 1.1 mmol, 1.2 eq) 
were placed in a round-bottom flask and dissolved in THF (8.7 mL) and H2O (8.7 mL).  
To this solution was added 4-pentenoic anhydride (0.20 mL, 1.1 mmol, 1.2 eq).  The 
reaction was allowed to stir for 18 hours.  The THF was then removed under vacuum, and 
the aqueous solution was washed with EtOAc (3×).  The pH of the resulting aqueous 
solution was lowered to 2 with 6 N HCl and extracted with EtOAc (3×) to afford Nα-
4PO-4-amino(NVOC)-phenylalanine 7.19 (0.41 g, 0.81 mmol, 90% yield). 1H NMR (300 
MHz, CD3OD, 298 K) δ 7.77 (1H, s), 7.37 (2H, d, J = 8.7 Hz), 7.25 (1H, s), 7.16 (2H, d, 
J = 8.4 Hz), 5.70 (1H, m), 4.97 (2H, d, J = 12.6 Hz), 4.93 (2H, s), 4.63 (1H, dd, J = 9.2, 
5.4 Hz), 3.94 (3H, s), 3.91 (3H, s), 3.16 (1H, dd, J = 14.0, 4.8 Hz), 2.89 (1H, dd, J = 14.1, 
9.3 Hz), 2.24 (4H, m); ESI-MS m/z calc’d for C24H27N3O9 [M+Na]:  524.2; found:  
523.9. 
 
239 
N
H
O
O
O
7.20
H
N O
O
O2N O
O
N
 
Nα-4PO-4-amino(NVOC)-phenylalanine cyanomethyl ester 7.20: The procedure 
described above for 7.9 was repeated using Nα-4PO-4-amino(NVOC)-phenylalanine 7.19 
(0.16 g, 0.32 mmol) as the starting material.  The crude product was purified by flash 
column chromatography (CH2Cl2, then 50% EtOAc in CH2Cl2 once the yellow product 
started eluting) to afford Nα-4PO-4-amino(NVOC)-phenylalanine cyanomethyl ester 7.20 
(0.091 g, 0.17 mmol, 54% yield).  Rf = 0.20 (17% EtOAc in CH2Cl2); 1H NMR (300 
MHz, CD3CN, 298 K) δ 8.01 (1H, s), 7.74 (1H, s), 7.41 (2H, d, J = 8.7 Hz), 7.20 (3H, m), 
6.75 (1H, d, J = 7.8 Hz), 5.78 (1H, m), 5.52 (2H, s), 5.00 (2H, m), 4.79 (2H, s), 4.67 (1H, 
m), 3.96 (3H, s), 3.91 (3H, s), 3.03 (2H, m), 2.25 (2H, m), 1.97 (2H, m); ESI-MS m/z 
calc’d for C26H28N4O9 [M+Na]:  563.2; found:  563.1. 
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Nα-4PO-4-amino(NVOC)-phenylalanine-dCA 7.21: The procedure described above for 
7.10 was repeated using Nα-4PO-4-amino(NVOC)-phenylalanine 7.19 (0.017 g, 0.025 
mmol, 3 eq) as the starting material, except that the reaction was allowed to stir for 6 
hours, to afford Nα-4PO-4-amino(NVOC)-phenylalanine-dCA 7.21 (0.00071 g, 0.00064 
mmol, 8% yield). MALDI-MS m/z calc’d for C43H51N11O21P2 [M+H]:  1120.3; found:  
1120.5 
H2N
OH
O
7.22
NO2
 
4-Nitro-phenylalanine 7.22:  The procedure described above for 7.18 was repeated using 
tBoc-4-nitro-phenylalanine (0.31 g, 1.0 mmol) as the starting material to afford 4-nitro-
phenylalanine 7.22 (0.21 g, 1.0 mmol, 100% yield).  1H NMR (300 MHz, D2O, 298 K) δ 
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8.10 (2H, d, J = 2.1 Hz), 7.41 (2H, d, J = 8.7 Hz), 4.27 (1H, dd, J = 7.7, 6.3 Hz), 3.33 
(1H, dd, J = 14.6, 6.0 Hz), 3.22 (1H, dd, J = 14.6, 7.8 Hz). 
O
O NO2
O N
H
O
OH
O
7.23
NO2
 
NVOC-4-nitro-phenylalanine 7.23:  The procedure described above for 7.8 was repeated 
using 4-nitro-phenylalanine 7.22 (0.21 g, 1.0 mmol, 1 eq) as the starting material.  After 
stirring for 4 hours, the mixture was poured into distilled H2O (200 mL) and washed with 
ether (3×).  Under vigorous stirring, the aqueous solution was adjusted to pH 2 by slowly 
adding 6 N HCl.  Once a white precipitate began to form in the yellow solution, the 
mixture was refrigerated overnight to encourage the formation of more solid.  The 
subsequent day the precipitate was filtered to afford NVOC-4-nitro-phenylalanine 7.23 as 
a solid (0.34 g, 0.75 mmol, 75% yield). 1H NMR (300 MHz, d6DMSO, 298 K) δ 8.13 
(2H, d, J = 8.7 Hz), 7.93 (1H, d, J = 8.4 Hz), 7.68 (1H, s), 7.54 (2H, d, J = 8.7 Hz), 7.09 
(1H, s), 5.30 (2H, q, J = 15 Hz), 4.27 (1H, m), 3.86 (6H, s), 3.25 (1H, m), 3.01 (1H, dd, J 
= 14.1, 10.5 Hz). 
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NVOC-4-nitro-phenylalanine cyanomethyl ester 7.24:  The procedure described above 
for 7.9 was repeated using NVOC-4-nitro-phenylalanine 7.23 (0.28 g, 0.63 mmol) as the 
starting material.  The crude product was purified by flash column chromatography 
(CH2Cl2, then 5% EtOAc in CH2Cl2 once the yellow product started eluting) to afford 
NVOC-4-nitro-phenylalanine cyanomethyl ester 7.24. 1H NMR (300 MHz, d6DMSO, 
298 K) δ 8.20 (2H, d, J = 8.1 Hz), 8.12 (2H, d, J = 8.4 Hz), 7.67 (1H, s), 7.54 (2H, d, J = 
8.7 Hz), 7.08 (1H, s), 5.29 (2H, d, J = 6.0 Hz), 5.02 (2H, s), 4.51 (1H, m), 3.85 (3H, s), 
3.84 (3H, s), 3.24 (1H, dd, J = 13.8, 5.4 Hz), 3.07 (1H, dd, J = 13.8, 10.5 Hz). 
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NVOC-4-nitro-phenylalanine-dCA 7.25:  The procedure described above for 7.10 was 
repeated using NVOC-4-nitro-phenylalanine cyanomethyl ester 7.24 (0.020 g, 0.040 
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mmol, 5 eq) as the starting material, except that the reaction was stirred for 24 hours, to 
afford NVOC-4-nitro-phenylalanine 7.25.  MALDI-MS m/z calc’d for C38H43N11O22P2 
[M+H]:  1068.2; found:  1068.3. 
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4-Acetamido-phenylalanine 7.26:  N-FMOC-4-acetamido-phenylalanine (0.25 g, 0.56 
mmol) was placed in a round-bottom flask under Ar (g) and dissolved in 20% piperidine 
in DMF (10 mL).  The reaction was stirred for 30 minutes, and then the solvent was 
removed under vacuum to afford 4-acetamido-phenylalanine 7.26.  1H NMR (300 MHz, 
d6DMSO, 298 K) δ 9.87 (1H, s), 7.45 (2H, d, J = 8.4 Hz), 7.14 (2H, d, J = 8.4 Hz), 4.09 
(1H, t, J = 8.4 Hz), 3.06 (1H, dd, J = 14.6, 3.9 Hz), 2.75 (1H, dd, J = 14.4, 8.1 Hz); ESI-
MS m/z calc’d for C11H14N2O3 [M+H]:  223.1; found:  223.2. 
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NVOC-4-acetamido-phenylalanine 7.27: The procedure described above for 7.8 was 
repeated using 4-acetamido-phenylalanine 7.26 (0.080 g, 0.36 mmol, 1 eq) as the starting 
material to afford NVOC-4-acetamido-phenylalanine 7.27 (0.073 g, 0.16 mmol, 44% 
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yield). 1H NMR (300 MHz, CD3OD, 298 K) δ 7.74 (1H, s), 7.44 (2H, d, J = 8.7 Hz), 7.20 
(2H, d, J = 9.0 Hz), 5.42 (2H, m), 4.6 (2H, m), 4.4 (1H, m), 3.90 (3H, s), 3.86 (3H, s), 
3.2-2.8 (2H, m), 2.01 (3H, s); ESI-MS m/z calc’d for C21H23N3O9 [M+Na]:  484.1; found:  
484.1. 
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NVOC-4-acetamido-phenylalanine cyanomethyl ester 7.28:  The procedure described 
above for 7.9 was repeated using NVOC-4-acetamido-phenylalanine 7.27 (0.073 g, 0.16 
mmol) as the starting material.  The crude product was purified by flash column 
chromatography (CH2Cl2, then 40% EtOAc in CH2Cl2 once the yellow product started 
eluting) to afford NVOC-4-acetamido-phenylalanine cyanomethyl ester 7.28 (0.050 g, 
0.10 mmol, 63% yield).  ESI-MS m/z calc’d for C23H24N4O9 [M+Cl]:  535.6; found:  
535.1. 
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NVOC-4-acetamido-phenylalanine-dCA 7.29:  The procedure described above for 7.10 
was repeated using NVOC-4-acetamido-phenylalanine cyanomethyl ester 7.28 (0.020 g, 
0.040 mmol, 5 eq) as the starting material, except that the reaction was allowed to stir for 
24 hours, to afford NVOC-4-acetamido-phenylalanine-dCA 7.29 (0.00016 g, 0.0015 
mmol, 2% yield). MALDI-MS m/z calc’d for C40H47N11O21P2 [M+H]:  1080.2; found:  
1080.3. 
 
Nonsense Suppression In Vivo 
The site-directed mutagenesis of TAG mutants, gene construction, synthesis of 
suppressor tRNA, and ligation of aminoacyl-tRNA to tRNA have been described 
previously.46-49  Plasmid DNAs were linearized with Not1, and mRNA was transcribed 
using the T7 mMESSAGE mMACHINE kit (Ambion, Austin, TX). 
Oocytes from Xenopus laevis were isolated and maintained at 18 °C in ND96 solution 
(96 mM sodium chloride, 2 mM potassium chloride, 1.8 mM calcium chloride, 1 mM 
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magnesium chloride, 5 mM HEPES, 2.5 mM sodium pyruvate, 0.5 mM theophyline, 10 
µg/mL gentamycin at pH 7.5) according to published procedures.50  Each oocyte was 
microinjected with 50 nL of a 1:1 mixture of mRNA (0.04 ng/nL for ShB and GABAC, 
0.5 ng/nL of a 20:1:1:1 α:β:γ:δ for nAChR) and tRNA (1 µg/µL).   
NVOC-protected aminoacylated tRNA was deprotected prior to injection by irradiating 
the sample for either 5 or 10 minutes with a 1000 W Hg/Xe arc lamp (Oriel, Irvine, CA) 
operating at 400 W equipped with WG-335 and UG-11 filters (Schott, Duryea, PA).51  In 
certain cases noted in the text, hydroxylamine hydrochloride (0.029 M solution in H2O, 
0.2× volume of tRNA solution) was added to the tRNA solution prior to photolysis. 
4PO-protected aminoacylated tRNA was deprotected prior to injection by incubating the 
sample for 15 minutes in saturated I2 (aq).  This saturated I2 solution was made by adding 
an excess of I2 to H2O, then sonicating the mixture for 5 minutes, and then heating the 
mixture to 60 °C for 5 minutes. 
 
Electrophysiology 
The work in the 3,5-dimethylphenylalanine section was a collaborative effort that 
included important contributions from Dr. Christopher Ahern.  Representative methods 
for the electrophysiological studies discussed in this section that were not performed by 
the author can be found in Ahern et al.13 and Ahern et al.18 
Electrophysiological recordings on ShB were carried out 24 hours after injection.  
Whole-cell currents from oocytes were measured using an OpusXpress and pCLAMP 
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software (Axon Instruments, Foster City, CA) in the two-electrode voltage-clamp 
configuration.  Microelectrodes were filled with 3 M potassium chloride and had 
resistances ranging from 0.5 to 1.5 MΩ.  Oocytes were continuously perfused with a 
nominally calcium-free bath solution consisting of 96 mM sodium chloride, 2 mM 
potassium chloride, 1 mM magnesium chloride, and 5 mM HEPES at pH 7.5.  The 
current from ShB expressing oocytes was measured during a depolarizing jump from the 
holding potential to +70 mV.  Varying concentrations of TEA were applied, and then the 
depolarizing jump was repeated.  The amount of current blocked by TEA was taken as 
the difference between the first and the second depolarizing jump.  As noted in the text, 
some of the recordings were interrupted to bathe the oocytes in a solution of either 100 
mM sodium dithionite in 100 mM phosphate buffer pH 7.4 or 24 mM sodium dithionite 
in 50 mM phosphate buffer pH 7.4 for varying amounts of time. 
Electrophysiological recordings on GABAC were carried out 48 to 72 hours after 
injection.  Whole-cell currents from oocytes were measured as above.  Microelectrodes 
were also as above.  Oocytes were continuously perfused with a bath solution consisting 
of 96 mM sodium chloride, 2 mM potassium chloride, 1 mM magnesium chloride, 1.8 
mM calcium chloride, and 5 mM HEPES at pH 7.5.  Microscopic GABA-induced 
currents were recorded in response to bath application of GABA at a holding potential of 
−80 mV. 
Electrophysiological recordings on nAChR were carried out 48 hours after injection.  
Whole-cell currents from oocytes were measured as above.  Microelectrodes were also as 
above.  Oocytes were continuously perfused with a nominally calcium-free bath solution 
consisting of 96 mM sodium chloride, 2 mM potassium chloride, 1 mM magnesium 
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chloride, and 5 mM HEPES at pH 7.5.  Microscopic ACh-induced currents were recorded 
in response to bath application of ACh at a holding potential of −80 mV. 
 
Analyzing the Extent of NVOC Deprotection and 4-Nitro-Phenylalanine Conversion 
Di-NVOC-4-amino-phenylalanine-dCA (3 mM solution in DMSO, 3 µL) was placed in 
front of the 1000 W Hg/Xe arc lamp described above and irradiated for varying amounts 
of time.  The sample was then analyzed by reverse-phase analytical HPLC with a linear 
solvent gradient from 5% acetonitrile in 25 mM NH4OAc buffer pH 4.5 to 100% 
acetonitrile.  An unphotolyzed sample was used as the control. 
tBoc-4-nitro-phenylalanine (0.0059 g, 0.021 mmol) was dissolved in DMSO (50 µL) and 
analyzed by reverse-phase analytical HPLC with a linear solvent gradient from 5% 
acetonitrile in 25 mM NH4OAc buffer pH 4.5 to 100% acetonitrile.  To this solution was 
added sodium dithionite (100 mM in 100 mM phosphate buffer pH 7.4, 50 µL), and the 
reaction was allowed to sit for varying amounts of time before it was analyzed again by 
reverse-phase analytical HPLC with the same linear solvent gradient as above.  This 
procedure was repeated for tBoc-4-amino-phenylalanine (0.0049 g, 0.017 mmol). 
 
Nonsense Suppression In Vitro 
Translation was carried out using rabbit reticulocyte lysate translation system (Promega, 
Madison, WI) according to manufacturer’s protocol.  Lysate mix (8.75 µL), amino acid 
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mix (0.35 µL), RNAse inhibitor (0.25 µL), H2O (1.75 µL), mRNA (0.5 µL, 1 µg/µL for 
suppression experiments and 0.3 µg/µL for wild-type experiments), and either tRNA (1 
µL, 1 µg/µL) or H2O (1 µL, for mRNA-only negative control) were combined and 
incubated at 30 °C for 106 minutes.  The in vitro translation mix was then kept at −80 °C 
until further use. 
To prepare for gel loading, the in vitro translation mix (2.5 µL) was added to 4% sodium 
dodecyl sulfate (SDS) (2.5 µL) and then that mixture was added to 10% SDS (2 µL), H2O 
(7 µL), and 2× SDS loading buffer (100 mM tris chloride at pH 6.8, 4% SDS, 0.2% 
bromophenol blue, 20% glycerol) (14 µL).  Samples were loaded in 5 µL aliquots into 
prepoured 12% tris chloride gels (Bio-Rad, Hercules, CA) for SDS-polyacrylamide gel 
electrophoresis (PAGE).  Western blotting was preformed using nitrocellulose transfer, a 
mouse anti-HA primary antibody, and a goat anti-mouse secondary antibody conjugated 
to horseradish-peroxidase.  Protein was detected by chemiluminescence. 
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C h a p t e r  V I I I 
 
A NEW APPROACH TO PHOTOCHEMICAL CLEAVAGE OF PROTEIN AND 
PEPTIDE BACKBONES 
 
Nature has an array of important processes that rely on distinct protein cleavage events 
for their initiation.  Site-specific proteolysis upon the addition of an outside experimental 
stimulus would allow for the scientific exploration of these events and, more generally, of 
protein function and modular design.  o-Nitrophenylglycine (Npg) was the first example 
of an unnatural amino acid that could site-specifically cleave the protein backbone upon 
irradiation with UV light, but this amino acid was inefficient at ribosomal incorporation 
and required prolonged photolysis times for productive proteolysis.  Subsequently, other 
examples of similar compounds followed in the literature, but none of them were 
designed for use with in vivo nonsense-suppression techniques.  Herein are presented two 
α-hydroxy acids that were specifically designed to overcome the limitations of Npg.  
Through the use of model reactions, these two selenium-containing compounds were 
found to be capable of cleaving the peptide through an SN2 attack at the carbinol carbon 
that was integrated into the backbone upon the incorporation of the α-hydroxy acid.  
Unfortunately, the same success was not seen when ribosomally expressed in proteins.  
Though both were compatible with nonsense-suppression techniques, neither has yet 
been observed to cleave a full protein in in vitro or in vivo experiments. 
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Introduction 
Many proteins have a modular design, with different structural domains that work in 
unison to achieve a function or perform separate functions in complex systems.  In 
addition, many proteins are processed by cleavage into smaller fragments, revealing a 
previously protected reactive center or producing smaller signaling molecules. The 
processing of the amyloid-β protein into a neurodegenerative element,1 the partitioning of 
the hepatitis C polyprotein into its viral components,2 and the activation of caspase-3 into 
a cysteine protease that triggers apoptosis,3 are a few examples of the powerful 
consequences of nature’s ability to cleave the protein backbone at specific sites.  
Mimicking this process by inserting a photolabile group into a protein allows for 
synthetic control over proteolysis.  The function of a specific protein can be either turned 
on or turned off simply by exposing the system to UV light.   
In 1997 Dr. Pamela England, a postdoctoral researcher in the Dougherty laboratory, 
spearheaded such a strategy for photochemically initiating backbone cleavage of a 
protein, allowing dissection of a protein into its separate domains or processing a 
preprotein with temporal and spatial control.4  She synthesized and tested the unnatural 
amino acid o-nitrophenylglycine (Npg, figure 8.1), which creates an o-nitrobenzylamide 
on incorporation into a protein.  Photolysis then launches the well known o-nitrobenzyl 
“deprotection” of the amide, cutting the protein backbone.  
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Figure 8.1.  Npg and its mechanism for cleaving the peptide backbone. 
 
Npg was incorporated into both the Shaker B voltage-gated K+ channel (ShB) and the 
muscle nicotinic acetylcholine receptor (nAChR), two channels introduced earlier in this 
thesis, by in vivo nonsense suppression in Xenopus oocytes.4  Photolysis produced site-
specific, nitrobenzyl-induced photochemical proteolysis (SNIPP).  In ShB England 
incorporated Npg into two sites, Leu47 and Pro64, both of which are located in the 
“chain” that connects the channel blocking “ball” to the six transmembrane helices 
(figure 8.2).  These two sites have been previously discussed in chapter 6 of this thesis.  
Irradiation and proteolysis destroys a link in the chain connecting the “ball” and the 
channel.  Without the covalent attachment of the “ball,” the potential for N-terminal 
inactivation is eliminated.  
Npg was also incorporated into two sites in the nAChR:  α1Val132 and β1Leu262 (figure 
8.3).4  α1Val132 is located in the extracellular domain of the channel in the Cys-loop.  
This site was chosen since proteolysis was expected to result in a loss of the integrity of 
this structurally and functionally important loop, thus inhibiting channel function.  
β1Leu262 is the famous 9’ residue in the β1 subunit, and it is found in the 
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transmembrane region of the channel.  This residue is part of a hydrophobic band of 
residues that forms the narrowest point in the pore of the channel.  A conformational 
change in the protein induced by the binding of ACh widens this band of leucines enough 
to allow ions to diffuse through the channel pore.  Disruption of the protein at this site 
was expected to hinder this gating process.  As expected, incorporation of Npg at both 
sites showed a reduction in channel activity after irradiation.   
 
Figure 8.2.  Incorporation of Npg into ShB.  Figure adapted from England et al.4 
 
Figure 8.3.  Incorporation of Npg into the α1 subunit of the nAChR.  Figure adapted from England et al.4 
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Together these data demonstrate that Npg can produce SNIPP regardless of whether it is 
in an intracellular site, an extracellular site, or the transmembrane region.  Although 
successful in demonstrating the essential SNIPP concept, Npg was not an ideal reagent.  
Its incorporation into proteins by nonsense suppression was often inefficient, perhaps 
because of the steric crowding associated with an ortho-substituted phenylglycine 
derivative.  At α1Val132 three separate injections of Npg-tRNA into each oocyte were 
necessary for efficient in vivo nonsense suppression.  In addition, while o-nitrobenzyl 
“caged” side chains of Tyr and Cys have been efficiently photocleaved in Xenopus 
oocytes,5-8 photochemical decaging of proteins containing Npg can require prolonged 
photolysis times.  England found 4 to 7.5 hours of irradiation necessary for the functional 
effects of proteolysis via Npg to be evident.  More recently, however, Endo et al. did 
achieve efficient photolysis of Npg when incorporated into the soluble protein caspase-3.9  
In their in vitro experiment, proteolysis released a functional enzyme after only one 
minute of irradiation. 
Other strategies for photochemical cleavage of protein and peptide backbones have 
recently appeared.  Bosques and Imperiali10 and Kron and co-workers11 have employed 
o-nitro-β-phenylalanine as a linker between two protein or peptide fragments (figure 
8.4A), while Pellois and Muir12 have employed a highly expanded nitrobenzyl linker that 
can both ligate to the C-terminus of a recombinant protein and photorelease upon 
irradiation (figure 8.4B).  Otaka and co-workers introduced a novel system based on a 
nitrobenzyl-caged phenol and the “trimethyl lock” motif, in which intramolecular 
cleavage of the backbone amide occurs through attack by the phenol once it has been 
decaged (figure 8.4C).13  While these newer approaches are attractive, they would not 
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likely be compatible with in vivo protein expression, as β-amino acids and highly 
crowded systems such as the trimethyl lock are not compatible with nonsense-
suppression and other approaches to incorporating unnatural amino acids into proteins 
expressed in cells. 
 
Figure 8.4.  Other strategies for the photochemical cleavage of peptides and proteins.  The bonds that break 
are highlighted in blue.  A)  o-Nitro-β-phenylalanine.10,11  B)  The core of the ligation and photorelease 
molecule.12  C)  The o-nitrobenzyl-caged phenol with its trimethyl lock motif.13  Note here that two bonds 
break, the first is the nitrobenzyl-phenol bond, and the second is in the backbone through the attack of the 
carbonyl by the decaged phenol. 
 
A Novel Direction for SNIPP 
In this chapter the design and synthesis of two new residues that can induce backbone 
cleavage by an unprecedented reaction mechanism are described (figure 8.5).  This novel 
approach to SNIPP has the potential to be superior to Npg while still being compatible 
with in vivo protein expression by nonsense suppression.  First, selenide anions are 
among the strongest of known nucleophiles.  Since selenols have pKa values on the order 
of 5-6,14 the selenide anion should be the dominant moiety at physiological pH.  
Selenium should be well tolerated in nonsense suppression, as both selenocysteine and 
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selenomethionine are known to be incorporated into proteins.  In fact selenocysteine is 
frequently referred to as the 21st amino acid because it has its own tRNA that 
contranslationally inserts it at certain UGA opal stop codons.15  
 
Figure 8.5.  The two novel SNIPP-capable compounds described in this chapter and their predicted 
mechanism of proteolysis. 
 
Second, α-hydroxy acids (instead of α-amino acids) are quite compatible with ribosomal 
protein synthesis,16-20 as well as standard solid-phase protocols for peptide synthesis.21,22  
Incorporation of an α-hydroxy acid produces a backbone ester bond, and selenides can 
“hydrolyze” esters (but not amides) by an SN2-type mechanism—the softness of the 
selenide favors attack of the soft carbinol carbon over the hard carbonyl carbon.23  While 
this is typically efficient only with methyl esters, the anticipation is that the 
intramolecularity of the reaction proposed here will compensate for the fact that the 
reaction is occurring at a tertiary center.  In addition, the inductive effect of the adjacent 
carbonyl could accelerate the SN2 reaction.  
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We also anticipate that the new system could overcome the limitations of Npg.  First, the 
steric congestion associated with Npg, which appears to limit its efficiency in ribosomal 
protein incorporation, has been decreased.  Second, decaging of an unencumbered 
selenide should be more efficient than “deprotection” of a backbone amide, based on both 
steric factors and the much lower pKa of a selenol versus an amide. 
The final design issue is the nature of X in figure 8.5.  Formation of a five-membered 
ring is generally most favorable in such systems, and our initial design employed a 
simple aliphatic chain, X = –CH2CH2CH2–, making the target α-hydroxy acid compound 
8.1.  We subsequently considered a second design, 8.2, in which an aromatic ring was 
incorporated into X.  Both strategies have advantages.  Compound 8.1 contains an 
aliphatic selenide, which is anticipated to be a stronger nucleophile than the aromatic 
selenide of 8.2.24  On the other hand, compound 8.2 more closely resembles the phenyl 
selenide anion typically used in the SN2 cleavage of esters, and fewer rotatable bonds 
have to be restricted to form the SN2 transition state for 8.2.  In addition, the arylalkyl 
selenide of 8.2 is likely more stable to oxidative degradation since its lack of δ-hydrogen 
atoms prevents the possibility of syn elimination of any selenoxide that forms.  However, 
the increased steric size of 8.2 could be a problem for ribosomal incorporation into 
proteins.  
The design and predicted mechanism of these two compounds represents novel 
chemistry, and therefore, before applying it to a biological system, we felt it was essential 
to establish that the chemistry does indeed proceed as predicted, including isolation and 
full characterization of the novel selenacyclopentane fragmentation product.  The 
simplest relevant synthetic targets were depsipeptides containing 8.1 and 8.2.  With these 
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in hand, photolysis conditions were optimized, and the novel selenacyclopentane 
fragmentation products were successfully isolated, proving that indeed, proteolysis was 
possible through the proposed mechanism for each novel compound.  Unfortunately, 
though the chemistry was shown to work, photolysis-induced proteolysis was never seen 
in a full protein in either in vitro or in vivo experiments. 
 
Results and Discussion  
Synthesis of Alkyl Selenide α-Hydroxy Acid 8.1 
A former graduate student in the Dougherty laboratory, Dr. Niki Zacharias, completed 
the first synthesis of alkyl selenide α-hydroxy acid 8.1.  The molecule was made 
racemically via the procedure shown in scheme 8.1.  First, δ-valerlactone was 
hydroxylated following the procedure of Best et al.25  Opening of the lactone26,27 with 
30% hydrogen bromide in acetic acid followed by treatment with ethanol resulted in the 
basic frame of the α-hydroxy acid protected as the ethyl ester.  The bromine was 
exchanged for selenium from reaction with disodium diselenide.28  Reduction of the 
diselenide, addition of o-nitrobenzylbromide,29,30 and treatment with base produced the 
final product, racemic 8.1.  A large amount of work went into the development of the 
synthesis; a full description of which is in Zachrias’s thesis.31 
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Scheme 8.1.  The first synthesis of racemic alkyl selenide α-hydroxy acid 8.1. 
 
The major limitation of this scheme was that it resulted in racemic 8.1.  Since the initial 
goal was to synthesize a depsipeptide containing 8.1 that could be used to test the 
proteolytic capabilities of the α-hydroxy acid, having enantiopure 8.1 would allow for a 
single diastereomeric depsipeptide instead of the mixture of diastereomers that would be 
produced from racemic 8.1.  After the completion of the racemic synthesis, Zacharias 
discovered a publication by Guindon et al. that described the opening of a furan ring with 
dimethylboron bromide.32  This reaction framed the retrosynthetic design of the pathway 
to enantiopure 8.1 (figure 8.6). 
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Figure 8.6.  Retrosynthesis for enantiopure alkyl selenide α-hydroxy acid 8.1. 
 
A small but important feature of this new synthetic plan was the nature of the group that 
masked the acid during the central steps of the synthesis.  tert-Butyl esters are commonly 
used during both solution- and solid-phase peptide synthesis to mask acids.  Thus, this 
moiety was chosen since it would allow the esterified 8.1 to be taken directly into the first 
peptide coupling reaction.  While the tert-butyl esterification of S-(−)-tetrahydro-2-furoic 
acid was successful, the subsequent reaction with dimethylboron bromide32 converted the 
tert-butyl ester 8.3 back to the original acid. 
 
Scheme 8.2.  The acid-labile tert-butyl ester was not compatible with the conditions for furan ring opening. 
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There was literature precedent for successful ring opening of the racemic ethyl ester 
version of 8.3 by dimethylboron bromide.32  Therefore, S-(−)-tetrahydro-2-furoic acid 
was converted to the ethyl ester (scheme 8.3).33  As per the precedent in the literature, 
ring opening with dimethylboron bromide was now successful.32  Conversion to the 
diselenide from the in situ formation of the reactive disodium diselenide31 and ester 
hydrolysis then produced 8.7.34  This acid diselenide was directly reduced with sodium 
borohydride and the product alkylated with o-nitrobenzyl bromide to give the target 
compound 8.1.29 
 
Scheme 8.3.  Successful synthesis of enantiopure alkyl selenide α-hydroxy acid 8.1. 
 
Though this synthesis greatly benefited from Zacharias’s previous synthesis, each step 
shown in scheme 8.3 was evaluated and optimized.  Most notably, it was found that if the 
ethyl ester was acidified prior to being reduced and alkylated by o-nitrobenzylbromide, 
then the combined yield for the two steps could be improved from 45% (scheme 8.1) to 
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82% (scheme 8.3).  The yield probably also benefited from the care that was taken of the 
compounds after the addition of the selenium.  Compounds 8.6, 8.7, and 8.1 readily 
decomposed under mildly oxidative conditions.  The instability of the compounds was 
believed to be due to the presence of the δ-hydrogen atoms that enabled syn elimination 
of any selenides that had been oxidized to the selenoxide. 
 
Design of the Depsipeptide Model System 
A depsipeptide was envisioned as the simplest model system to test the proteolytic 
capability of 8.1 (figure 8.7).  By using a small peptide instead of a larger protein, the 
isolation and charaterization of the major photolysis product could be carried out by 
traditional organic synthetic methods.  The design of the depsipeptide was first discussed 
in Zacharias’s thesis.31  Phenylalanine was chosen to be the N-terminal amino acid in 
order to add hydrophobicity to the depsipeptide.  The novel 8.1 was the central piece so 
that any cleavage that occurs through the proposed mechanism will essentially split the 
backbone in half.  Glutamate was chosen to be the C-terminal amino acid since it could 
add even more hydrophobicity to the depsipeptide if each of its acids are masked as esters 
or it could make a hydrophilic depsipeptide if each of its acids were left as acids.  This 
feature of the design created the ability for the model studies to be carried out in both 
organic and aqueous solvents.   
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Figure 8.7.  Design of the depsipeptide model system. 
 
Synthesis of Depsipeptides Containing Alkyl Selenide α-Hydroxy Acid 8.1 
In a typical peptide coupling reaction, the desired N-terminal amino acid is protected as 
an amide, and the desired C-terminal amino acid is protected as an ester.  This strategy 
insures that the carboxylic acid of the former will react with the free amine of the latter to 
form the desired amide bond.  Since 8.1 was envisioned as the central of three amino 
acids in the depsipeptide, either end could be protected in the initial peptide coupling 
reaction.  Previously, Zacharias had protected the acid of racemic 8.1 as a tert-butyl ester 
using N,N-dimethylformamide di-tert-butyl acetal in refluxing toluene,35 but she found 
the selenium elimination product, 2-hydroxy-pent-4-enoic acid tert-butyl ester, to be a 
major product of the reaction.31   
To reduce the production of the unwanted elimination product, a new protection strategy 
was sought.  After planning various methods for protecting either the acid or the alcohol 
of 8.1, we realized that we could simply take advantage of the difference in reactivity of 
an alcohol and a primary amine for a carboxylic acid, capitalizing on 8.1 being an α-
hydroxy acid, not an α-amino acid.  Since a primary amine reacts much more readily with 
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a carboxylic acid and forms a stable amide bond, the alcohol is already “protected” in the 
reaction. 
With this strategy in hand, the first peptide coupling reaction was set up between 8.1 and 
di-tert-butyl glutamate (scheme 8.4). Several different reaction conditions were tried in 
order to maximize the yield of dipeptide 8.8.36,37  In all cases the yields were low, but the 
combination of benzotriazol-1-yl-oxytripyrrolidinophosphonium hexafluorophosphate 
(PyBop) and N-methylmorpholine was found to be the best available. 
 
Scheme 8.4.  Three sets of reagents were used to make dipeptide 8.8. 
 
Three different model depsipeptides were made by varying the aromatic N-terminal 
amino acid (scheme 8.5).  Depsipeptides 8.9 and 8.11 differed only in the nature of the N-
terminal amide.  Depsipeptide 8.10 varied from the original design by the addition of 
tryptophan to the N-terminus.  Tryptophan was chosen for its hydrophobicity and for its 
 
270 
variety.  Because the central and C-terminal residues are the same, these three different 
depsipeptides will produce the same selenacyclopentane product upon photolysis and 
proteolysis.  While it was anticipated that the α-hydroxy acid might be difficult to couple, 
the only change required from a traditional coupling reaction was the lengthening of the 
reaction time—each reaction was allowed to stir at room temperature for one to two days 
before the reaction was quenched. 
 
Scheme 8.5.  The second peptide coupling reaction in the synthesis of three different depsipeptide model 
systems. 
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Initial Photolysis Studies on Depsipeptides 8.9 and 8.10 
Prior to these studies Zacharias had run a single photolysis reaction on 8.1 in a 
dipeptide.31  Because of the low yield she obtained in the formation of racemic 8.1 tert-
butyl ester, she only had enough material to make the dipeptide, N-acetyl-phenylalanine-
8.1-tert-butyl ester.  She irradiated this dipeptide in deuterated acetonitrile that had been 
purged with argon and followed the progress of the reaction by nuclear magnetic 
resonance (NMR) spectrometry.38  The photolysis products were purified by preparatory 
thin-layer chromatography (TLC), and gas chromatography mass spectrometry (GC-MS) 
suggested that the product with an Rf of 0.77 (50% ethyl acetate in hexanes) contained 
the selenide cleavage product.  To get firmer evidence that 8.1 could cleave the peptide 
backbone through the predicted mechanism, the photolysis products of the newly 
synthesized depsipeptides, 8.9, 8.10, and 8.11, were pursued.  
The initial photolysis studies consisted of a 0.1 µM solution of depsipeptide in dry 
acetonitrile, and typically, 50 µL samples were exposed to 320 nm light from a 1000 W 
Hg/Xe arc lamp for five minutes.  Tetrahydrofuran, another common solvent compatible 
with photolysis studies, could not be used since the depsipeptides quickly decomposed 
while in this solvent.  Reactions were followed by electrospray ionization (ESI)-MS.  
NMR spectroscopy, TLC, and high-pressure liquid chromatography (HPLC) were 
difficult to use with such small-scale reactions and were therefore not performed in 
parallel to follow the reactions.  In ESI-MS the analyte (M) being measured exists as an 
ion in solution, typically as [M+H], [M+Na], [M+K], or [M−H].  Therefore, ESI-MS can 
both interpret the small quantities of material and also identify the selenium-containing 
mass-to-charge (m/z) ratios because of the characteristic selenium isotope pattern.  
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Unfortunately, ESI-MS is not quantitative, and the structures of products have to be 
inferred from likely candidate structures. 
Disappointingly, the desired selenacyclopentane was not seen by ESI-MS after photolysis 
of depsipeptide 8.9.  Instead, the major product m/z ratio was 1292.7, which by its ratio 
and isotope pattern agreed with the compound that would be formed upon o-nitrobenzyl 
deprotection and diselenide formation ([M+K] m/z = 1293.5) (figure 8.8A).  Although the 
formation of the diselenide prevents the possibility for cleavage to occur, its appearance 
suggested that the o-nitrobenzyl group was rapidly and efficiently decaging, one of the 
predicted advantages of 8.1 over Npg.  Formation of a diselenide is an oxidative process, 
which suggests that the photolysis reaction is taking place in an oxidative environment.  
Several other m/z ratios present in the ESI-MS also reinforced this assumption.  First, the 
m/z ratio with a selenium-isotope pattern nearest to the predicted mass for the decaged 
selenol ([M+K] m/z = 667.2) was 698.7, a ratio that could be explained by the oxidation 
of the selenol to selenic acid ([M+K] m/z = 699.3).  Second, another set of m/z ratios was 
seen at 568.8, 584.8, and 600.8.  These ratios, which did not contain the selenium isotope 
pattern, were suggestive of a depsipeptide that contained dehydronorvaline ([M+Na] m/z 
= 569.3, [M+K] m/z = 585.4) and the equivalent epoxide ([M+Na] m/z = 585.3, [M+K] 
m/z = 601.4) as its central component.  These unwanted side products could be produced 
from the syn elimination of the selenoxide formed under oxidative conditions (figure 
8.8B).39  All products seen for depsipeptide 8.9 were similarly reproduced with 
depsipeptide 8.10, giving more credit to the assigned identities. 
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Figure 8.8.  ESI-MS suggests oxidative products are formed upon irradiation of the depsipeptides in 
acetonitrile.  A)  Predicted products from the initial photolysis reaction of 8.9.  Similar products were 
predicted for 8.10.  B) Predicted oxidation and syn elimination of the selenoxide-containing depsipeptide 
8.9.  8.10 is expected to produce the same oxidation products. 
 
Oxidation Studies on Depsipeptides 8.9 and 8.10 
To confirm that the oxidative products predicted from the ESI-MS above would in fact be 
formed if depsipeptides 8.9 and 8.10 were exposed to an oxidative environment, these 
depsipeptides were subjected to a solution of the oxidant hydrogen peroxide.  Solutions 
of 0.1 µM 8.9 or 8.10 in acetonitrile were combined with twice the volume of 30% 
hydrogen peroxide.  After an hour of exposure to the oxidative hydrogen peroxide 
solution, ESI-MS of depsipeptide 8.9 showed m/z ratios of 546.9, 568.8, 698.8, 779.8, 
and 817.7, which corresponded to the dehydronorvaline containing depsipeptide ([M+H] 
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m/z = 547.3, [M+Na] m/z = 569.3), the selenic acid ([M+K] m/z = 699.3), and the 
selenoxide ([M+H] m/z = 780.3, [M+K] m/z = 818.4) (figure 8.9).  The presence of the 
same m/z ratios in this experiment as in the photolysis reactions above reaffirms that the 
products in the photolysis reaction were being created by oxidation.  The lack of m/z 
ratios for the diselenide and the presence of the selenoxide were expected since no means 
was provided for o-nitrobenzyl decaging. The same reaction conditions were repeated 
with water replacing the oxidant for a negative control.  The addition of water did not 
have an effect on the depsipeptide as studied by ESI-MS.  Depsipeptide 8.10 showed 
similar predicted products via ESI-MS after one hour of exposure to the hydrogen 
peroxide solution, but each had an increase of +16 over the predicted m/z ratio.  This 
increase was accredited to the concurrent oxidation of the tryptophan to 
oxindolylalanine.40 
 
Figure 8.9.  Predicted oxidative products from the reaction of 8.9 with hydrogen peroxide.  The oxidation 
of depsipeptide 8.10 showed similar predicted products, but with the tryptophan oxidized to 
oxindolylalanine. 
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Photolysis of Depsipeptides 8.9 and 8.10 in a Reducing Environment 
Creating a reducing environment in the photolysis reaction was expected to minimize the 
unwanted oxidative side products.  Dithiothreitol (DTT) is a commonly used reducing 
agent, and a study by Besse et al. found that 44 equivalents of DTT could reduce 50% of 
the diselenide bonds in their model depsipeptide system.41  Following this example, 50 
equivalents of DTT were added to the depsipeptide/acetonitrile mixture prior to 
photolysis.  After photolysis in this reducing environment, the dehydronorvaline-
containing depsipeptide was not seen or was seen in low abundance via ESI-MS.  The 
diselenide was seen in much lower abundance as well.  Therefore, irradiation in a 
reducing environment was successful at decreasing the oxidative side products.  
Unfortunately, the expected m/z ratio for the selenacyclopentane product was still not 
seen in the ESI-MS.  Instead, the new major product in the ESI-MS after irradiating 8.9 
was at an m/z ratio of 650.8, which corresponds to the decaged selenol product ([M+Na] 
m/z = 651.2).  Therefore, in this reducing, organic environment, the favored state of the 
alkyl selenium was the selenol, not the selenide anion expected to attack the carbinol 
carbon of the backbone.  The same was true for the photolysis of 8.10.   
Since the selenide anion was the nucleophile expected to induce cleavage of the 
depsipeptide backbone, conditions were desired that would encourage anion formation 
over selenol formation.  The pKa of decaged 8.1 was not determined in this study, but it 
is expected to be similar to that of selenocysteine, which has a pKa of 5.73,14 since they 
are both aliphatic selenols.  Thus, 8.1 should be anionic at physiological pH.  To test the 
effects of pH on the photolysis reaction, depsipeptides 8.9 and 8.10 were photolyzed in a 
solution of equal volumes of acetonitrile and pH 7 water in the presence of 50 equivalents 
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of DTT, but ESI-MS of the postphotolysis solution suggested only selenol was formed.  
Raising the pH to 8, 9, or 10 was also unsuccessful at eliciting the cleavage reaction.  
Increasing the relative amount of pH 10 water was also unsuccessful at inducing 
proteolysis.  Finally, addition of the organic base triethylamine also did not encourage 
any selenacyclopentane product formation as visualized by ESI-MS. 
Contrary to the results seen if water with high pH was added to the reaction prior to 
photolysis, if water with a pH of 8 or 9 was added after irradiation, a low-abundance m/z 
ratio with the selenium isotope pattern was seen at 443.9 in the ESI-MS, agreeing with 
the expected mass of the selencyclopentane ([M+Na] m/z = 444.1) (figure 8.10).  
Encouragingly, both MS/MS and MS/MS/MS on 443.9 caused the loss of the mass of a 
tert-butyl group (m/z Δ = 56.1), and the 443.9 m/z ratio was seen in the ESI-MS when the 
same conditions were repeated on 8.10.  These results were viewed as the first successful 
peptide cleavage induced by 8.1 in a depsipeptide.  It was surprising that successful 
cleavage required a much higher pH than expected and only when the pH was rasied after 
irradiation.   It was also disappointing that the low abundance of the m/z ratio in the ESI-
MS implied that the cleavage reaction was inefficient under these conditions.  
 
Figure 8.10.  Representation of the first successful peptide cleavage reaction with 8.9.  Only relevant 
products are shown.  Depsipeptide 8.10 showed the same pattern. 
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Photolysis Studies in a Reducing, Aqueous Environment 
The small-scale photolysis reactions thus far suggested that the deprotonation of the 
selenol encouraged proteolysis in the manner predicted by the design, but there were 
many facets to the formation of the selenide anion and subsequent proteolysis reaction.  
Importantly, the addition of base only encouraged cleavage of the peptide backbone once 
the selenol had already been decaged.  To probe whether the partially organic 
environment was hindering the cleavage reaction, a hydrophilic depsipeptide was desired 
so that the photolysis could be run in an entirely aqueous environment.  Thus, a mixture 
of trifluoroacetic acid in methylene chloride was used to remove the acid-sensitive 
protecting groups from the depsipeptides 8.9 and 8.10 (scheme 8.6). 
 
Scheme 8.6.  Removal of the acid-sensitive protecting groups reveals hydrophilic depsipeptides. 
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When 8.12 was photolyzed in the presence of 50 equivalents of DTT in double-distilled 
water, the ESI-MS postphotolysis contained an m/z ratio at 308.0, which corresponded to 
the desired selenacyclopentane ([M−H] m/z = 308.0) (figure 8.11).  The m/z ratio for the 
selenol, 514.9 ([M−H] m/z = 515.1), was also present.  Since the pH of the double-
distilled water is near the pKa of the selenol, it was hoped that raising the pH to a more 
physiologically relevant value would shift the equilibrium towards the selenide anion 
and, therefore, a higher abundance of the selenacyclopentane m/z ratio would be seen via 
ESI-MS.  But, the same products were seen if water pH 7, water pH 7.6, or phosphate 
buffer pH 7 was used.  Thus, there was a higher propensity for cleavage in this aqueous 
environment, but there was still something allowing selenol formation.   
 
Figure 8.11.  An aqueous environment was capable of producing some amount of the desired cleavage 
product.  Only relevant products shown. 
 
Exploring the Effects of DTT on the Cleavage Reaction 
DTT reduces diselenides by first forming a sulfur-selenium bond.  To probe the 
possibility that DTT was enhancing selenol formation through this mechanism of 
reduction, triscarboxyethylphosphine (TCEP) was substituted into the photolysis reaction 
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as the reducing agent.  TCEP is a highly potent reducer of diselenides.  By reducing 
diselenides through a mechanism involving its phosphine with the aid of water, TCEP 
allows for a nonthiol-based reduction mechanism to be tested in the photolysis and 
cleavage reaction.  TCEP could also be purchased immobilized on agarose, which 
allowed for easy removal after irradiation.  After depsipeptides 8.12 and 8.13 were 
irradiated in an aqueous environment with excess TCEP, ESI-MS still showed that the 
same two major products in this reaction were produced with TCEP as with DTT:  
selenacyclopentane and selenol.  Therefore, specific attributes of DTT were not 
increasing the probability of selenol formation.  
 
Using N-Methyl Maleimide to Test for Selenol Formation 
After irradiation of 8.12 in water with either DTT or TCEP, an m/z ratio of 514.9 in the 
product ESI-MS had always been assigned as the selenol (figure 8.11).  The same 
conclusions were made in the ESI-MS after the photolysis of 8.9, 8.10, and 8.13 as well.  
But, if the decaged selenide anion attacked the ester carbonyl instead of the carbinol 
carbon, a selenoester would be produced (figure 8.12).  The simple rearrangement of 
atoms means the selenoester has the same mass as the selenol, 516.1 g/mol.  The attack of 
the ester carbonyl requires a seven-member ring transition state, a much less likely 
occurrence than the five-member ring formed if the desired carbinol carbon were attacked 
to form the selenacyclopentane, but since both the selenol and the selenoester would give 
identical m/z ratios, neither can be excluded by the original ESI-MS data.  
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The addition of N-methyl maleimide to the reaction mixture after photolysis would 
discriminate between the two products since the maleimide can react with the selenol but 
not the selenoester.  Thus, after depsipeptides 8.9 and 8.10 were photolyzed in 
acetonitrile and after depsipeptide 8.12 was photolyzed in water, all with 50 equivalents 
of DTT, N-methyl maleimide was added to each reaction.  In the ESI-MS of the resulting 
solution of all three depsipeptides, an m/z ratio corresponding to the covalent addition of 
the N-methyl maleimide to the selenol was seen.  This result confirmed that the selenol 
was appropriately assigned in all of the previous ESI-MS data and gave further evidence 
that the selenium was not as efficient as desired at the intramolecular cleavage reaction. 
 
Figure 8.12.  The possible products formed by the decaged selenide that have a mass of 516.1.  To prove 
that the selenol was formed, it was trapped with N-methyl maleimide.  Similar products were seen with 
depsipeptides 8.9 and 8.10.  Only the relevant products in each reaction are shown. 
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Redesign of the Photoreactive α-Hydroxy Acid 
After irradiation of the depsipeptides, the repeated appearances of the m/z ratio that 
corresponded to the selenacyclopentane product in the ESI-MS were highly suggestive 
that 8.1 was indeed capable of cleaving the peptide backbone through the proposed 
mechanism.  Unfortunately, a clean ESI-MS of only the cleavage product was never 
obtained, despite the many attempts to alter the nature and pH of the photolysis 
environment.  We concluded that 8.1 was inefficient at SNIPP.  Efficient SNIPP is 
necessary in an in vivo experiment to trust that a phenotypic response seen after 
irradiation is an effect of the experimentally controlled proteolysis.  Ideally, all of the 
desired protein would be cleaved upon photolysis since results from a heterogeneous 
protein population could be skewed by the unknown percentage of protein that remained 
full and intact.  Thus, a more efficient analog of 8.1 was desired. 
We combined literature precedent with the knowledge gained through the previous 
photolysis experiments in the design of arylalkyl selenide α-hydroxy acid 8.2 (figure 
8.3).  Much of the inspiration for 8.2 came from the phenyl selenide anion used to cleave 
esters and lactones through the SN2 attack of the carbinol carbon.23,42,43  The decaged aryl 
selenide anion may be a less potent nucleophile than the decaged alkyl selenide anion in 
8.1 due to its delocalization of the negative charge, but literature precedent suggests that 
an aryl selenide anion should be potent enough to initiate attack of the carbinol carbon.  
Also, fewer rotatable bonds in 8.2 have to be restricted to form the transition state during 
the cleavage reaction, which should lower the reaction barrier necessary to form the ring-
closed product.  The final important element in the design of 8.2 was the removal of the 
δ-hydrogen atoms that caused the syn elimination of the selenoxide.  This change should 
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make 8.2 more stable than 8.1 to oxidative damage.  The combination of these design 
elements are anticipated to make 8.2 a superior photoreactive α-hydroxy acid capable of 
site-specifically cleaving the protein backbone. 
 
Attempts to Synthesize Arylalkyl Selenide α-Hydroxy Acid 8.2 
The initial strategy for the synthesis of 8.2 involved either a Grignard reaction or a 
lithium-halogen exchange reaction for the addition of selenium to the aromatic ring 
(scheme 8.7).  First, ο-bromophenylalanine was converted to an α-hydroxy acid,44 which 
was then protected on the acid as an oxazoline45 and on the alcohol as a large, bulky silyl 
ether46 to make 8.16.  Oxazoline and tert-butyldiphenyl silyl ether are protecting groups 
that are typically stable under Grignard and lithium-halogen exchange reactions.47  Also, 
tert-butyldiphenylsilyl ether is supposed to be stable to acid and have a low propensity to 
migrate.  Unfortunately, neither the Grignard reaction nor the lithium-halogen exchange 
reaction was capable for forming the aryl selenide. 
 
Scheme 8.7.  An unsuccessful route for the synthesis of 8.2. 
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Successful Synthesis of Arylalkyl Selenide α-Hydroxy Acid 8.2 
Another graduate student in the Dougherty laboratory, Angela Blum, succeeded in 
synthesizing arylalkyl selenide α-hydroxy acid 8.2.  The successful synthesis of 8.2 
(scheme 8.8) began with a reduction of 2-nitrophenylpyruvic acid by (+)-B-
chlorodiisopinocampheylborane (“Ipc2BCl”) as reported by Wang et al. to yield the α-
hydroxy acid in high-enantiomeric excess (94%).48  The selenocyanate was prepared by a 
modification of the standard sequence, and the nitrobenzyl group was introduced by 
reductive alkylation.  The bulky tert-butyl protecting groups were installed to discourage 
intramolecular cyclization seen during direct reduction of the nitro group of the o-nitro-
phenylalanine α-hydroxy acid and to improve the solubility and ease of purification of 
subsequent compounds in the sequence. 
 
Scheme 8.8.  Successful synthesis of arylalkyl selenide α-hydroxy acid 8.2. 
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Using the reagents precedented in the depsipeptide syntheses described above, Blum 
incorporated 8.2 into a depsipeptide that was similar to depsipeptide 8.10 (scheme 8.9). 
 
Scheme 8.9.  Synthesis of depsipeptide 8.17. 
 
Initial Photolysis Studies on Depsipeptide 8.17 
The conditions optimized for depsipeptides 8.9 and 8.10 were initially used in the 
photolysis of depsipeptide 8.17.  It was subsequently determined that a reduction to 10 
equivalents of DTT was enough to minimize the oxidative side products in the photolysis 
of 8.17.  The requirement for severalfold less DTT confirmed one of the key design 
elements that was supposed to make 8.2 and improvement over 8.1—that of increased 
stability to oxidative damage.  
While running small-scale photolysis studies on depsipeptide 8.17, Blum discovered that 
heating the reaction mixture after irradiation greatly improved the efficiency of the 
cleavage reaction. Heat was found to also improve the ability of 8.1 to cleave 
depsipeptides 8.9 and 8.11 (depsipeptides 8.10, 8.12, and 8.13 were not tested).  Heating 
to 70 ºC for one hour maximized the abundance of the m/z ratio corresponding to the 
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selenacyclopentane in the ESI-MS.  While heat, especially at this high of temperature, is 
not ideal for in vivo studies in Xenopus laevis oocytes, it allowed for the scaling up of the 
photolysis reaction to a preparatory scale, which was necessary to isolate and characterize 
the selenacyclopentane products. 
 
Isolation and Characterization of the Selenacyclopentane Cleavage Products 
Preparative-scale photolysis reactions were performed using a Hg-vapor UV immersion 
lamp with a pyrex filter (>300 nm).  The reactions were again followed by ESI-MS. 
Depsipeptide 8.11 was irradiated in an equal volume mixture of acetonitrile and pH 7.6 
20 mM phosphate buffer with 100 equivalents of DTT (scheme 8.10).  After irradiation 
but before heating, the major m/z ratio seen in the ESI-MS was 709.1, the selenol 
([M+Na] m/z = 709.3), but 444.0, 627.2, and 1391.2, the selenacyclopentane 8.18 
([M+Na] m/z = 444.1), dehydronorvaline ([M+Na] m/z = 627.3), and diselenide ([M+Na] 
m/z = 1393.5), were also seen.  The subsequent heating of 8.11 went smoothly and the 
final ESI-MS showed m/z ratios of 444.0, 627.2, and 862.9, corresponding to the 
selenacyclopentane 8.18 ([M+Na] m/z = 444.1), dehydronorvaline ([M+Na] m/z = 627.3), 
and noncovalent dimer of the selenacyclopentane ([2M+Na] m/z = 865.3), respectively.  
The reaction was considered complete since the abundances of the m/z ratios for the 
selenol and diselenide, the two products that could be driven to SN2 cleave the peptide 
backbone, were baseline.  The three m/z ratios reported above were of similar high 
abundances in the ESI-MS after heating, although after irradiation and prior to heating 
the abundance of the m/z ratio for the dehydronorvaline had been low.  ESI-MS is not 
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quantitative, but the shift in the abundance of the dehydronorvaline from low to high 
suggested that either the elimination reaction continued to occur during heating or the 
quantities of all of the final products were much reduced after heating.  Either situation 
would predict a decrease in the absolute quantity of the desired selenacyclopentane 
product present.  Purification of selenacyclopentane 8.18 was difficult due to the large 
amount of DTT present in the reaction.  After two successive purifications using flash 
column chromatography, pure 8.18 was obtained in 29% yield.  
Initially, irradiation of 8.17 was performed using the same immersion lamp and filter as 
was used for depsipeptide 8.11.  The reaction took place in a solution of equal volumes of 
acetonitrile and pH 8 water with 10 equivalents of DTT.  A surprising side product that 
formed after photolysis was the depsipeptide in which the original nitrobenzylselenyl α-
hydroxy acid had been replaced by its phenylalanine analog.  While this work was in 
progress, however, Kitahara and co-workers reported that short wavelength photolysis of 
arylalkyl selenides can lead to carbon-selenium bond cleavage.49  As suggested by that 
study, changing the photolysis wavelength from >280 nm to >330 nm (uranium filter) 
eliminated this side reaction. When reaction conditions were fully optimized for the 
photolysis reaction of depsipeptide 8.17, a 72% yield was obtained of the aryl 
selenacyclopentane 8.19 without the need for the additional heating step (scheme 8.11).  
The greater stability to oxidative damage, higher yield of cleavage product, and ability to 
efficiently cleave without heat proved that the addition of the aryl group in 8.2 created an 
improved α-hydroxy acid capable of SNIPP. 
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Scheme 8.10.  The progress of the large-scale photolysis and heating reaction on depsipeptide 8.11 as 
followed by ESI-MS.  Selenacyclopentane 8.18 was isolated in 29% yield.  Only relevant products are 
shown. 
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Scheme 8.11. The large-scale photolysis and heating reaction on depsipeptide 8.17.  Aryl 
selenacyclopentane 8.19 was isolated in 72% yield.  Only the relevant product is shown. 
 
Preparing 8.1 and 8.2 for Nonsense-Suppression Studies 
Since isolation and characterization of the predicted cleavage fragment proved that the 
proposed mechanism of the photoinduced proteolysis was correct, 8.1 and 8.2 could now 
be studied in full proteins.  To prepare 8.1 for both in vitro and in vivo nonsense-
suppression experiments, it was activated as the cyanomethyl ester, coupled to dCA, and 
ligated to both THG73 tRNA (CUA anticodon) and YFaFS tRNA (ACCC anticodon) 
(scheme 8.12).  The same was repeated for 8.2.  Typically, amino acids are also protected 
on their α-amino group due to the instability induced by the electron withdrawing effects 
of the amine.  Neither 8.1 nor 8.2 needed to be protected on its α-hydroxy group because 
the hydroxyl does not have the same inductive effect as the amine. 
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Scheme 8.12.  The activation, coupling, and ligation reactions performed on 8.1 in preparation for in vitro 
and in vivo nonsense-suppression experiments.  The same were repeated for 8.2. 
 
Attempts to Visualize Proteolysis Using Western Blotting Techniques 
Western blotting was anticipated to produce a clear visual result if photolysis of either 8.1 
or 8.2 led to proteolysis of a large protein. Proteins made using the in vitro nonsense-
suppression methodology will separate by polyacrylamide gel electrophoresis (PAGE) 
based on their mass, and visualization through Western blotting techniques will identify 
if irradiated samples contain the smaller protein fragment predicted for SNIPP.  Earlier 
studies performed by Zacharias using rabbit reticulocyte lysate to incorporate 8.1 at 
Leu250 in the α1 nAChR subunit showed that 8.1 was ribosomally competent and was 
susceptible to base hydrolysis of the backbone ester, but irradiation-induced proteolysis 
was never seen.31  Rabbit reticulocyte lysate is the preferred system for in vitro nonsense 
suppression because it is readily available; because it is also a eukaryotic system like 
Xenopus laevis, the traditional system for in vivo nonsense suppression; and because it is 
much higher yielding than other in vitro transcription methods.  The drawback for using 
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this lysate in these experiments is that this lysate contains a high level of heme, which 
makes it deep red in color and may stifle the photolysis reaction.   
Zacharias tried to isolate the in vitro transcribed protein from the lysate and the negative 
effects of the heme prior to irradiation using a seven-histidine tag that had been 
incorporated into the C-terminal sequence of the protein.  This short sequence enables the 
protein to bind to a column of Ni2+ agarose beads, isolating it from the rest of the lysate 
mixture.50-52  Elution with 300 mM imidazole followed by irradiation resulted in a 
complete loss of protein, not only in the experiment but also in the positive controls.  
Potentially, the high levels of imidazole were aggregating the protein during photolysis. 
Enantiopure 8.1 was incorporated into two sites in the nAChR α1 subunit, α1Leu253 and 
α1Ile247, using in vitro nonsense-suppression techniques and rabbit reticulocyte lysate.  
The histidine tag was again used to purify the transcribed protein, but unlike the previous 
experiments performed by Zacharias, the protein was eluted from the column of Ni2+ 
agarose beads using an eluant with a pH of 4.5,53 removing the potential for imidazole-
related protein loss upon photolysis.  The eluate’s pH was raised, and then it was split 
into equal portions, one of which was irradiated by the same 1000 W Hg/Xe arc lamp 
used in the small-scale depsipeptide reactions, and one of which was left untreated.  
Unfortunately, though photolyzed protein was now present in the Western blot, 
proteolysis was never seen and the quantitiy of photolyzed protein was much less than the 
untreated portion (figure 8.13). Neither dilution nor the addition of TCEP encouraged 
proteolysis.  The same loss of protein was not seen when the same techniques were used 
to visualize caged phosphoproteins.53  Due to these inconsistencies, another in vitro 
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transcription system was sought that would eliminate the need to purify the transcribed 
protein prior to photolysis. 
 
Figure 8.13. Western blot of rabbit reticulocyte lysate in vitro nonsense suppressed proteins.  The asterisk 
marks the full-length protein.  Control reactions are not shown.  A reduction in the quantity of protein was 
seen upon exposure to UV light.  Proteolysis was not seen. 
 
Wheat germ lysate is another commonly used in vitro translation system, and its 
translucent white color made it a better choice for photolysis experiments than the rabbit 
reticulocyte lysate system.  Several different commercially available wheat germ lysate 
translation systems were compared to determine which system was most proficient at 
nonsense suppression.  The TNT T7 Coupled Wheat Germ Extract System (Promega, 
Madison, WI) and the Wheat Germ Extract Plus (Promega, Madison, WI) gave 
inefficient or no suppression, but the wheat germ extract from the Rabbit Reticulocyte 
Lysate/Wheat Germ Extract Combination System (Promega, Madison, WI) gave reliably 
consistent suppression.  This system successfully incorporated 8.1 but not 8.2 into 
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proteins using in vitro nonsense suppression (figure 8.14).  Potentially, 8.2 was too large 
to be compatible with the yeast ribosome.  Protein containing 8.1 was found to be 
susceptible to base cleavage of the backbone ester, but irradiation-induced cleavage was 
never observed.  Attempts to optimize photolysis by using different UV light sources (the 
1000 W Hg/Xe arc lamp described above and a 288 W Hg lamp), by increasing the pH of 
the protein-solubilizing solutions, by the addition of TCEP, and by exposing the protein 
to 70 °C heat for one hour postphotolysis did not encourage proteolysis. 
 
Figure 8.14.  Western blot of various wheat germ lysate in vitro nonsense suppressed proteins.  The asterisk 
marks the full-length protein.  The arrowheads mark the hydrolysis products.  Alanine was used as a 
positive control for efficient suppression and a negative control for the addition of base or UV light.  Serine 
α-hydroxy acid (Sah) was used as a positive control for base hydrolysis of an ester backbone.  Proteolysis 
is only seen upon the addition of base to proteins with an ester in the backbone, not upon irradiation of 
protein containing 8.1.  No suppression of 8.2 was seen. 
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A Positive In Vivo Control for the Efficiency of the UV Light Sources  
Although no successful SNIPP was seen in the in vitro photolysis reactions, conditions 
for successful in vivo photolysis reactions were still sought.  Several UV light sources 
were available for irradiating Xenopus oocytes in these in vivo experiments, including a 
500 W Hg arc lamp connected to an electrophysiology rig by a liquid light guide and the 
288 W Hg lamp mentioned above.  To ensure that these sources of UV light could 
successfully initiate the o-nitrobenzyl deprotection event, the reproduction of the 
previously published o-nitrobenzyl-protected tyrosine (TyrONB) suppression and 
photoinduced deprotection in the nAChR was sought.5 The TyrONB markedly differs in 
size from the natural tyrosine, and its suppression makes a mutant channel that is 
relatively insensitive to agonist.  Upon the addition of 300-350 nm wavelength light, the 
tyrosine is decaged and a wild-type channel is revealed, increasing the channel’s 
sensitivity to agonist. 
Whole-cell recordings were done on an OpusXpress workstation at both 24 and 48 hours 
after injection of TyrONB-tRNA and the mRNA for the muscle nAChR containing an 
amber suppression codon at either α1Tyr93 or α1Tyr198.  A solution of 250 µM ACh 
was used to test for channel expression and function.  Little to no current was seen prior 
to photolysis (figure 8.15).  After photolyzing the oocytes suppressed at either site for as 
short as 10 seconds on the 288 W Hg lamp described above, an increase in whole-cell 
current was seen.  The same result was observed with 5 seconds of irradiation from the 
500 W Hg lamp on the electrophysiology rig.  Thus, the o-nitrobenzyl deprotection was 
efficient with brief exposure to UV light by both UV light sources. 
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Figure 8.15.  Whole-cell currents from the suppression of the nAChR at α1Tyr93 with TyrONB after 
photolysis.  The first trace shows the lack of current prior to photolysis.  The second trace shows the 
increase in current after 1 minute of photolysis on the 288 Hg arc lamp.  The third trace shows the increase 
in current after 5 seconds of photolysis on the 500 W Hg lamp connected to the electrophysiology rig.  250 
µM ACh was applied to the oocytes during the time noted by the black bar above the traces. 
 
Attempts to Observe Photolysis-Induced Proteolysis In Vivo 
8.1 had previously been incorporated by Zacharias into ShB at Leu47 in the “chain” 
region of the channel, a site at which England incorporated Npg (figure 8.2).4,31  
Zacharias found that 8.1 suppressed well and that one minute of photolysis resulted in a 
33 ± 5% reduction in N-terminal inactivation.  This result was extremely promising—one 
minute was a vast improvement over the 4 hours necessary to remove two of the four N-
terminal inactivation domains of ShB with Npg (a 27% reduction in inactivation).4   
Unfortunately, this same encouraging result was not seen when the photolysis 
experiments were repeated in these studies, although suppression of the UAG amber 
nonsense codon with both 8.1 and 8.2 at Leu47 and at Pro64 in ShB was successful.  The 
- - 
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read through and reaminoacylation negative controls were always run in conjunction with 
each experiment to ensure that the current seen in the experiment was at least ten times 
greater than that seen for mRNA only (a test for read through) and of mRNA and 
unaminoacylated tRNA (THG73 ligated with dCA, a test for reaminoacylation).  
Reaminoacylation often led to substantial current with both Leu47UAG and Pro64UAG.  
Suppression of the GGGU four-base codon with both 8.1 and 8.2 at Pro64 was also 
successful.  The four-base codon suppression method was anticipated to limit the amount 
of protein made from reaminoacylated tRNA since the YFaFS tRNA has been shown to 
be more orthogonal to the Xenopus oocyte translation system than THG73.54  In each of 
the successful suppression experiments, irradiation of Xenopus oocytes containing ShB in 
which either 8.1 or 8.2 had been incorporated did not cause a reduction of N-terminal 
inactivation.  Both of the UV light sources tested above with TyrONB were tried, as well 
as the 1000 W Hg/Xe arc lamp used in the small-scale depsipeptides studies.  Oxidation 
was not expected to be a problem due to the naturally reducing environment of the cell, 
but no amount of optimization encouraged 8.1 or 8.2 to cleave the protein backbone at 
these sites in ShB.   
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Figure 8.16.  Whole-cell currents from the suppression of ShB Pro64GGGU with 8.1, 8.2, and dCA 
(negative control).  No decrease in N-terminal inactivation was seen after one minute of photolysis on the 
500 W Hg arc lamp connected to the electrophysiology rig for channels containing 8.1 or 8.2.  The 
membrane voltages of the representative voltage jumps are shown at the bottom of the figure. 
 
Hydrophobic protein environments have been known to increase pKa values.55 If this 
effect were occurring here, it would decrease the likelihood that the selenide was anionic.  
To encourage the formation of a selenide anion, the extracellular site used by England in 
- 
- 
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the Npg studies was targeted4 since the pH of the extracellular environment could be 
controlled. Whole-cell recordings were made on the OpusXpress workstation by applying 
a high concentration of ACh (1000 µM = 20x wild-type EC50) to each oocyte to test for 
channel expression.  Suppression of α1Val132UAG by either 8.1 or 8.2 was difficult.  
Triple injections were necessary to get 200 nA of current, although the reaminoacylation 
negative control (injection of dCA-tRNA) produced 100 nA of current under the same 
conditions. Oocytes were then irradiated in pH 9.0 ND96 buffer with CHES replacing the 
HEPES,56 and then channel expression and function were tested again.  Since ACh is not 
stable at high pH, all whole-cell recordings were run in pH 7.5 ND96 buffer (with 
HEPES) to ensure any observed decreases in current would be from successful 
proteolysis.  As described by England et al., photolysis of channels with Npg at this site 
resulted in a dramatic decrease in current.4  The suppression of neither 8.1 nor 8.2 caused 
a decrease in whole-cell current after irradiation.  Though the negative control showed a 
substantial amount of current, suggesting that there could be a mixed population of 
channels—some expressing the desired α-hydroxy acid and some expressing a natural 
amino acid, proteolysis was still expected to show some decrease in current.  None was 
seen.  Thus, the high pH environment did not foster backbone cleavage upon irradiation. 
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Figure 8.17.  Whole-cell currents from the suppression of nAChR at α1Val132 with 8.1, 8.2, and dCA 
(negative control).  No decrease in current was seen after one minute of photolysis on the 500 W Hg arc 
lamp connected to the electrophysiology rig for channels containing 8.1 or 8.2, though there was a 
substantial amount of reaminoacylation current. 
 
No further in vivo experiments were attempted.  Thus, neither 8.1 nor 8.2 were successful 
at SNIPP in a full protein in these studies even though proteolysis was seen in the 
depsipeptide model system.  Despite the speed of deprotection of 8.1 and 8.2, Npg 
remains the superior SNIPP-capable compound due to its in vivo success, even with the 
extended photolysis times needed. 
 
Conclusion 
In this study a novel approach to photochemically-induced backbone cleavage of peptides 
and proteins was described.  The two unnatural α-hydroxy acids presented here were 
- 
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proven to cleave the protein backbone by the anticipated mechanism through the isolation 
of the cleavage fragment from model studies using depsipeptides.  Unfortunately, though 
photochemical decaging of both selenides was complete in approximately 10 minutes in 
the model studies as monitored by ESI-MS, proteolysis of a full protein in either an in 
vitro system or an in vivo system was never seen. 
The model studies provided important information about the selenide compounds.  The 
initial model studies showed the sensitivity of the alkyl selenide 8.1 to oxidative 
elimination and diselenide formation.  Since this sensitivity was minimized in a reducing 
environment, as seen from the addition of DTT or TCEP, it was not expected to play 
much of a roll in vivo due to the reducing environment of the cell.  Selenomethionine 
would form dehydroalanine if oxidative elimination were rampant in the cell.  However, 
minimizing the possibility of forming these unwanted byproducts was anticipated to 
strengthen the success of the cleavage reaction, something that was gained through the 
aryl selenide 8.2.  The initial depsipeptide studies also showed that the alkyl selenide α-
hydroxy acid 8.1 was not efficient at cleaving the peptide backbone on its own and that 
the aryl selenide α-hydroxy acid 8.2 could only cleave the peptide backbone without an 
outside driving force under extremely optimized conditions.  The surrounding pH was 
very important, and the addition of heat drastically improved the efficiency of the 
reactions.  These two elements did not translate to encourage successful proteolysis in the 
in vitro or the in vivo experiments though.  Further attempts could be made to incorporate 
8.1 or 8.2 into a more exposed extracellular site than nAChR α1Val132. 
Ideally, SNIPP would be instantaneous upon irradiation—there would be no lag time 
between the time of photolysis and the time of proteolysis, and proteolysis would occur 
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in all of the desired proteins.  Unfortunately, neither 8.1 nor 8.2 met the requirements for 
the speed and efficiency of the ideal SNIPP.  Npg still allows for in vivo SNIPP, even if 
irradiation times are prolonged.  Other potential solutions include further enhancing the 
propensity for the ring-closing reaction of 8.2 by incorporating the trimethyl lock 
elements that made the o-nitrobenzyl caged phenol successful.13  Though successful 
suppression by in vitro transcription reaction with wheat germ lysate of 8.2 was not 
observed by Western blot, this bulky α-hydroxy acid was successfully incorporated into 
channels in the Xenopus oocyte.  Therefore, the rabbit reticulocyte lysate might be a 
better translation system to test the suppression of any trimethyl lock derivatives that may 
be developed in the future. 
 
Methods  
The work in this chapter was a collaborative effort that included important contributions 
from Zacharias and Blum.  Detailed methods for the experiments discussed in this 
chapter that were not performed by the author can be found in Zacharias’s thesis31 and in 
Eastwood et al.57 
 
Synthesis 
All reactions were performed at ambient temperature unless otherwise noted.  All 
reactions involving potentially air-sensitive compounds were conducted under an inert 
atmosphere using Schlenk techniques.  Solvents were purified by passage through 
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alumina.58  Unless otherwise noted, all chemicals and reagents were used as received 
without further purification.  Flash chromatography was performed using EMD 
(Gibbstown, NJ) silica gel 60 (particle size 0.040-0.063 mm).  TLC was performed using 
EMD (Gibbstown, NJ) silica gel 60 F254 precoated plates (0.25 mm) and visualized by 
UV light, potassium permanganate, or ceric ammonium molybdate.  NMR spectroscopy 
was preformed on either a Varian (Palo Alto, CA) Mercury 300 or Inova 500 instrument, 
and NMR resonances are reported relative to Me4Si (δ 0.0), CD3OD (δ 3.31 for 1H NMR 
and δ 49.1 for 13C NMR), or D2O (δ 4.79 for 1H NMR).  Data for 1H NMR spectra are 
reported as follows: chemical shift (δ ppm), integration, multiplicity, and coupling 
constant (Hz).  Data for 13C NMR spectra are reported as chemical shift (δ ppm).  High-
resolution mass spectroscopy (HRMS) spectra were obtained from the Caltech Mass 
Spectrometry Lab.  ESI-MS used to analyze the proteolysis reactions was preformed on 
an LCQ Classic ion trap (ThermoFinnigan, Waltham, MA) in direct infusion mode.  
HPLC was preformed using Waters (Milford, MA) equipment and software (510 HPLC 
pumps and 996 Photodiode Array Detector) and reverse-phase Nova-Pak 18C columns 
(3.9 × 150 mm analytical column, 7.8 × 300 mm preparatory column). 
 
tert-Butyl ester 8.3:  (S)-(−)-Tetrahydro-2-furoic acid (2.42 mL, 25.0 mmol, 1 eq) was 
placed in a round-bottom flask under Ar (g) and dissolved in THF (250 mL).  To this 
solution was added 4-(dimethylamino)-pyridine (0.919 g, 7.5 mmol, 0.3 eq) and di-tert-
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butyl dicarbonate (11.5 mL, 50.0 mmol, 2 eq), at which time the solution turned yellow.  
The reaction was allowed to stir for 4 hours, and then the solvent was removed under 
vacuum.  The crude product was purified by flash column chromatography (9% EtOAc in 
hexanes) to afford tert-butyl ester 8.3 (4.15 g, 24.1 mmol, 96% yield).  Rf = 0.33 (9% 
EtOAc in hexanes); 1H NMR (300 MHz, CDCl3, 298 K) δ 4.4 (1H, m), 4.0 (2H, m), 2.2 
(1H, m), 2.0 (3H, m), 1.5 (9H, s). 
Conversion back to (S)-(−)-tetrahydro-2-furoic acid:  tert-Butyl ester 8.3 (0.045 g, 0.26 
mmol, 1 eq) was placed in a round-bottom flask under Ar (g) and dissolved in CH2Cl2 (5 
mL).  This solution was cooled to 0 °C and charged with the dropwise addition of 
triethylamine (0.010 mL, 0.075 mmol, 0.29 eq).  Dimethylboron bromide (2.0 M in 
CH2Cl2, 0.50 mL, 1.0 mmol, 3.8 eq) was added via cannula to the solution.  The reaction 
was allowed to stir at 0 °C for 2 hours.  To quench, the reaction mixture was poured over 
saturated NaHCO3 (aq) and stirred for 20 minutes.  An extraction with ether was 
attempted, but the product remained in the aqueous layer.  The pH of the aqueous layer 
was lowered to 3 with concentrated HCl and then extracted with EtOAc (2×), dried over 
Na2SO4 (s), and concentrated to afford the original acid (0.022 g, 0.19 mmol, 73% yield).  
1H NMR (300 MHz, CDCl3, 298 K) δ 4.4 (1H, q), 3.9 (2H, dq), 2.2 (1H, m), 2.0 (3H, m). 
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Ethyl ester 8.4:  (S)-(−)-Tetrahydro-2-furoic acid (25.0 g, 215 mmol) was placed in a 
round-bottom flask under Ar (g) and dissolved in ethanol (63 mL) and toluene (72 mL).  
To this solution was added concentrated H2SO4 (1.2 mL), and the reaction was allowed to 
reflux for 6 hours at 80 °C.  The reaction was then cooled to room temperature, quenched 
with concentrated H2SO4 (2 mL), diluted with toluene, and washed with saturated 
(NH4)2SO4 (aq), and then H2O.  The aqueous layers were back extracted with toluene 
(2×).  The combined organic layers were washed with saturated (NH4)2SO4 (aq) and then 
saturated NaHCO3 (aq), dried over Na2SO4 (s), and concentrated.  The crude product was 
purified by flash chromatography (33% EtOAc in hexanes) to yield ethyl ester 8.3 as a 
yellow oil (18.3 g, 127 mmol, 61% yield).  Rf = 0.35 (33% EtOAc in hexanes).  1H NMR 
(300 MHz, CDCl3, 298 K) δ 4.43 (1H, dd, J = 8.1, 5.1 Hz), 4.19 (2H, qd, J = 7.2, 0.9 Hz), 
4.01 (1H, m), 3.91 (1H, m), 2.23 (1H, m), 1.95 (3H, m), 1.27 (3H, t, J = 7.2 Hz); 13C 
NMR (75 MHz, CDCl3, 298 K) δ 173.3, 76.7, 69.2, 60.7, 30.1, 25.2, 14.2; HRMS-EI 
(m/z): [M+] calc’d for C7H13O3 145.0865, found 145.0877. 
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Bromoalcohol 8.5:  Ethyl ester 8.4 (18.3 g, 127 mmol, 1 eq) was placed in a round-
bottom flask under Ar (g) and dissolved in CH2Cl2 (450 mL).  This solution was cooled 
to 0 °C and charged with the dropwise addition of triethylamine (2.54 mL, 19.1 mmol, 
0.15 eq).  Dimethylboron bromide (1.56 M in CH2Cl2, 163 mL, 254 mmol, 2 eq) was 
added via cannula to the solution.  The reaction was allowed to stir at 0 °C for 2 hours.  
To quench, the reaction mixture was poured over saturated NaHCO3 (aq) and stirred for 5 
minutes.  It was then extracted with ether, washed with brine (2×), dried over Na2SO4 (s), 
and concentrated.  The crude product was purified by flash column chromatography 
(20% EtOAc in hexanes) to afford bromoalcohol 8.5 as an orange oil (20.4 g, 90.6 mmol, 
71% yield).  Rf = 0.31 (33% EtOAc in hexanes); 1H NMR (300 MHz, CDCl3, 298 K) δ 
4.26 (2H, dq, J = 7.2, 0.9 Hz), 4.20 (1H, m), 3.45 (2H, m), 2.81 (1H, d, J = 5.4 Hz), 2.00 
(3H, m), 1.79 (1H, m), 1.31 (3H, t, J = 7.2 Hz); 13C NMR (75 MHz, CDCl3, 298 K) δ 
174.9, 69.7, 62.0, 33.3, 32.8, 28.2, 14.2; HRMS (EI) m/z calc’d for C7H14BrO3 [M+]:  
225.0126, found 225.0137. 
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Diselenide ester 8.6:  Elemental selenium (3.58 g, 45.3 mmol, 0.5 eq) and sodium 
borohydride (3.43 g, 90.6 mmol, 1 eq) were placed in a round-bottom flask and dissolved 
in H2O (265 mL).  After stirring for 20 minutes, more elemental selenium (3.58 g, 45.3 
mmol, 0.5 eq) was added.  The mixture was then stirred over a steam bath for 15 minutes, 
at which time it turned dark brown suggesting the formation of Na2Se2.  Bromoalcohol 
8.5 (20.4 g, 90.6 mmol, 1 eq) was dissolved in a 1:1 mixture of THF:H2O (106 mL) and 
added to the reaction.  After stirring overnight, the reaction was quenched with 1 N 
AcOH (106 mL) and H2O (264 mL), extracted with CH2Cl2 (4×), dried over MgSO4 (s), 
filtered through a pad of celite, and concentrated.  The crude product was purified by 
flash column chromatography (50% EtOAc in hexanes, dry loaded in CH2Cl2) to afford 
diselenide ester 8.6 as a yellow oil (19.7 g, 43.9 mmol, 97% yield).  Rf = 0.17 (33% 
EtOAc in hexanes); 1H NMR (300 MHz, CDCl3, 298 K) δ 4.26 (4H, q, J = 7.2 Hz), 4.20 
(2H, m), 2.91 (4H, m), 1.84 (8H, m), 1.31 (6H, t, J = 7.2 Hz); 13C NMR (75 MHz, 
CDCl3, 298 K) δ 175.1, 70.0, 61.8, 34.0, 29.3, 26.3, 14.2; HRMS (FAB) m/z calc’d for 
C14H26O6Se2 [M+]:  450.0059, found 450.0080. 
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Diselenide acid 8.7:  Diselenide ester 8.6 (18.6 g, 41.5 mmol) was placed in a round-
bottom flask and dissolved in 6 M HCl (240 mL).  The reaction was allowed to stir at 75 
°C for 12 hours.  The solvent was concentrated yielding diselenide acid 8.7 as a yellow 
solid (15.6 g, 39.8 mmol, 96% yield).  Rf = 0.06 (1% formic acid in EtOAc); 1H NMR 
(300 MHz, CDCl3, 298 K) δ 4.04 (2H, dd, J = 7.1, 3.6 Hz), 2.96 (4H, t, J = 6.9 Hz), 1.85 
(8H, m); 13C NMR (75 MHz, CD3OD, 298 K) δ 177.9, 71.1, 35.2, 30.4, 27.9; HRMS 
(TOF) m/z calc’d for C10H18O6Se2 [M−H]:  392.9356, found 392.9360. 
HO
OH
O
8.1
Se
O2N
 
Alkyl selenide α-hydroxy acid 8.1:  Diselenide acid 8.7 (12.5 g, 31.7 mmol, 1 eq) was 
placed in a round-bottom flask and dissolved in 0.5 N NaOH (169 mL) and ethanol (42.5 
mL) at 0 °C.  Slowly NaBH4 (12.0 g, 317 mmol, 10 eq) was added.  The dark orange 
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solution turned white as it was allowed to come to room temperature.  The temperature of 
the reaction was lowered back to 0 °C and then 2 N NaOH (84.3 mL) and o-
nitrobenzylbromide (27.4 g, 127 mmol, 4 eq) were added.  The reaction was allowed to 
stir for 3 hours as it warmed to room temperature.  The mixture was washed with EtOAc 
(3×), and then the pH of the aqueous layer was lowered to 4.  The product was removed 
from the now cloudy aqueous layer by extraction with EtOAc (3×).  The organic solution 
was filtered through a pad of celite and concentrated to afford alkyl selenide α-hydroxy 
acid 8.1 as an orange oil (17.9 g, 53.9 mmol, 85%).  Rf = 0.11 (1% formic acid and 49.5% 
EtOAc in hexanes); 1H NMR (500 MHz, CDCl3, 298 K) δ 7.99 (1H, d, J = 8.0 Hz), 7.53 
(1H, td, J = 7.5, 1.5 Hz), 7.38 (2H, t, J = 8.0 Hz), 4.25 (1H, m), 4.10 (2H, s), 2.59 (2H, 
m), 1.92 (1H, m), 1.78 (3H, m); 13C NMR (125 MHz, CDCl3, 298 K) δ 178.6, 148.1, 
135.9, 133.2, 131.9, 127.9, 125.6, 76.5, 69.7, 34.1, 25.5, 24.2, 23.8; HRMS (TOF) m/z 
calc’d for C12H15NO5Se [M−H]:  332.0037, found 332.0050. 
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Alkyl selenide-glutamate dipeptide 8.8:  Method A: Alkyl selenide α-hydroxy acid 8.1 
(0.787 g, 2.40 mmol, 1 eq), L-glutamic acid di-tert-butyl ester (0.775 g, 0.262 mmol, 1.1 
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eq), 1,3-dicyclohexylcarbodiimide (0.480 g, 2.33 mmol, 0.97 eq), and 1-
hydroxybenzotriazole (0.324 g, 2.40 mmol, 1 eq) were placed in a round-bottom flask 
under Ar (g) and dissolved in CH2Cl2 (20 mL).  After stirring for 24 hours, the reaction 
was diluted with EtOAc.  The solution was then washed with 1N HCl, H2O, saturated 
NaHCO3 (aq), H2O, and brine, filtered through a pad of celite, dried over MgSO4 (s), and 
concentrated.  The crude product was purified by flash column chromatography (33% 
EtOAc in hexanes, dry loaded in CH2Cl2) to afford the dipeptide 8.8 as a pale yellow oil 
(0.373 g, 0.650 mmol, 33% yield). 
Method B:  Alkyl selenide α-hydroxy acid 8.1 (0.076 g, 0.23 mmol, 1 eq), L-glutamic 
acid di-tert-butyl ester (0.076 g, 0.26 mmol, 1.1 eq), 1,3-dicyclohexylcarbodiimide (0.083 
g, 0.40 mmol, 2 eq), and 4-(dimethylamino)pyridine (0.013 g, 0.10 mmol, 0.5 eq) were 
placed in a round-bottom flask under Ar (g) and dissolved in CH2Cl2 (2 mL).  After 
stirring for 24 hours, the reaction was diluted with EtOAc and gravity filtered to remove 
the solid dicyclohexylurea byproduct.  The eluate was washed with saturated NaHCO3 
(aq) and brine, filtered through a pad of celite, dried over Na2SO4 (s), and concentrated.  
The crude product was purified by flash column chromatography (33% EtOAc in 
hexanes, dry loaded in CH2Cl2) to afford the dipeptide 8.8 as a pale yellow oil (0.045 g, 
0.070 mmol, 34% yield).   
Method C:  Alkyl selenide α-hydroxy acid 8.1 (0.998 g, 3.00 mmol, 1.1 eq), L-glutamic 
acid di-tert-butyl ester (0.808 g, 2.73 mmol, 1 eq), and benzotriazol-1-yl-
oxytripyrrolidinophosphonium hexaflurophosphate (1.56 g, 3.00 mmol, 1.1 eq) were 
placed in a round-bottom flask under Ar (g) and dissolved in DMF (10 mL).  To this was 
added N-methylmorpholine (0.99 mL, 9.01 mmol, 3.3 eq), and the reaction stirred for 12 
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hours.  The reaction was then diluted with EtOAc, and the solution was washed with 5% 
KHSO4 (2×), 5% NaHCO3 (2×), and brine, filtered through a pad of celite, dried over 
Na2SO4 (s), and concentrated.  The crude product was purified by flash column 
chromatography (50% EtOAc in hexanes, dry loaded in CH2Cl2) to afford the dipeptide 
12 as a pale yellow oil (0.698 g, 1.22 mmol, 41% yield).  Rf = 0.25 (50% EtOAc in 
hexanes); 1H NMR (500 MHz, CDCl3, 298 K) δ 7.98 (1H, d, J = 7.5 Hz), 7.53 (1H, td, J 
= 7.3, 1.0 Hz), 7.38 (2H, t, J = 7.5 Hz), 7.22 (1H, d, J = 8.0 Hz), 4.47 (1H, dt, J = 8.5, 5.5 
Hz), 4.13 (1H, m), 4.09 (1H, s), 2.56 (2H, t, J = 6.5 Hz), 2.30 (2H, m), 2.15 (1H, m), 1.92 
(1.5H, m), 1.79 (1H, m), 1.71 (0.5H, m), 1.47 (9H, s), 1.44 (9H, s); 13C NMR (125 MHz, 
CDCl3, 298K) δ 174.0, 172.1, 171.1, 161.0, 148.1, 136.0, 133.1, 131.9, 127.8, 125.6, 
82.5, 80.9, 71.3, 52.0, 34.8, 31.5, 28.1, 28.0, 27.5, 25.7, 24.2, 23.7; HRMS (FAB) m/z 
calc’d for C25H38N2O8Se [M+H]:  575.1871, found 575.1862. 
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N-Acetyl-phenylalanine-alkyl selenide-glutamate depsipeptide 8.9:  Dipeptide 8.8 (0.373 
g, 0.650 mmol, 1 eq), N-acetyl-L-phenylalanine (0.135 g, 0.650 mmol, 1 eq), 4-
(dimethylamino)pyridine (0.0794 g, 0.650 mmol, 1 eq), and N,N’-
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dicyclohexylcarbodiimide (0.136 g, 0.660 mmol, 1 eq) were placed in a round-bottom 
flask under Ar (g) and dissolved in CH2Cl2 (120 mL).  After stirring for 24 hours, the 
reaction mixture was diluted with EtOAc and gravity filtered to remove the solid 
dicyclohexylurea by-product.  The solution was washed with 1 M KHSO4 (2×), water, 
and 5% NaHCO3.  The organic layer was filtered through a pad of celite, dried over 
MgSO4 (s), and concentrated.  The crude product was purified by flash column 
chromatography (33% EtOAc in hexanes, dry loaded in CH2Cl2) to afford depsipeptide 
8.9 as a pale yellow oil (0.330 g, 0.433 mmol, 67% yield).  Rf = 0.26 (50% EtOAc in 
hexanes); 1H NMR (300 MHz, CDCl3, 298 K) δ 8.03 (1H, dd, J = 7.95, 1.2 Hz), 7.57 
(1H, td, J = 7.35, 1.2 Hz), 7.30 (7H, m), 5.13 (1H, t, J = 6.3 Hz), 4.77 (1H, q, J = 7.2 Hz), 
4.38 (1H, m), 4.10 (2H, s), 3.16 (2H, t, J = 6.9 Hz), 2.47 (2H, t, J = 7.2 Hz), 2.36-1.8 
(8H, m), 2.02 (3H, s), 1.48 (9H, s), 1.48 (9H, s); ESI-MS m/z calc’d for C36H49N3O10Se 
[M+Cl]:  798.8, found 798.2.  
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Tryptophan-alkyl selenide-glutamate depsipeptide 8.10:  Dipeptide 8.8 (5.51 g, 9.60 
mmol, 1 eq), N-(tert-butoxycarbonyl)-L-tryptophan (3.32 g, 10.9 mmol, 1.1 eq), 4-
(dimethylamino)pyridine (0.586 g, 4.80 mmol, 0.5 eq), and N,N’-
dicyclohexylcarbodiimide (3.98 g, 19.3 mmol, 2 eq) were placed in a round-bottom flask 
under Ar (g) and dissolved in CH2Cl2 (84 mL).  After stirring for 48 hours, the reaction 
mixture was diluted with EtOAc and gravity filtered to remove the solid dicyclohexylurea 
by-product. The solution was washed with 1 M KHSO4 (2×), water, and 5% NaHCO3 
(2×).  The organic layer was filtered through a pad of celite, dried over MgSO4 (s), and 
concentrated.  The crude product was purified by flash column chromatography (20% 
EtOAc in hexanes, dry loaded in CH2Cl2) to afford depsipeptide 8.10 as a pale yellow oil 
(0.989 g, 1.15 mmol, 12% yield).  1H NMR (300 MHz, CDCl3, 298 K) δ 8.1 (1H, d), 7.6 -
6.9 (8H, m), 6.6 (1H, s), 5.1 (1H, m), 4.4 (1H, m), 4.1 (1H, m), 4.0 (2H, s), 3.3 (1H, m), 
2.6-1.6 (10H, m), 1.4 (9H, s), 1.4 (9H, s), 1.4 (9H, s); ESI-MS m/z calc’d for 
C41H56N4O11Se [M+K]:  899.4, found 898.9.  
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tBoc-Phenylalanine-alkyl selenide-glutamate depsipeptide 8.11:  Dipeptide 8.8 (0.160 g, 
0.280 mmol, 1 eq), N-(tert-butoxycarbonyl)-L-phenylalanine (0.0891 g, 0.340 mmol, 1.2 
eq), 4-(dimethylamino)pyridine (0.0171 g, 0.140 mmol, 0.5 eq), and N,N’-
dicyclohexylcarbodiimide (0.1156g, 0.560 mmol, 2 eq) were placed in a round-bottom 
flask under Ar (g) and dissolved in CH2Cl2 (3 mL).  After stirring for 45 hours, the 
reaction mixture was diluted with EtOAc and gravity filtered to removed the solid 
dicyclohexylurea byproduct. The solution was washed with 1 M KHSO4 (2×), H2O, and 
5% NaHCO3 (2×).  The organic layer was filtered through a pad of celite, dried over 
MgSO4 (s), and concentrated.  The crude product was purified by flash column 
chromatography (50% EtOAc in hexanes, dry loaded in CH2Cl2) to afford depsipeptide 
8.11 as a pale yellow oil (0.144 g, 0.176 mmol, 63% yield).  Rf = 0.53 (50% EtOAc in 
hexanes); 1H NMR (500 MHz, CDCl3, 298 K) δ 7.99 (1H, dd, J = 8.25, 1.0 Hz), 7.53 
(1H, td, J = 7.5, 1.5 Hz), 7.37 (2H, m), 7.28 (3H, m), 7.19 (3H, m), 5.16 (1H, m), 4.99 
(1H, d, J = 7.5 Hz), 4.59 (1H, q, J = 5.0 Hz), 4.41 (1H, dt, J = 8.0, 5.0 Hz), 4.07 (1H, s), 
3.24 (1H, dd, J = 14.3, 5.0 Hz), 3.12 (1H, m), 2.49 (2H, dt, J = 7.5, 2.5 Hz), 2.31 (2H, m), 
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2.14 (1H, m), 1.92 (3H, m), 1.65 (2H, m), 1.45 (9H, s), 1.44 (9H, s), 1.40 (9H, s); 13C 
NMR (125 MHz, CDCl3, 298 K) δ 172.1, 170.8, 170.3, 169.3, 155.8, 148.1, 135.9, 135.8, 
133.1, 131.9, 129.2, 128.8, 127.8, 127.2, 125.6, 81.1, 80.7, 80.3, 74.2, 54.5, 52.3, 37.2, 
32.0, 31.6, 28.3, 28.1, 28.0, 27.1, 25.5, 23.7; HRMS (FAB) m/z calc’d for C39H55N3O11Se 
[M+H]:  822.3080, found 822.3046.  
O
O
H
N
O
OH
OHO
H
N
O
O
Se
O2N
8.12  
Deprotected N-Acetyl-phenylalanine-alkyl selenide-glutamate depsipeptide 8.12:  
Depsipeptide 8.9 (0.076 g, 0.10 mmol) was placed in a round-bottom flask and was 
dissolved in trifluoroacetic acid (2 mL) and CH2Cl2 (2 mL).  The reaction was allowed to 
stir for 45 minutes and then it was concentrated under vacuum.  The crude product was 
purified by reverse-phase semipreparative HPLC using a linear solvent gradient from 5% 
acetonitrile in 25 mM NH4OAc buffer pH 4.5 to 100% acetonitrile to afford depsipeptide 
8.12.  1H NMR (300 MHz, D2O, 298 K) δ 7.92 (1H, d, J = 8.1 Hz), 7.51 (1H, t, J = 6.6 
Hz), 7.34 (2H, t, J = 6.6 Hz), 7.19 (5H, m), 4.88 (1H, q, J = 6.0 Hz), 4.6 (1H, m), 3.99 
(3H, m), 2.9 (2H, m), 2.47 (2H, m), 2.05 (2H, m), 2.0-1.0 (6H, m); ESI-MS m/z calc’d for 
C28H33N3O10Se [M−H]:  650.1, found 650.0. 
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Deprotected tryptophan-alkyl selenide-glutamate depsipeptide 8.13:  Depsipeptide 8.10 
(0.086 g, 0.10 mmol) was placed in a round-bottom flask and was dissolved in 
trifluoroacetic acid (2 mL) and CH2Cl2 (2 mL).  The reaction was allowed to stir for 45 
minutes and then it was concentrated under vacuum.  The crude product was purified by 
reverse-phase semipreparative HPLC using a linear solvent gradient from 5% acetonitrile 
in 25 mM NH4OAc buffer pH 4.5 to 100% acetonitrile to afford depsipeptide 8.13.  ESI-
MS m/z calc’d for C28H32N4O9Se [M−H]:  647.1, found 647.1. 
HO
O
OH
Br
8.14  
Bromophenylalanine α-hydroxy acid 8.14:  o-Bromophenylalanine (1.0 g, 4.0 mmol, 1 
eq) was placed in a round bottom flask and dissolved in 8:2 H2O:acetic acid (40 mL).  
This solution was cooled to 0 ºC and charged with the dropwise addition of sodium 
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nitrate (2 M in H2O, 8.0 mL, 16 mmol, 4 eq).  The reaction was stirred for 3 hours and 
then quenched with methylamine (2M in THF, 4 mL).  The THF was removed under 
vacuum, and the pH of the resulting aqueous solution was lowered to 2 with concentrated 
HCl.  This solution was extracted with EtOAc (3×), dried over MgSO4 (s), and 
concentrated to afford bromophenylalanine α-hydroxy acid 8.14 (0.980 g, 4.0 mmol, 
100% yield). Rf = 0.47 (50% EtOAc in hexanes); 1H NMR (300 MHz, CDCl3, 298 K) 
δ 7.6 (1H, d), 7.3 (2H, m), 7.2 (1H, m), 4.6 (1H, m), 3.5 (1H, m), 3.1 (1H, m); 13C NMR 
(75 MHz, CDCl3, 298 K) δ 178, 136, 133, 132, 129, 128, 125 70, 40; ESI-MS m/z calc’d 
for C9H9BrO3 [M−H]:  243.0, found 242.9. 
HO
N
O
Br
8.15  
Oxazoline 8.15:  Bromophenylalanine α-hydroxy acid 8.14 (1.10 g, 4.00 mmol, 1 eq) was 
placed in a round-bottom flask under Ar (g) and dissolved in 2-amino-2-methyl-1-
propanol (0.380 mL, 4.00 mmol, 1 eq) and xylene (5 mL).  The reaction was connected to 
a Dean-Stark trap and allowed to reflux for 4 hours at 160 ºC.  The crude product was 
vacuum distilled on a kugelrohr (Büchi GKR-50, set to 200 ºC) to yield oxazoline 8.15 as 
a yellow oil (0.149 g, 0.500 mmol, 100% yield). Rf = 0.65 (11% EtOAc in hexanes); 1H 
NMR (300 MHz, CDCl3, 298 K) δ 7.6 (1H, dd), 7.4 (1H, dd), 7.3 (1H, td), 7.2 (1H, td), 
4.6 (1H, m), 4.0 (2H, m), 3.3 (1H, m), 3.1 (1H, m), 1.2 (3H, s), 1.2 (3H, s); ESI-MS m/z 
calc’d for C13H16BrNO2 [M+H]:  298.0, found 297.8. 
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TBDPSO
N
O
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8.16  
TBDPS ether 8.16:  Oxazoline 8.15 (2.54 g, 8.50 mmol, 1 eq), imidazole (1.27 g, 18.7 
mmol, 2.2 eq), and tert-butylchlorodiphenylsilane (2.43 mL, 9.35 mmol, 1.1 eq) were 
placed in a round-bottom flask under Ar (g) and dissolved in DMF (5 mL).  The reaction 
was allowed to stir for 24 hours, and then the solvent was removed under vacuum.  The 
crude product was purified by flash column chromatography (9% EtOAc in hexanes, then 
flushed with CH2Cl2) to yield TBDPS ether 8.16 as a yellow oil (3.28 g, 6.10 mmol, 72% 
yield).  Rf = 0.83 (50% EtOAc in hexanes); 1H NMR (300 MHz, CDCl3, 298 K) δ 7.8-7.1 
(14H, m), 4.3 (1H, m), 4.0-3.0 (4H, m), 1.1 (6H, s) 1.1 (9H, s); ESI-MS m/z calc’d for 
C29H34BrNO2Si [M+H]:  536.2, found 535.9. 
O
H
N
O
O
OO
8.18
Se
 
Selenacyclopentane 8.18:  Depsipeptide 8.11 (0.0722g, 0.088 mmol, 1 eq) was placed in 
a pyrex photochemical reaction vessel and dissolved in acetonitrile (125 mL).  To this 
was added dithiothreitol (1.36 g, 8.8 mmol, 100 eq) and 20 mM phosphate buffer, pH 7.6 
(125 mL).  The resulting solution was stirred under N2 (g), and a 450 W medium-pressure 
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Hg-vapor UV immersion lamp (ACE Glass), filtered with a pyrex glass absorption sleeve 
and equipped with a water cooling jacket, was assembled to the reaction vessel.  The 
progress of the reaction was followed by ESI-MS.  After 1 hour of photolysis, at which 
point the temperature of the reaction had increased from 25 to 32 ºC, the two major ratios 
seen in the mass spectrum of the reaction were the depsipeptide 8.11 ([M+Na] m/z = 844) 
and the nitrobenzyl-deprotected selenol ([M+Na] m/z = 709).  After 5 hours of photolysis, 
the m/z ratio attributed to 8.11 ([M+Na] m/z = 844) had diminished to a negligible level 
while the m/z ratios corresponding to the nitrobenzyl-deprotected selenol ([M+Na] m/z = 
709), the nitrobenzyl-deprotected diselenide ([M+Na] m/z = 1391), the olefin-containing 
depsipeptide derived from the oxidative elimination of the selenium ([M+Na] m/z = 627), 
and the desired selenacyclopentane 8.18 ([M+Na] m/z = 444) persisted.  At this time, the 
reaction was removed from the photoreactor, heated to 70 ºC, and monitored by ESI-MS.  
After 3 hours of heating at this temperature, both nitrobenzyl-deprotection products (m/z 
ratios 709 and 1391) were no longer detectable, but the m/z ratio attributed to the desired 
selenacyclopentane 8.18 ([M+Na] m/z = 444) and a m/z ratio corresponding to its dimer 
([M+Na] m/z = 865) remained.  The resulting mixture was extracted with EtOAc (2×), 
dried over MgSO4 (s), and concentrated. The crude product was purified twice by flash 
column chromatography (11% EtOAc in hexanes, then 33% EtOAc in hexanes after the 
DTT eluted, dry loaded in CH2Cl2) to afford selenacyclopentane 8.18 as a yellow oil 
(0.0107 g, 0.0255 mmol, 29% yield).  Rf = 0.28 (33% EtOAC in hexanes); 1H NMR (500 
MHz, CDCl3, 298 K) δ 7.08 (1H, d, J = 13.5 Hz), 4.44 (1H, dt, J = 13.5, 8 Hz), 4.08 (1H, 
m), 3.15 (1H, m), 2.97 (1H, m), 2.37 (1.5H, m), 2.26 (1.5H, m), 2.14 (4H, m), 1.92 (1H, 
m), 1.47 (9H, s), 1.44 (9H, s); 13C NMR (125 MHz, CDCl3, 298 K) 172.3, 172.1, 170.8, 
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82.3, 80.7, 52.845.4, 37.4, 32.4, 31.5, 28.1, 28.0, 27.5, 27.1. HRMS (TOF) m/z calc’d for 
C18H31NO5Se [M+H]:  422.1446, found 422.1465. 
HO O
O
Se
O2N
8.20
N
 
Cyanomethyl ester 8.20:  Alkyl selenide α-hydroxy acid 8.1 (0.23 g, 0.69 mmol) was 
added to a round-bottom flask under Ar (g) and dissolved in chloroacetonitrile (2 mL).  
To this solution was added triethylamine (0.25 mL).  The mixture was stirred at room 
temperature for 75 minutes and then the solvent was removed under vacuum.  The 
residue was purified by flash column chromatography (CH2Cl2, then 5% EtOAc in 
CH2Cl2) to afford cyanomethyl ester 8.20 (0.073 g, 0.20 mmol, 29% yield).  Rf = 0.45 
(17% EtOAC in CH2Cl2); 1H NMR (300 MHz, CDCl3, 298 K) δ 7.98 (1H, d, J = 8.4 Hz), 
7.50 (1H, t, J = 7.5 Hz), 7.38 (2H, t, J = 7.5 Hz), 4.82 (2H, s), 4.28 (1H, m), 4.09 (2H, s), 
2.58 (2H, m), 2.00-1.50 (4H, m); 13C NMR (75 MHz, CDCl3, 298 K) δ 171.1, 133.1, 
131.9, 127.9, 125.5, 69.9, 49.0, 33.9, 29.7, 25.3, 23.8. 
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Alkyl selenide-dCA 8.21:  Cyanomethyl ester 8.20 (0.018 g, 0.048 mmol, 3 eq) was 
added to a round-bottom flask under Ar (g) and dissolved in DMF (0.5 mL).  This 
solution was transferred to another round-bottom flask under Ar (g), which contained 
dCA (0.020 g, 0.017 mmol, 1 eq) as a tetrabutylammonium salt (2.4 eq).  The reaction 
was stirred at room temperature for 18 hours while being monitored by reverse-phase 
analytical HPLC with a linear solvent gradient from 5% acetonitrile in 25 mM NH4OAc 
buffer pH 4.5 to 100% acetonitrile.  The crude product was purified using reverse-phase 
semipreparative HPLC with the same linear solvent gradient.  The fractions containing 
the alkyl selenide-dCA 8.21 were combined, and the solvent was removed by 
lyophilization.  The solid was redissolved in 10 mM acetic acid and reconcentrated via 
lyophilization (3×) to afford alkyl selenide-dCA 8.21 as a white powder (0.014 g, 0.015 
mmol, 88% yield).   ESI-MS m/z calc’d for C12H39N9O17P2Se [M−H]:  950.1, found:  
950.2. 
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Small-Scale Depsipeptide Model Reactions  
General method:  0.1 µM solution of depsipeptide in a 1:1 mixture of acetonitrile and 20 
mM phosphate buffer pH 7.6 (50 µL) was placed in PCR tube and was irradiated for ten 
minutes with a 1000 W Hg/Xe arc lamp (Oriel, Irvine, CT) operating at 400 W equipped 
with WG-335 and UG-11 filters (Schott, Elmsford, NY).  After photolysis, the reaction 
was heated to 70 °C for one hour using an iCycler PCR machine (Bio-Rad, Hercules, 
CA) and then the products were analyzed by ESI-MS. 
Many reaction variables were changed during the course of the work presented in this 
chapter.  These factors include the container used to hold the solution of depsipeptide 
during irradiation, the solvent used during photolysis, the concentration of the 
depsipeptide in solution, the volume of solution irradiated, the filters used for the arc 
lamp during photolysis, the addition of a reducing agent (including the point at which the 
reducing agent was applied to the reaction), the length of time of irradiation, the 
application of heat after irradiation (including the specific temperature, the length of time 
of application, and the method of heating), and the addition of high pH water after 
irradiation.  The variables that were found to be important are discussed in the results and 
discussion section. 
Oxidation:  0.1 µM solution of depsipeptide in acetonitrile (50 µL) was placed in a 1.5 
mL eppendorf tube, to which was added a solution of 30% H2O2 in H2O (100 µL).  After 
an hour the products of the reaction were analyzed by ESI-MS.  As a negative control, 
double-distilled H2O (100 µL) replaced the H2O2. 
 
321 
Addition of N-methyl maleimide: 0.1 µM solution of depsipeptide 8.9 or 8.10 in 
acetonitrile (50 µL, 1 eq) and DTT (50 eq) were placed in a 1.5 mL eppendorf tube and 
photolyzed as described above for 10 minutes.  ESI-MS was used to analyze the products 
of the irradiated solution.  Excess N-methyl maleimide was added to the reaction, and 
after several minutes the resulting solution was analyzed by ESI-MS.  The same 
procedure was repeated for depsipeptide 8.12 except it was dissolved in double-distilled 
H2O instead of acetonitrile. 
 
Nonsense Suppression In Vitro 
The site-directed mutagenesis of TAG mutants, gene construction, synthesis of 
suppressor tRNA, and ligation of aminoacyl-tRNA to tRNA have been described 
previously.59-62  Plasmid DNAs were linearized with Not1, and mRNA was transcribed 
using the Ambion (Austin, TX) T7 mMESSAGE mMACHINE kit. 
Method A:  Translation was carried out using rabbit reticulocyte lysate translation system 
(Promega, Madison, WI) according to the manufacturer’s protocol.  Lysate mix (140 µL), 
amino acid mix (6 µL), RNAse inhibitor (4 µL), H2O (18 µL), mRNA (16 µL, 1 µg/µL 
for suppression experiments and 0.3 µg/µL for wild-type experiments) or H2O (16 µL, 
for lysate-only negative control), and either tRNA (16 µL, 1 µg/µL) or H2O (16 µL, for 
mRNA-only negative control) were combined and incubated at 30 °C for 106 minutes.  
Portions of each in vitro translation reaction were purified on Ni2+-columns according to 
the protocol described in Rothman et al.53  The eluted purified protein (30 µL) was 
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diluted with buffer B (70 µL) from Rothman et al.53 to raise the pH and lower the 
concentration of the protein in solution.  This sample was irradiated on the 1000 W 
Hg/Xe arc lamp described above for 10 minutes.  Samples for sodium dodecyl sulfate 
(SDS)-PAGE were prepared by mixing the unpurified in vitro translation mix (5 µL) with 
2× SDS loading buffer (100 mM tris chloride at pH 6.8, 4% SDS, 0.2% bromophenol 
blue, 20% glycerol) (5 µL), the eluates from the column purification (10 µL) with 2× 
SDS loading buffer (10 µL), and the photolysis reactions (10 µL) with 2× SDS loading 
buffer (10 µL).  The samples were then kept at −80 °C until further use. 
Method B: Translation was carried out using wheat germ lysate translation system 
(Promega, Madison, WI) according to the manufacturer’s protocol.  Lysate mix (6.25 
µL), amino acid mix (1 µL), RNAse inhibitor (0.25 µL), 1M KOAc (1 µL), water (2.5 
µL), mRNA (0.5 µL, 1 µg/µL for suppression experiments and 0.3 µg/µL for wild-type 
experiments) or H2O (0.5 µL, for lysate-only negative control), and either tRNA (2 µL, 1 
µg/µL) or H2O (2 µL, for mRNA-only negative control) were combined and incubated at 
30 °C for 4 hours.  Portions of the in vitro translation reactions were subjected to base to 
test for ester hydrolysis following the protocol described in England et al.63  Portions of 
the in vitro reactions were irradiated to test for SNIPP.  For the photolysis, the in vitro 
translation reaction (2.5 µL) was irradiated for 10 minutes on the 1000 W Hg/Xe arc 
lamp described above or for 30 minutes at 4 °C on the 288 W Hg lamp (BLAK-RAY 
Longwave Ultraviolet Lamp, Ultraviolet Products, San Gabriel, CA) equipped with a 360 
nm band-pass filter at a distance of 15-30 cm.  Other photolysis reactions had pH 10.4 
H2O (5 µL) added prior to irradiation.  In certain cases, the reactions were heated to up to 
90 °C after irradiation.  Samples for SDS-PAGE of the hydrolysis reactions were 
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prepared according to protocol.63  Samples for SDS-PAGE of the photolysis reactions 
were prepared by mixing the volume of the reaction (2.5 µL for photolysis reaction with 
base, 7.5 µL for the photolysis reaction with base) with an equivalent volume of 2× SDS 
loading buffer.  The samples were then kept at −80 °C until further use. 
Western blot analysis:  Samples were loaded into prepoured 12% tris chloride gels (Bio-
Rad, Hercules, CA) for SDS-PAGE.  Western blotting was preformed using 
nitrocellulose transfer, a mouse anti-hemagglutinin (HA) primary antibody, and a goat 
anti-mouse secondary antibody conjugated to horseradish-peroxidase.  Protein was 
detected by chemiluminescence. 
 
Nonsense Suppression In Vivo 
Oocytes from Xenopus laevis were isolated and maintained at 18 °C in ND96 solution 
(96 mM sodium chloride, 2 mM potassium chloride, 1.8 mM calcium chloride, 1 mM 
magnesium chloride, 5 mM HEPES, 2.5 mM sodium pyruvate, 0.5 mM theophyline, 10 
µg/mL gentamycin at pH 7.5) according to published procedures.64  Each oocyte was 
microinjected with 50 nL of a 1:1 mixture of mRNA (0.04 ng/nL for ShB and 0.5 ng/nL 
of a 20:1:1:1 α:β:γ:δ for nAChR) and tRNA (1 µg/µL) or unaminoacylated dCA-tRNA (1 
µg/µL).  4PO-protected aminoacylated tRNA was deprotected prior to injection by 
incubating the sample for 15 minutes in saturated I2 (aq).  This saturated I2 solution was 
made by adding an excess of I2 to H2O, then sonicating the mixture for 5 minutes, and 
then heating the mixture to 60 °C for 5 minutes. 
 
324 
Electrophysiology 
Electrophysiological recordings were carried out 24 to 72 hours after injection.  Whole-
cell currents from oocytes were measured using a Geneclamp 500 amplifier (ShB) or an 
OpusXpress (nAChR) and pCLAMP software (Axon Instruments, Foster City, CA) in the 
two-electrode voltage-clamp configuration.  Microelectrodes were filled with 3 M 
potassium chloride and had resistances ranging from 0.5 to 1.5 MΩ.  Oocytes were 
continuously perfused with a nominally calcium-free bath solution consisting of 96 mM 
sodium chloride, 2 mM potassium chloride, 1 mM magnesium chloride, and 5 mM 
HEPES at pH 7.5.  In the ShB experiments, the currents from ShB expressing oocytes 
were measured during depolarizing jumps from the holding potential to +70 mV in 25 
mV increments.  In the nAChR experiments, microscopic ACh-induced currents were 
recorded in response to bath application of ACh at a holding potential of −80 mV. 
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